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Vascular cognitive impairment (VCI) results from a heterogeneous range of 
cerebrovascular injuries, such as stroke, cerebral large and small vessel disease, or 
cerebral amyloid angiopathy, which reduce cerebral blood flow and starve brain cells of 
oxygen and nutrients needed for normal function. Blood flow reductions are central to 
VCI and can range from mild chronic hypoperfusion to severe issues such as focal 
ischemic stroke. Cerebrovascular pathology and blood flow reductions are also a feature 
of Alzheimer’s disease, which has considerable overlap with VCI.  There are few 
therapeutic options to treat VCI, and they are limited by mechanistic insight.  
Synapse loss is considered to be the pathological feature that underpins cognitive 
decline in Alzheimer’s disease and dementia. In Alzheimer’s disease (AD), synaptic 
dysfunction is known to occur early in the disease progression and it is thought to be the 
result of synaptotoxicity caused by oligomeric forms of soluble β-amyloid, a central 
pathogenic feature of AD. Previous studies have found that severe reductions in cerebral 
blood flow (ischaemia) cause immediate synaptic and neuronal degeneration. However, 
there is limited understanding of the longer-term impact of ischaemia on synapses, and 
even less knowledge of whether more modest reductions of blood flow also cause 
alterations in synapses. Gaining a better understanding of those issues is important in 
determining how synaptic changes contribute to the spectrum of VCI, and whether there 
are common changes that may be targeted therapeutically.  
Glutamate is the main excitatory neurotransmitter in the brain. There is evidence that 
glutamatergic neurons and synapses are particularly vulnerable in a number of 
neurodegenerative conditions, including stroke and AD. Dendrites and axons, the 
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neuronal processes that pre- and postsynaptic terminals project from, have also been 
found to be susceptible to degeneration in pathological conditions. The studies in this 
thesis, therefore, investigate the overarching hypothesis that a range of cerebral blood 
flow reductions causes a long-term loss of glutamatergic pre- and postsynaptic terminals 
culminating in VCI, and that the additional comorbidity of β-amyloid pathology will lead 
to worsened synapse loss and functional impairment. 
At the outset, the first aim was to assess the long-term effects of modest cerebral 
hypoperfusion on dendrites and glutamatergic pre- and postsynaptic terminals. Modest 
cerebral blood flow reductions were surgically induced in mice, by bilateral common 
carotid stenosis (BCAS). The densities of dendrites and glutamatergic pre- and 
postsynaptic terminals were measured with histological and immunohistochemical 
approaches in wild-type (WT) mice, 1 and 3 months after BCAS. Spatial working memory 
was assessed using an 8-arm radial arm maze at 3 months, although there was no 
significant difference between sham and BCAS animals. In the BCAS group, there were 
no overall significant alterations in dendrites and glutamatergic pre- and postsynaptic 
terminals compared to sham at either 1 month or 3 months. In the majority of mice (12 
out of 16) there was no evidence of ischaemic neuronal damage at either 1 month or 3 
months. However, in a subset of mice (4 out of 16), global hypoperfusion resulted in 
ischaemic neuronal damage in the CA1 region of the hippocampus (in 3 mice from the 1 
month cohort and 1 mouse from the 3 month cohort). These mice exhibited focal 
dendritic loss in the same regions showing ischaemic neuronal damage, without changes 
in the synapse density. Overall, this study demonstrated that modest chronic cerebral 
hypoperfusion does not induce degeneration of dendrites and glutamatergic pre- and 
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postsynaptic terminals in the CA1, apart from in the few animals with ischaemic 
neuronal pathology in this region, which coincided with a significant loss of dendrites. 
The second study focused on the long-term changes to glutamatergic pre- and 
postsynaptic terminals and axons in a model of focal ischaemia. Previous publications 
have shown that synaptic terminals are vulnerable within hours to days after ischaemic 
stroke, however, little is known about chronic synaptic changes. Focal ischaemia was 
induced with 15 minutes of middle cerebral artery occlusion (MCAO), followed by 3 
months of recovery. This model results in a diffuse ischaemic lesion in the ipsilateral 
striatum. The transgenic line used for this study was generated by crossing TgSwDI mice, 
which produce progressive β-amyloid pathology, with mice expressing enhanced green 
fluorescent protein (eGFP) tagged onto the postsynaptic protein PSD95 (PSD95:eGFP). 
TgSwDI x PSD95:eGFP mice and their WT x PSD95:eGFP littermates, underwent MCAO 
surgery to determine if focal ischaemia resulted in long-term synaptic degeneration and 
whether these changes are exacerbated by concurrent β-amyloid pathology. Histological 
techniques were used to determine the volumes of ischaemic neuronal pathology and 
axonal pathology for each brain. These measurements were compared between WT and 
TgSwDI mice, and showed that there was no genotype effect on total volume of 
ischaemic neuronal pathology or axonal pathology. The densities of glutamatergic pre- 
and postsynaptic terminals were analysed with immunohistochemistry and expression of 
PSD95:eGFP, within the striatal ischaemic lesion and surrounding peri-lesion. There was 
a significant loss of glutamatergic pre- and postsynaptic terminals within the ischaemic 
lesion in both WT and TgSwDI mice, but there were no significant differences between 
these groups. Glial responses are a feature of vascular pathology and may be involved in 
synapse degeneration. In this study the levels of microglia/macrophages and astrocytes 
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were increased in the lesion 3 months after MCAO, with evidence that 
microglia/macrophages levels were inversely correlated with the density of postsynaptic 
terminals. Overall, the results from this study demonstrated that brief focal ischaemia 
leads to long-term neuron and axon damage, loss of glutamatergic pre- and postsynaptic 
terminals, and glial responses within the ischemia lesion, however, the concurrent 
expression of TgSwDIAPP transgene did not exaggerate these changes.  
Finally, the third study investigated the impact of secondary neurodegeneration 
following focal ischaemia, and whether it is exacerbated by β-amyloid pathology. In 
patients with focal ischaemic damage or stroke, pathological changes have been found in 
remote brain regions that are connected to the ischaemic territory. In the current study, 
after 15 minutes of MCAO in mice there was long-term axon degeneration in the 
ipsilateral internal capsule, as well as axon degeneration and postsynaptic loss in the 
ipsilateral substantia nigra pars reticulata (SNR). In addition, microglia/macrophage and 
astrocyte levels were increased in the ipsilateral internal capsule and SNR. Interestingly, 
there was a larger increase in these glial markers in the internal capsule in the TgSwDI 
mice compared to the WT mice, although there were no signs of exaggerated axon 
degeneration in these mice. The results may indicate that white matter tracts are 
sensitive to glial responses and were exacerbated by concurrent TgSwDIAPP expression. 
Additionally, there was a small long-term increase in glutamatergic post-synaptic 
terminals in the ipsilateral thalamus of WT and TgSwDI mice, which may suggest that 
there is some synaptic rewiring in brain regions to compensate for synapse loss in other 
brain regions. The levels of glial cells were increased in the TgSwDI ipsilateral thalamus 
compared to the WT mice, which coincided with areas of β-amyloid immunostaining. 
Taken together, the results of this study indicate that focal ischaemia can stimulate long-
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term secondary synaptic and axon degeneration, as well as small increases in synapse 
terminal density, in brain regions that are connected to the lesion site. There were no 
genotype effects on synaptic and axon degeneration; however, the presence of β-
amyloid did result in an even greater level of glial cells in the ipsilateral internal capsule 
and thalamus of TgSwDI mice after MCAO surgery, which may impact the integrity and 
function of this white matter tract. 
As part of the studies within the thesis, an alternative approach for inducing focal 
ischaemia was developed using Rose Bengal photothrombosis to generate a lesion in the 
cortex. This technique has been used for capturing real-time changes in the brain with 
multiphoton microscopy. Experiments were performed to optimise this method with the 
aim to measure dynamic synaptic changes in the presence of an ischaemic lesion and β-
amyloid with multiphoton microscopy. This study found that Rose Bengal 
photothrombosis caused large ischaemic lesions in the cortex, and in some cases the 
underlying subcortical structures, with variation and a lack of reproducibility between 
cases. Because of the challenges with using photothrombosis and multiphoton 
microscopy, the study design was changed to using MCAO and histological methods to 
measure synaptic changes, as described above.  
Overall, the studies in this thesis further support the hypothesis that the degree and type 
of cerebral blood flow reduction has an impact on the extent of synaptic and neuron 
degeneration. The results showed that modest global cerebral hypoperfusion was 
insufficient to cause reductions in synaptic and dendritic densities, indicating that in this 
model cognitive impairment occurs independently of synaptic loss. Focal ischaemia, 
however, did cause chronic synaptic loss within the lesion and remote brain regions, 
coinciding with glial responses and with evidence that postsynaptic loss in the lesion 
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relates to the density of microglia/macrophages. Interestingly, the concurrent 
TgSwDIAPP expression did not exacerbate synapse and neuron degeneration, whereas it 
did increase the levels of glial cells in the ipsilateral internal capsule and thalamus. The 
data implies that in cases of chronic cerebral hypoperfusion, cognitive decline is not a 
result of glutamatergic synaptic degeneration. In patients with ‘mixed’ ischaemic and 
Alzheimer’s pathology, degeneration of glutamatergic synaptic terminals is driven by 
mechanisms related to cerebral blood flow changes, rather than β-amyloid. However, 
concurrent β-amyloid can result in exaggerated glial responses in brain regions distal 
from the lesion site. 
These studies demonstrate the long-term impact of brief or modest cerebral blood flow 
reductions on synapses and brain function. The results imply the need for adequate 
recognition, prevention and treatment measures which could help patients avoid the 
development of vascular cognitive impairment and dementia. Furthermore, this work 
suggests that while the presence of β-amyloid might contribute in some extent to glial 
responses, it has little impact on synaptic and neuronal damage. Therefore, the 
implications are that therapeutic intervention targeted at processes relating to 
ischaemia, rather than β-amyloid, would be more effective at alleviating synaptic and 
neuronal degeneration in cases of mixed pathology. Moreover, the studies indicated that 
glial changes are persistent features of cerebrovascular injury and can be exaggerated 
with multiple disease comorbidities. Future developments should focus on gaining a 





The human brain requires a constant blood supply, for delivering oxygen and nutrients to 
support the function of the cells. Neurons are a major type of brain cell; they form 
complex networks throughout the brain and communicate between one another 
through protrusions known as synapses. Synapses are essential for brain function, 
enabling our brains to perform tasks such as thinking, memorising and problem solving. 
They require high levels of oxygen and nutrients to function properly; therefore, if the 
brain blood flow is interrupted it may have a negative impact on the synapses. Loss of 
synapses is proposed to underpin the decline in brain function experienced by people 
with dementia causing impairment in their memory and problem solving abilities, as well 
as other brain functions. Reductions in brain blood flow have been shown to be 
associated with the development of dementia, however, it is not clear whether this 
occurs from damage to the synapses.  
A number of different risk factors (such as high blood pressure, high fat diet) can cause 
disease in the brain blood vessels which results in reduced blood flow. These can result 
in a range of different blood flow changes, with some causing an overall decrease in 
blood flow throughout the brain, whilst in other cases the blood flow may be completely 
halted in a small area of the brain, leading to damage in this area. There is evidence 
linking the various types of blood flow reduction to the development of dementia, 
therefore, it is important to understand how a range of blood flow reductions can impact 
on the synapses. The studies in this thesis sought to investigate the long-term effect of 
(1) a modest and sustained reduction in blood flow throughout the brain, and (2) briefly 
halting blood flow in a small part of the brain, has on the synapses. The latter of these 
studies also investigated whether the addition of a protein, called β-amyloid, which is 
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thought to be damaging to synapses, results in worsened changes to the synapses. These 
studies used surgical mouse models to modulate brain blood flow. The first study 
revealed that a reduction in the entire brain blood flow did not result in memory decline 
in the mice, nor did it result in a loss of synapses. In the latter studies, halting blood flow 
in a small part of the brain caused long-term loss of synapses in that brain region and in 
other regions, as the damage spread along the networks of connected neurons. There 
was no difference in the synapses between mice with and without β-amyloid present, 
therefore, we concluded that this did not cause further synapse damage. The results 
imply that in humans if there is a reduction in brain blood flow and a build-up of β-
amyloid protein simultaneously, it is the changes in blood flow that drives the 
mechanisms causing damage to the synapses, and dysfunction to the brain. 
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Chapter 1: Introduction 
1.1 Overview 
Synapses are neurochemically complex structures that facilitate the transfer of 
information between neurons within networks, and are totally essential for brain 
function. There are different types of synapses, which are normally categorised by the 
type of neurotransmitter they release (O’Rourke et al. 2013). Glutamate is the main 
excitatory neurotransmitter in the brain. In healthy conditions, glutamate is released 
from excited presynaptic neurons into the synaptic cleft, binding to receptors on the 
postsynaptic terminals, and stimulating depolarisation in the next neurons. Energy-
dependent ion pumps and uptake of excess glutamate by nearby astrocytes is needed to 
reset the system (Mahmoud et al. 2019; Attwell & Laughlin 2001). The function of 
synapses and neurons is extremely metabolically demanding (Attwell & Laughlin 2001), 
so the brain requires a continuous blood supply to provide the cells with glucose and 
oxygen. This means that reductions in cerebral blood flow (CBF) and depletion of oxygen 
and glucose levels may cause dysfunction and degeneration of synaptic terminals. 
Ischaemia occurs when cerebral blood flow is reduced by 70% of its baseline (Heiss & 
Rosner 1983). The sudden lack of oxygen and glucose initiates the ischaemic cascade, 
causing impairment in ion balance and extracellular glutamate overload, leading to 
excitotoxicity, and synaptic and neurodegeneration (Dirnagl et al. 1999; Lai et al. 2014). 
While severe ischemia is well-understood, it is unclear whether more modest reductions 
in cerebral blood flow can also cause mechanisms leading to glutamatergic synaptic loss.  
Synaptic degeneration is considered to underpin cognitive impairment and dementia, a 
condition extremely prevalent in our ageing population, affecting 40-50 million people 
28 
worldwide – a number which is expected to rise to 115 million people by 2050 
(Wortmann 2012; Nichols et al. 2019). Although widely studied, the mechanisms which 
drive synaptic degeneration are still not fully understood. Robert Terry and colleagues 
were among the first to demonstrate that synapse loss occurs in Alzheimer’s disease and 
correlates with cognitive decline (Terry et al. 1991). Less attention has been given to 
synaptic degeneration in vascular dementia, with a limited number of papers showing a 
decrease in synaptic protein levels (Sinclair et al. 2015; Kirvell et al. 2010). But as 
Alzheimer’s disease and vascular dementia are overlapping conditions, with the most 
common forms of dementia having mixed pathology associated with both diseases 
(Hachinski & Bowler 1993; Gorelick et al. 2011), degeneration of synapses and neurons 
may occur through pathways related to both Alzheimer’s and vascular pathology.  
Reductions in cerebral blood flow (CBF) are prevalent features of Alzheimer’s disease 
and vascular dementia. Modest, sustained CBF reduction or ‘hypoperfusion’ is a 
predictor for the development of cognitive decline and dementia (Alsop et al. 2010; Chao 
et al. 2010; Ruitenberg et al. 2005; Huang et al. 2002). Additionally, rapid and severe CBF 
decreases in the form of a stroke or transient ischaemic attack increases the risk of 
future dementia (Kalaria et al. 2016). There are a limited number of preclinical studies 
investigating the impact of CBF changes on synaptic density, and most of them have 
used models of severe global ischaemia or only analysed short-term changes after focal 
ischaemia. This has left gaps in the literature regarding long-term consequences of either 
chronic cerebral hypoperfusion or focal ischaemia on synapses. Furthermore, it has been 
predicted that dementia is the consequence of a number of disease comorbidities. The 
Nun Study showed that patients with Alzheimer’s and vascular pathology had worsened 
cognitive outcomes than patients with just vascular pathology (Snowdon et al. 1997), 
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however, there have been very few preclinical studies published that were focused on 
uncovering these mechanisms.  
A pathological hallmark of Alzheimer’s disease is the deposition of plaques in the 
parenchyma and cerebral vasculature. The main component of these plaques is β-
amyloid. There is a large body of evidence from rodent studies indicating that β-amyloid 
can cause toxicity for synapses and neurons, particularly in its soluble oligomeric form 
(Selkoe 2002; Walsh et al. 2002). Clinical trials targeting β-amyloid, however, have not 
been successful (Mehta et al. 2017), which may suggest that other disease factors are 
key contributors for synapse degeneration.  
The studies presented in this thesis were conducted to address these gaps in our 
knowledge. They were designed to investigate the long-term impact of chronic cerebral 
hypoperfusion and focal ischaemia on synapses, and to establish whether concurrent β-
amyloid pathology further exaggerates synapse degeneration. 
1.2 Cerebrovascular architecture and blood flow regulation 
The brain has low endogenous energy reserves, yet it has high metabolic activity. To 
support its function a continuous blood supply, at a rate of ~50ml/100g/min, is required 
to provide the brain with oxygen and nutrients, and for the removal of toxic waste 
(Cipolla 2009). The volume of blood which passes through the brain is disproportionately 
high for its mass; as 20% of cardiac output is received by the brain, although its mass  
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constitutes only 2% of the total body mass. Furthermore, the brain uses ~20% and ~25% 
of the body’s oxygen and glucose intake, respectively (Zlokovic 2008).  
Oxygenated blood is supplied to the brain via the left and right common carotid arteries, 
which arise from the aortic arch. The common carotid arteries (CCA) branch into the 
internal (ICA) and external carotid arteries (ECA), which supply the brain and scalp 
respectively. The internal carotid arteries meet with the basilar artery (BA) (which 
Figure 1.1 Schematic of cerebrovascular architecture and the neurovascular unit. (A) 
Blood is supplied to the brain via arteries connected at the circle of Willis. The arteries 
divide into small arteries and arterioles that penetrate into the brain. (B) Cerebral 
blood flow is regulated by a ‘unit’ of cells, the Neurovascular Unit. Figure based on 
figures from Jessen et al. 2015; Wardlaw et al. 2019 . 
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supplies the back of the brain) to form an anastomotic ring at the base of the brain, 
known as the circle of Willis. This structure gives rise to three sets of cerebral arteries, 
anterior (ACA), middle (MCA), and posterior (PCA), which track along the surface of the 
brain (see Figure 1.1A). The cerebral vasculature in the grey matter is organised in a 
hierarchical manner, as the vessels on the surface are large, and branch into smaller 
arteries and arterioles, which penetrate into the brain (Cipolla 2016). The penetrating 
arteries divide into the parenchymal arterioles, which then supply the capillary beds, 
deep within the brain. The grey matter capillary beds are densely organised to support 
the high metabolic demand, whilst the density of the white matter capillaries is 10% of 
the grey matter (Klein et al. 1986).  
1.2.1 The Neurovascular Unit 
Cerebrovascular function is closely linked to neuronal activity through the neurovascular 
unit (NVU), which is a ‘unit’ of cells composed of neurons, endothelial cells, mural cells 
(pericytes and vascular smooth muscle cells (VSMCs)) and glial cells (astrocytes and 
microglia) (see Figure 1.1B) (Iadecola 2004). Bi-directional communication between 
these cells enables for the diameters of blood vessels to be mediated, as a response to 
neuronal activity or changes in the blood pressure (autoregulation). Endothelial cells line 
the lumen of blood vessels and are packed together connected by tight junction 
proteins, forming part of the blood brain barrier (BBB) and restricting the movement of 
cells and molecules into the brain (Anderson & Van Itallie 2009). Mural cells cover the 
abluminal side of the endothelium; for arteries and arterioles these cells are vascular 
smooth muscle cells (VSMCs), whilst they are pericytes at the capillary level (Hill et al. 
2015; Haseloff et al. 2015). Structural integrity is provided to the endothelium by an 
abluminal basement membrane and functions as part of the blood brain barrier (Zlokovic 
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2008). Astrocytes form extensive connections with the endothelium through their 
specialised ‘endfeet’ processes. They also interact with neurons at nodes of Ranvier, and 
synapses in the ‘tripartite synapse’ (Araque et al. 1999), which have vital roles in synapse 
dynamics, modulating transmission, stability and plasticity (Liu et al. 2018). This physical 
interaction between the blood vessels and neurons through astrocytes is a key 
component for the NVU and regulating blood flow according to neuronal activity 
(Iadecola & Nedergaard 2007). Moreover, it is estimated that almost every neuron is 
linked to its own capillary (Zlokovic 2005). Inflammatory cells can also play a part in the 
NVU, as the release of cytokines and chemokines by resident microglia can modify the 
expression of tight junction proteins in the endothelium and allow the BBB to become 
permeable to other immune cells (Hudson et al. 2005).  
1.2.2 Blood Brain Barrier 
The BBB is the barrier formed by tight junctions in the endothelial cell layer, to restrict 
the movement of molecules and cells into the brain (Anderson & Van Itallie 2009). The 
endothelium is specialised to prevent easy movement between the cells and through the 
cells. An important role of the BBB is to protect the brain from peripheral infection and 
the movement of peripheral inflammatory cells from the blood stream.  
1.2.3 Neurovascular coupling 
Neuronal activity influences CBF through neurovascular coupling. Action potentials are 
generated through depolarisation of the neurons, whereby sodium ions diffuse into the 
cells through voltage-gated channels, then ATP-dependent ion channel transporters are 
required to restore the resting potential of the neuron, before another action potential 
can be generated. Continuous blood flow is required to supply oxygen and glucose for 
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ATP production to maintain the ion balance in neurons. If CBF is greatly reduced and ATP 
production is limited, neurons cannot restore their ion balance and return to their 
resting membrane potential, which can lead to hyperexcitability and excitotoxic cell 
death (Section 1.4.1.1) (Dirnagl et al. 1999). Under physiological conditions, neuronal 
activity can mediate CBF by the release of vasoactive neurotransmitters, such as 
serotonin, acetylcholine and norepinephrine, which bind to receptors on the 
endothelium and VSMCs of arteries and arterioles (Hamel 2006). These signals stimulate 
VSMCs to adjust vascular tone by vasodilation or vasoconstriction. Another approach by 
which neuronal activity is communicated to the vasculature is through the connections 
with astrocytes. Neuronal activity stimulates an increase in calcium ions in astrocytes, 
either through direct contact with astrocytic processes or induced by neurotransmitter 
release, which in turn induces the release of vasoactive molecules that modulate 
vascular tone (Bazargani & Attwell 2016).  
1.2.4 Autoregulation of Cerebral Blood Flow 
Constant CBF is critical to support brain function, therefore, the rate of CBF is 
autoregulated by adjusting the vascular tone of large surface arteries and arterioles, to 
counter any fluctuations in blood pressure (Fog 1938; Cipolla 2009). The mechanisms for 
autoregulation are unclear, however, it may be stimulated by the release of vasoactive 
substances during states of reduced CBF, such a H+, K+, O2 and adenosine (Cipolla 2009). 
As previously mentioned, healthy CBF is maintained at ~50mL per 100g of brain tissue 
per minute, if the cerebral perfusion pressure is within a range of ~60 to 160 mmHg. 
Autoregulation cannot be maintained if the pressure is above or below this range; when 
it is decreased below this limit the result is cerebral ischaemia (Cipolla 2009; Phillips & 
Whisnant 1992). Maintaining a healthy CBF is essential for supporting brain function, as 
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persistent reductions in CBF are associated with the development of cerebrovascular 
disease (CVD) and vascular cognitive impairment (VCI).  
1.3 Vascular cognitive impairment  
Vascular cognitive impairment (VCI) is a broad term describing any degree of cognitive 
decline, from mild cognitive impairment to dementia, that develops following any form 
of cerebrovascular disease (CVD) (Dichgans & Leys 2017). Dementia refers to a collection 
of conditions characterised by severe decline in memory and executive functions, with 
the most common forms being Alzheimer’s disease and vascular dementia (Gorelick et 
al. 2011). Historically, these diseases were viewed as distinct from each other, however, 
it is now accepted that these conditions overlap significantly, and in fact the most 
common form of dementia is ‘mixed dementia’; which combines both vascular and 
Alzheimer related pathology (Hachinski & Bowler 1993; Gorelick et al. 2011). 
CVD is caused by a combination of vascular risk factors, such as age, stroke, 
hypertension, diabetes mellitus, atrial fibrillation and atherosclerosis (Abraham et al. 
2016; Hofman et al. 1997; Knopman et al. 2001). These risk factors are associated with 
the development of a wide range of vascular pathologies, including reduced CBF, 
impaired vasodilation, vessel stiffening, dysfunctional interstitial fluid drainage, BBB 
dysfunction, large and small vessel disease, white matter rarefaction, myelin damage, 
ischaemic injury, secondary neurodegeneration and neuroinflammation (Wardlaw et al. 
2019). Vascular dysfunction is thought to contribute to 50% of all dementia (Wardlaw et 
al. 2019). It has been hypothesised that changes leading to VCI and dementia begin to 
occur during mid-life, and over years and decades there is an accumulation of vascular 
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risk factors and subclinical brain lesion, culminating in symptomatic impairment 
(Knopman et al. 2001).  
Reduced CBF is associated with cognitive decline. These reductions in perfusion can vary 
in degree: chronic cerebral hypoperfusion describes a sustained reduction in CBF, whilst 
cerebral ischaemia occurs when CBF is reduced by 70% of the baseline (Heiss & Rosner 
1983). Different severities of CBF reductions may induce varying downstream 
mechanisms, culminating in VCI and dementia. 
1.3.1 Chronic cerebral hypoperfusion and dementia  
Cerebral hypoperfusion can result from large or small vessel diseases, cardiac arrest, 
severe cardiac failure, arrhythmias and severe hypotension (Stefansdottir et al. 2013; Qiu 
et al. 2006; Alosco et al. 2013; Justin et al. 2013; Dichgans & Leys 2017). The main causes of 
cerebral vessel disease are processes related to ageing and hypertension, as well as 
aggregation of β-amyloid in the vessel walls in cerebral amyloid angiopathy (CAA) (Pantoni 
2010). These conditions are associated with the development of cognitive decline, 
therefore, it has been proposed that cerebral hypoperfusion also is associated with 
cognitive decline. Evidence to support this has been presented by neuroimaging studies 
indicating that reduced cerebral perfusion is a predictor for the progression from normal 
cognition to cognitive impairment (Ruitenberg et al. 2005), and the conversion of mild 
cognitive impairment (MCI) to dementia; with the degree of CBF reduction correlating with 
the severity of dementia (Alsop et al. 2010; Chao et al. 2010; Huang et al. 2002).  
White matter changes are pathological hallmarks of cerebrovascular disease, which are 
observed in neuroimaging studies of patients as white matter hyperintensities (WMH) 
using T2-weighted magnetic resonance imaging (MRI). There is evidence that low CBF 
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relates to the severity of WMH burden, leading to the hypothesis that cerebral 
hypoperfusion leads to the development of WMH, culminating in cognitive impairment 
(Duncombe et al. 2017). Evidence published by our group and others have supported this 
theory, as they found that surgically inducing cerebral hypoperfusion in rats and mice 
results in white matter pathology and cognitive impairment (Kitamura et al. 2017; Manso 
et al. 2018; Coltman et al. 2011; Farkas et al. 2007).  
An alternative theory is that reduced CBF, as measured in patient neuroimaging studies, 
may result from a loss of viable tissue from cerebrovascular pathology, rather than being 
the causative factor of cerebrovascular pathology and VCI (Wardlaw et al. 2019). This is 
supported by evidence indicating that the baseline burden of WMHs in patients is a 
predictor for reductions in CBF, but not the vice versa (Wardlaw et al. 2019; Shi et al. 
2016). It has been proposed that analysis of resting CBF is not a reliable measurement for 
lesion-related vascular changes, as CBF fluctuates considerably from minute to minute, and 
varies between brain regions (Promjunyakul et al. 2018; Wardlaw et al. 2019). Moreover, 
resting CBF is not necessarily an indicator of the amount of oxygen extracted and used by 
the tissue, as oxygen extraction is less efficient with high capillary flow velocities 
(Østergaard et al. 2016). It has been proposed a better indicator of cerebrovascular 
pathology is to measure changes in neurovascular coupling; the ability of arterioles and 
capillaries to dilate with increased neuronal activity (Thrippleton et al. 2018; Wardlaw et al. 
2019). This is consistent with a study of patients with the genetic form of SVD called 
CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and 
Leukoencephalopathy); which found no difference in resting CBF compared with controls, 
but did find them to have impaired neurovascular coupling (Huneau et al. 2018). A decline 
in neurovascular coupling was reported in a previous study by our group, demonstrating 
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that while resting CBF was unchanged between young and aged mice, aged mice had 
reduced vascular reactivity to neuronal stimulation (Duncombe et al. 2017). Impaired 
cerebrovascular reactivity has been associated with aging and higher WMH burden (Sam et 
al. 2016; Blair et al. 2016). Furthermore, increased systolic blood pressure, pulse pressure 
and intracranial vascular pulsatility have been linked to reduced cerebrovascular reactivity, 
whereas there is a lack of association with reduced resting CBF (Shi et al. 2020; Wardlaw et 
al. 2019; Blair et al. 2019). Taken together, these studies indicate that it is still uncertain 
whether cerebral hypoperfusion is a causative factor in VCI or a result of reduced demand 
for a high blood supply to damaged tissue.  
1.3.2 Stroke, focal ischaemia and dementia 
Stroke is a sudden cerebral attack that cuts off blood supply in a focal part of the brain, 
which can manifest through ischaemia or a haemorrhage. Ischaemic stroke is the 
common type, accounting for about 80% of strokes (Kalaria et al. 2016). They are usually 
caused by vessel occlusion from an embolism or thrombosis, halting blood supply with 
nutrients and oxygen to the parenchyma. In Time Is Brain-Quantified, Saver estimates 
that every minute of an untreated ischaemic stroke leads to on average a loss of 1.9 
billion neurons, 14 million synapses and 12km of myelinated fibres (Saver 2006). Rapid 
treatment with intravenous recombinant tissue-type plasminogen activator (r-tPA) is 
used to break down the clot and restore blood flow. This treatment will be effective only 
within a small window of about 4.5 hours (Powers et al. 2015). Improved treatment has 
increased the survival rate, however, even with the best treatments patients can still 
experience long-term motor and cognitive disabilities. Around 30% of stroke survivors 
38 
will experience some cognitive decline within 3 years of the attack, and stroke more than 
doubles the risk of developing dementia (Kalaria etal. 2016).  
1.4 Neuropathology of VCI 
Cerebrovascular pathology is extremely heterogeneous in VCI given that cerebral blood 
flow can be reduced by varying degrees of severity; globally or focally; transient or 
permanent; and occurs in different brain regions. This wide range of different types of 
vascular pathology associated with VCI, is shown in Figure 1.2 (Dichgans & Leys 2017). It 
Figure 1.2 Neuropathology of VCI. Vascular causes and cerebrovascular injuries: 
hypoperfusion, artery occlusion, CAA, infarct, microinfarcts, microbleeds, haemorrhage, 
white matter lesion, and secondary degeneration. Figure based on a figure from Dichgans & 
Leys 2017. 
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is important, therefore, to gain insight into the long-term degenerative processes 
following global and focal cerebral blood flow changes, and of varying severities. 
 
1.4.1 Ischaemic Damage 
Ischaemic neuron damage occurs when blood flow is reduced to 30% of the normal level 
(Heiss & Rosner 1983). The drop in blood flow diminishes the supply of oxygen and 
nutrients to the cells, setting in motion processes that result in ischaemic damage, 
known as the ischaemic cascade. 
1.4.1.1 The Ischaemic Cascade 
Ischemic stroke or global ischaemia causes an immediate lack of blood and supply of 
oxygen and glucose resulting in an energy imbalance. Neurons and glia become unable 
to maintain their ionic gradients, which are ATP dependent, causing a build up of 
intracellular Na+ ions and for the cells to depolarise. Presynaptic Ca2+ concentrations 
increase with the activation of voltage-gated Ca2+ channels (VGCCs) and reverse Na+/Ca2+ 
exchange, leading to the release excitatory neurotransmitters into the synaptic cleft and 
extracellular space. Glutamate is the main excitatory neurotransmitter for the brain. 
Furthermore, energy-dependent reuptake of glutamate and other neurotransmitters by 
synaptic vesicle recycling and by astrocytes is impaired, which leads to extracellular 
glutamate overload. This in turn activates postsynaptic and extrasynaptic AMPA- and 
NMDA-receptors, resulting in spreading depolarisation to neighbouring neurons. 
Excessive influx of Na+ ions into the postsynaptic terminal unblocks Mg2+ from NMDARs, 
leading to large cation influxes. For both the pre- and postsynaptic neurons, the lack of 
ATP impairs their ability to restore the ion balance, causing an osmotic gradient and  
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Figure 1.3 The Ischaemic Cascade. Adapted from (Mayor & Tymianski 2017). 
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water flows into the cells, leading to oedema. Brain oedema is one of the earliest 
markers for focal ischaemic damage, which can be studied with MRI and computed 
tomography neuroimaging (Dirnagl et al. 1999; Lai et al. 2014; Mayor & Tymianski 2017) 
(Figure 1.3). 
Activation of glutamate receptors leads to an overload of intracellular Ca2+ ions, which 
initiates downstream mechanisms that can cause delayed cell damage to the cells in the 
peri-lesion, the area around the ischaemic core. This includes the activation of 
proteolytic enzymes, such as calpains, that degrade the neuronal and synaptic proteins 
causing them to become dysfunctional and lose structural integrity (Lai et al. 2014). 
Furthermore, calcium-dependent activation of phospholipase A2 and cyclooxygenase 
leads to the cells becoming overwhelmed with the generation reactive oxygen species 
(ROS), which damage lipids, proteins and DNA, as well as stimulating neuroinflammation 
and apoptosis (Dirnagl et al. 1999). Calcium-dependent neuronal nitric oxide synthase 
Figure 1.4 Damaging events in focal cerebral ischaemia at acute and sub-acute 
timeframe. Ischaemia results in early excitotoxicity within minutes, followed by peri-
lesion depolarisation. Neuron damage stimulates inflammation and apoptosis over the 
following hours and days. Adapted from (Dirnagl et al. 1999). 
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(nNOS) is activated by Ca2+ influx particularly in postsynaptic terminals, due to this 
enzyme being tethered to NMDA-receptors by scaffold protein PSD95, producing 
peroxynitrite which is highly reactive and damaging (Lai et al. 2014). Injury to neuronal 
mitochondrial further impairs the production of ATP and causes greater energy 
deprivation; whilst perforations in the membrane causes cytochrome C release and 
stimulates apoptosis. 
Focal ischaemia leads to rapid lesion formation due to this bioenergetics failure, 
surrounded by a region of tissue of constrained blood flow with partially preserved 
metabolism, known as the peri-lesion or penumbra. In the absence of treatment or 
reperfusion, this surrounding area may also become part of the lesion, through delayed 
spreading depolarisation and apoptotic cell death (Dirnagl et al. 1999). There is evidence 
that focal ischaemic damage can also lead to delayed secondary neurodegeneration, in 
brain regions that connect with the injured region (Zhang et al. 2012) (see Figure 1.4). 
Injured neurons release factors known as damage-associated molecular patterns 
(DAMPs), which elicit local inflammation (Liesz et al. 2015). Resident microglia and 
astrocytes become activated, and the release of chemokines and cytokines promotes 
infiltration of circulating neutrophils and macrophages into the parenchyma (see Figure 
1.4). There is evidence that neuroinflammatory cells can be elevated in ischaemic lesions 
for months after the injury has occurred (Mena et al. 2004), however, it is unclear 
whether this is protective or detrimental to the brain tissue (see Section 1.4.4).  
1.4.1.2 Ischaemic pathology and infarction 
Ischaemic lesions can vary hugely in location, size and severity of tissue damage, ranging 
from areas of diffuse selective neuronal loss with intact extracellular matrix, to large 
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infarcts with pannecrosis – necrosis of all cell types within the NVU (Baron et al. 2014). 
The resulting lesion will depend on the location and type of vessel occlusion and whether 
there is reperfusion. This may also depend on the presence of other disease 
comorbidities, such as β-amyloid. Large infarcts (strokes) or multiple small subcortical 
infarcts or ischaemic lesions are linked to cognitive decline and high risk of dementia 
(Hachinski et al. 1974; Schneider et al. 2003). Infarcts can have a severe impact on 
cognition if they are present in strategic brain regions, such as the basal ganglia, caudate 
nucleus and globus pallidus, thalamus and angular gyrus (Jellinger 2008; Szirmai et al. 
2002). The CA1 region of the hippocampus is particularly vulnerable to global ischaemia, 
and its damage is thought to contribute to spatial working memory deficits (Tsien et al. 
1996; Stackman et al. 2016). Sudden reperfusion to an ischaemic area can cause 
‘reperfusion injury’, associated with the generation of reactive oxygen species (ROS) 
initiating cell death sequences, and causing more tissue injury (Wu et al. 2018). 
Furthermore, focal ischaemic injury can spread through spreading depolarisation and 
secondary neurodegeneration, resulting in progressive neurodegeneration of more 
extensive tissue damage than the primary lesion site (Hartings et al. 2003; Zhang et al. 
2012).  
1.4.2 White Matter Pathology 
White matter is particularly vulnerable to blood flow disruption, as its collateral supply is 
limited. Cerebral white matter tracts are composed of myelinated and unmyelinated 
axons, oligodendrocytes which ensheath the myelinated axons, astrocytes and microglia, 
and blood vessels. As the white matter tracts enable neuronal circuits and different brain 
regions to communicate, white matter injury can have detrimental effects on brain 
function. White matter pathology is present to different degrees in normal aging, stroke, 
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vascular dementia and Alzheimer’s disease (de Leeuw et al. 2006; Brun & Englund 1986). 
The presence of white matter infarcts increases the risk of mortality (Conijin et al 2011). 
In dementia patients, the extent of white matter damage is related to a decline in 
cognitive processing speed (Mungas et al. 2001) and impairment in executive function 
(Cohen et al. 2002). Loss of white matter integrity is thought to be an early stage of 
pathological progression to dementia, as it has been seen in patients with mild cognitive 
impairment. There is a relationship between the global volume of white matter lesions 
and cognitive impairment in these patients (Garde et al. 2000). Disruption in white 
matter tracts is also a feature of Alzheimer’s disease, and is associated with 
neurofibrillary tangles, one of the classical pathological hallmarks of the disease 
(Kantarci et al. 2017).  
White matter pathology is predicted to have a vascular origin. It is present in 64-86% of 
all stroke patients (Fu et al 2005; Li et al 2013). Low cerebral blood flow in the intact 
white matter of stroke/transient ischaemic attack patients predicts the appearance of 
white matter hyperintensities on follow-up MR imaging (Bernbaum et al. 2015). Previous 
findings from our lab have demonstrated that surgically induced modest cerebral 
hypoperfusion in mice is sufficient to cause long term white matter disruption, 
predominantly in the corpus callosum, internal capsule and optic tract (Coltman et al. 
2011; Holland et al. 2011; Kitamura et al. 2017). The extent of white matter pathology 
has an impact on the functional outcome, as the decrease of white matter integrity in 
the corpus callosum correlates with impaired spatial working memory, and reduced 
action potential conduction across this structure (Kitamura et al. 2017).  
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1.4.3 Alzheimer’s pathology  
Alzheimer’s disease (AD) and vascular dementia (VaD) are overlapping conditions, with 
the majority of dementia cases have mixed Alzheimer’s and vascular pathology 
(Hachinski & Bowler 1993; Gorelick et al. 2011). There is a growing body of evidence 
indicating that these different pathologies interact and may exacerbate each other. 
Furthermore, there is evidence that the presence of both Alzheimer’s and vascular 
pathology may worsen the cognitive outcome, compared to dementia patients with just 
vascular pathology (Snowdon et al. 1997).  
Histologically, Alzheimer’s pathology was classified by the presence of extracellular 
amyloid plaques (also known as senile plaques) that are predominantly composed of β-
amyloid protein, and intracellular neurofibrillary tangles containing 
hyperphosphorylated tau. β-amyloid proteins can exist in different forms, with the 
molecules aggregated together in insoluble deposits, as well as being present in soluble 
monomers and oligomers. Soluble oligomeric β-amyloid has been shown to induce a 
reduction in synaptic activity and is considered to be the main driver for synaptic loss in 
AD (Section 1.7.1-2). In addition, β-amyloid has many negative implications for the 
vasculature. It is a potent vasoconstrictor and has been shown to reduce 
neurotransmitter-mediated vasodilation (Thomas et al. 1996). This may contribute to the 
cerebral hypoperfusion in the early stages of AD (Huang et al. 2002). Furthermore, 
administration of Aβ40, the main β-amyloid species in the vasculature, to mouse brains 
lead to a reduction of their CBF (Niwa et al. 2001). β-amyloid proteins can become 
aggregated within the basement membrane of vessels, particularly in the 
leptomeningeal arteries and cortical arterioles, known as cerebral amyloid angiopathy 
(CAA) (Pimentel-coelho et al. 2013; Love & Miners 2016). This can be very damaging to 
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blood vessels, as it is associated with the development of small vessel disease, white 
matter injury and arteriolosclerosis (Thal et al. 2003; Gurol et al. 2006; Charidimou et al. 
2016). β-amyloid deposition in the vasculature can cause the vessels to become rigid and 
loose vascular tone (Kimbrough et al. 2015). Moreover, β-amyloid and 
neuroinflammation induced by it, can exert degenerating effects on smooth muscle cells 
and pericytes (Brown & Thore 2011; Reijmer et al. 2016; Sengillo et al. 2013). This can 
lead to BBB break down, resulting in microbleeds or haemorrhages, and promoting 
further immune responses (Dierksen et al. 2010; Gurol et al. 2012).  
The increased burden in β-amyloid may result from impairment in its clearance 
pathways, which normally prevents it from aggregating. In normal conditions, β-amyloid 
and other waste substances are cleared from the brain through the two main drainage 
pathways: perivascular drainage of interstitial fluid (ISF), and glymphatic drainage 
through cerebrospinal fluid (CSF) (Hawkes et al. 2014; Iliff et al. 2012). In perivascular 
drainage, waste solutes move with ISF bulk-flow through the basement membrane of 
capillaries and drain along the arterioles and arteries, towards the leptomeningeal 
arteries at the brain’s surface and eventually reaching the cervical lymph nodes at the 
exterior of the skull. Alternatively, in glymphatic drainage CSF is pumped from the 
Virchow-Robin spaces (see Figure 1.1) into para-arterial spaces around penetrating 
arteries, then into the parenchyma where CSF/ISF solute exchange occurs, and exits 
through para-venous spaces into subarachnoid compartments. The CSF-ISF fluid 
dynamics through the parenchyma rely of the aquaporin water channels expressed at 
the astrocytic endfeet that ensheath the vasculature in the NVU (Sun et al. 2018). 
Arterial pulsation is thought to be a main driver for both types of drainage. There is 
evidence that aggregation of β-amyloid in the vasculature can obstruct drainage 
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pathways, which would in turn prevent the clearance of β-amyloid through these 
pathways, and result in further accumulation leading to CAA (Hawkes et al. 2011; 
Hawkes et al. 2014). Drainage pathways can become impaired after ischaemic and 
haemorrhagic stroke. A study of different focal ischaemia in mouse models showed that 
glymphatic drainage was impaired during ischaemia, but was restored with spontaneous 
arterial recanalization (Gaberel et al. 2014). If ischaemic or haemorrhagic damage 
impairs cerebral drainage, this may at least partially account for β-amyloid burden in 
patients with VCI.  
Another mechanism by which β-amyloid is removed from the brain is by transportation 
across the BBB via low density lipoprotein receptor-related protein (LRP1), expressed by 
endothelial cells and astrocytes (Liu et al. 2017; Storck & Pietrzik 2017). There is 
evidence from a mouse model that reduced CBF results in decreased protein levels of 
LRP1 whilst protein levels of Aβ1-42 and Aβ1-40 were increased (Ashok et al. 2016). This 
indicates that cerebrovascular injuries leading to reduced perfusion may impair β-
amyloid clearance through the BBB into the bloodstream, and contribute to an increase 
in β-amyloid burden in the brain. Alternatively, the production of β-amyloid may be 
enhanced by cerebrovascular injuries. BACE1 is one of the enzymes that process amyloid 
precursor protein (APP) into β-amyloid and its expression has been shown to be 
increased with hypoxia (Salminen et al. 2017). The exposure to hypoxia following CBF 
reduction, therefore, can stimulate the expression of BACE1 and enhance β-amyloid 
production. Taken together, the evidence indicates that β-amyloid can exacerbate 
vascular pathology, whilst vascular pathology can stimulate more β-amyloid production 
and decrease its clearance. 
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1.4.4 Neuroinflammation 
Neuroinflammation is the brain’s immune response to pathological changes, such as 
cellular injury, build-up of debris and invading pathogens. As with all neurological and 
neurodegenerative conditions, it is clear that neuroinflammation plays key roles in CVD 
and Alzheimer’s diseases, and may have both detrimental and protective roles. Glial 
cells, microglia and astrocytes, are the resident cells that can detect even subtle changes 
in the brain environment, and can propagate an immune response depending on the 
stimulation (Sims & Yew 2017; Salter & Stevens 2017; Liddelow & Barres 2017; 
Hammond et al. 2019). Noxious stimuli in the brain activate microglia and astrocytes, 
causing morphological and phenotypic changes, and proliferate. Microglia are 
transformed from ramified cells with small somas and long processes, to an ‘amoeboid’ 
morphology (Schilling et al. 2003). Astrocytes also undergo a similar morphology change, 
as their somas become bigger and the processes become shorter and thicker. Activation 
of astrocytes includes an upregulation of intermediate filament proteins, such as glial 
fibrillary acidic protein (GFAP), which is often used as a marker for immunohistochemical 
detection of reactive astrocytes (Eng et al. 1971). As previously mentioned, activated 
microglia and astrocytes can have both detrimental and beneficial roles in brain injuries. 
This has lead to the classification of their activation states being shoe-horned into either 
pro-inflammatory (M1 and A1) or anti-inflammatory (M2 and A2). However, there is now 
a greater understanding of different transcriptomic, proteomic and epigenomic 
characteristics of activated microglia and astrocytes, revealing that their activation states 
are much more complex and context-dependent (Sims & Yew 2017; Salter & Stevens 
2017; Liddelow & Barres 2017; Hammond et al. 2019).  
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Stroke and focal ischaemic lesions trigger a robust neuroinflammatory response, as 
damaged neurons release DAMPs (Liesz et al. 2015). Resident microglia are the first to 
respond, increasing their cell numbers within hours of injury and maintaining high levels 
over the following days, as found in rodent models (Wattananit et al. 2016; Zarruk et al. 
2017; Yoon et al. 2018; Rajan et al. 2018). Astrocytes are also activated in the acute 
phase, potentially by pro-inflammatory signals released from activated microglia 
(Liddelow et al. 2017). They further contribute to the pro-inflammatory environment by 
releasing cytokines, which recruit peripheral immune response to the lesion site (Li et al. 
2017). Focal ischaemia causes endothelial activation, upregulation of adhesion 
molecules and infliltration of myeloid cells and lymphocytes (Gauberti et al. 2013; 
Neumann et al. 2015; De Meyer et al. 2016; Shi et al. 2019). Release of pro-inflammatory 
signals, including cytokines, chemokines, ROS and matrix metallopeptidases (MMPs), 
contributes to neurotoxic cell death and compromises BBB function, as well as further 
promoting immune responses by the infiltration of leukocytes (Giraud et al. 2015; 
Neumann et al. 2015).  
Microglia and astrocytes have protective and restorative roles following focal ischaemia, 
through the release of anti-inflammatory cytokines, such as IL-10 and TGF-β, and 
neuroprotective factors, glial cell line-derived neurotrophic factor (GDNF) and brain-
derived neurotrophic factor (BDNF) (Sandvig et al. 2018; Gordon 2003; Neumann et al. 
2006; Liu & Chopp 2016a). There is evidence that depletion of microglia with colony-
stimulating factor-1 receptor (CFS1R) inhibitor in a mouse model of transient focal 
ischaemia, results in a larger lesion and exacerbated the levels of pro-inflammatory 
cytokines and lymphocyte levels at 1 and 3 days after surgery, indicating that microglia 
do provide some neuroprotection and anti-inflammatory functions (Jin et al. 2017). 
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Recently, the use of single-cell RNA sequencing has enabled better characterisation of 
the activation states of microglia and astrocytes in brain injures. Rajan et al. found that 
microglia are the predominant immune cell at day 3 after focal ischaemia and express 
pro-inflammatory signals, such as the gene for TNFα (Rajan et al. 2019). Interestingly, 
their study revealed that macrophage levels increased at day 3 and expressed genes for 
anti-inflammatory and wound healing signals. They proposed, therefore, that microglia 
may have a predominately deleterious effect at the early stages after a focal ischaemic 
injury, and macrophages infiltrate into the lesion to counteract microglial activity.  
Astrocytes are also very sensitive to ischaemia, causing them to change to their activated 
morphology. They also lose their ability for glutamate uptake from the synaptic cleft, 
thereby contributing to glutamate overload and excitotoxicity (Ouyang et al. 2007). An 
important function of astrocytes in a focal injury is that they bundle to form a glial scar, 
which encapsulates the lesion, seals the damaged BBB and protects the surrounding 
tissue from exposure to neurotoxic molecules and invading immune cells (Sofroniew 
2009). Although this scar may act as a barrier to prevent damage to healthy tissue, the 
astrocytes in the scar express a number of molecules that prevent axon regeneration in 
this region (Gris et al. 2007). Astrocytes also have neuroprotective roles by providing 
metabolic support to neurons during ischaemia (Rossi et al. 2007). There is evidence that 
astrocytes partake in a number of reparative processes, including regulating 
neurogenesis, promoting synaptogenesis, and enhancing BBB repair and angiogenesis 
(Liu & Chopp 2016).  
Post-ischaemic neuroinflammation is not confined to the primary injury site, but is 
elevated throughout the brain and can persist for weeks/months/year afterwards (Mena 
et al. 2004; Shi et al. 2019; Linck et al. 2019). As previously described, focal ischaemic 
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injury can lead to diaschisis and secondary neurodegeneration in distal brain regions 
(Hartings et al. 2003; Zhang et al. 2012). Studies conducted in human stroke patients and 
rodent models indicate that chronic neuroinflammation coincided with these changes 
(Morris et al. 2018; Linck et al. 2019; Weishaupt et al. 2016; Rodriguez-Grande et al. 
2013). The mechanisms underlying global neuroinflammation following ischaemic injury 
are unknown, yet it may result from the spread of pro-inflammatory mediators and 
cytokines through the cerebrospinal fluid (CSF) and extracellular space (Shi et al. 2019). 
Furthermore, there is evidence that sustained inflammation worsens the outcome of 
focal ischaemia, as elevated levels of inflammatory components, is associated post-
stroke cognitive decline and recurrence of stroke (Boehme et al. 2016; Elkind et al. 2014; 
Narasimhalu et al. 2015; Shi et al. 2019). Activated microglia and astrocytes have been 
found in regions of white matter pathology, and may be stimulated for clearance of 
myelin debris (Johnson 2013; Lloyd et al. 2017). There is evidence that more modest CBF 
changes can induce neuroinflammation. Previous research from our group and others 
have demonstrated that chronic cerebral hypoperfusion causes an increase in 
microglia/macrophages and astrocyte densities, particularly in the white matter tracts 
(Shibata et al. 2004; McQueen et al. 2014; Reimer et al. 2011; Holland et al. 2011). 
Moreover, white matter neuroinflammation in this model appears to impact the 
function of the white matter, as increased level of microglia/macrophages correlated 
with the slowing conduction velocity in the corpus callosum; which was alleviated by 
treatment with anti-inflammatory drugs (Fowler et al. 2018; Manso et al. 2018). There is 
also evidence that hypoperfusion stimulates a release of pro-inflammatory cytokines and 
chemokines in the white matter, which may cause axon-glial integrity and conduction 
velocity (Reimer et al. 2011). Collectively, these studies demonstrate that reductions in 
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CBF can lead to chronic neuroinflammation, which may contribute to degenerative 
changes and worsened functional outcome.  
Neuroinflammation is also a prominent feature of AD and is associated with β-amyloid 
pathology. Microglia express a number of cell-surface receptors that bind to soluble β-
amyloid oligomers and insoluble fibrils (Stewart et al. 2010; Bamberger et al. 2003; Paresce 
et al. 1996); activating them for β-amyloid clearance by phagocytosis or the release of 
degradation enzymes (Lee & Landreth 2010; Paresce et al. 1996). Astrocytes may also have 
roles in internalising and degrading β-amyloid (Wyss-Coray et al. 2003; Jiang et al. 2008). 
Activation of these cells, however, results in increase levels of pro-inflammatory cytokines, 
which can have downstream neurotoxic effects (Heneka et al. 2015), as previously 
discussed. Moreover, impairment in β-amyloid clearance may be a major contributor to 
disease progression. Advancements have been made in understanding genetic variants 
linked with AD, and revealed that the majority of the identified loci are expressed in 
microglia or myeloid cells (Villegas-Llerena et al. 2016; Efthymiou & Goate 2017). This 
includes a variant of TREM2, which has functions in inflammatory and phagocytic 
signalling, and could reduce β-amyloid clearance (Hsieh et al. 2009; Colonna & Wang 
2016). Another proposed mechanism by which microglia may contribute to AD 
pathogenesis and cognitive decline is by aberrant synaptic stripping (Hong et al. 2016). This 
is the theory that microglia physically engulf and remove synaptic terminals during 
neurodegenerative disease (Rajendran & Paolicelli 2018). β-amyloid may also ‘prime’ or 
‘sensitise’ glial cells, leading to an exaggerated immune response with subsequent 
stimulation. Glial priming has been found in ME7 neurodegeneration prion disease mice 
and Tg2576 mice, as LPS-induced systemic inflammation resulted in even higher levels of 
neuroinflammatory cells compared to WT mice (Cunningham et al. 2005; Sly et al. 2001). 
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These studies imply that multiple disease comorbidities can exacerbate 
neuroinflammation, which may result in worsened neurotoxicity and degeneration. 
Taken together, there is a large body of evidence indicating that neuroinflammatory 
responses to CBF reductions and β-amyloid pathology can contribute to degenerative 
changes in the brain. The mechanisms behind the pathobiology of VCI and AD are not fully 
elucidated, however, the use of rodent models to mimic aspects of these diseases are 
enabling greater understanding of the underlying processes.  
1.5 Models of reduced CBF 
Advancements in our understanding of the mechanisms underlying CVD and VCI have 
been made through the use of rodent models, which mimic the breadth of human 
cerebrovascular injuries. Surgical models have been established to investigate the impact 
of reduced CBF on the brain and whether it is causative for the development of CVD and 
VCI. 
1.5.1 Global ischaemia and hypoperfusion models 
Surgical procedures have been established to reduce global CBF in rodents. Common 
approaches for this is to permanently or transiently block or restrict flow through one or 
both common carotid arteries (Jessica Duncombe et al. 2017).  
1.5.1.1 Chronic cerebral hypoperfusion rodent models 
A number of rodent models have been developed to mimic the chronic reductions of 
cerebral perfusion that occur in aging and early stages of dementia, without inducing 
overt ischaemic damage, usually by restricting the flow through one or both of the 
common carotid arteries. In one of these mouse models, bilateral common carotid 
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stenosis (BCAS), CBF in the forebrain is decreased through application of microcoils to 
both common carotid arteries (Shibata et al. 2004). This model usually uses C57Bl/6J 
mice, as 90% mice of this strain have an incomplete circle of Willis (McColl et al. 2004). 
CBF measurements with laser speckle imaging show that the initial reduction after BCAS 
is ~30-40% of the baseline, with recovery to ~20% over the following month, in 3-4 
month-old mice (McQueen et al. 2014).  
A number of groups, including ours, have found that BCAS surgery in mice leads to 
cognitive impairment, particularly in tasks assessing spatial working memory deficits, such 
as the 8-arm Radial Arm Maze (RAM). The RAM was first designed by Olton and Samuelson 
in 1976 for rats and has since been adapted for mice (Olton & Samuelson 1976). The 
apparatus consists of a maze with 8 identical arms that radiate from a central platform and 
are equidistant from each other. Prior to starting the experiment the rodents are food 
restricted, providing an incentive for them to explore the maze which is baited with a food 
pellet at the end of each arm. The task requires the rodents to use external visual cues on 
the surrounding walls to remember which arms they have been in and to go into novel 
arms to collect their food reward. Visiting an arm more than once is known as a ‘revisiting 
error’ and the number of revisiting errors is used as a measure of spatial working memory 
deficit. A previous study from our group found that after one month of BCAS surgery, the 
mice had a small impairment in spatial learning memory, but the spatial learning and 
memory abilities were unchanged compared to sham animals (Coltman et al. 2011). Spatial 
learning and memory was assessed with the Morris Water Maze (Morris et al. 1982). This is 
a widely used method, designed by Richard Morris, which requires the rodents to swim 
within a tank of cloudy water, and use external visual cues to learn and remember where a 
hidden platform is, enabling them to escape. Escape latency is measured as an assessment 
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of memory. The task usually has a second stage when the hidden platform is removed and 
the time the rodent spends in the correct quadrant is measured. Another previous study by 
our group found that spatial working memory deficits were present 3 month after BCAS 
surgery (Kitamura et al. 2017), whilst our collaborates used a 3D 9-arm radial arm maze to 
show BCAS induces cognitive decline at 4 months after BCAS surgery (Hase et al. 2017). At 
6 months after BCAS surgery, cognitive deficits were evident from both RAM and WMW 
tasks, indicating that longer term hypoperfusion impacts more cognitive functions (Holland 
et al. 2015).  
Studies from our group and others have demonstrated that BCAS has acute and chronic 
effects predominately in the white matter. At 3 days, microarray analysis indicated that 
genes related to angiogenesis and neuroinflammation were altered in the white matter 
(Reimer et al. 2011). White matter tracts are shown to be vulnerable to this surgery, as 
shown by histological analysis and MRI/DTI, 1 months and 6months after surgery 
(Holland et al. 2011; Holland et al. 2015; Shibata et al. 2004; Coltman et al. 2011). Other 
pathological features present at this time-point are activation of astrocytes and 
microglia, axon-glial breakdown and disruption in the blood brain barrier. To date, most 
studies have focussed on the impact of BCAS on the evolving diffuse white matter 
pathology, but limited studies have also shown degenerative effects. At 6 months, BCAS 
results in multiple subcortical microinfarcts and microbleeds (Holland et al. 2015), and at  
8 months BCAS lead to hippocampal atrophy (Nishio et al. 2010). This model was used in 
the work presented in Chapter 3 of this thesis, to investigate the impact of chronic CBF 
reductions on glutamatergic synapses.  
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A disadvantage of the BCAS model is that the mice experience an initial large reduction 
in CBF followed by gradual recovery. This is unlike the human condition where the 
restriction of the blood vessels causes progressive reduction in CBF. An alternative 
model could be gradual common carotid artery stenosis (GCAS), which uses ameroid 
restrictors on the carotid arteries instead of microcoils. The restrictors absorb water and 
swell over time, gradually restricting CBF over 28 days (Hattori, Kitamura, Nagatsuka, et 
al. 2014). This procedure results in multiple infarcts in the cortex, corpus callosum, 
hippocampal fimbria and caudoputamen.  
1.5.1.2 Global ischaemia rodents models  
Many previous studies have used vessel occlusion models to induce hypoperfusion with 
ischemic damage. Although these models were not used in the present research, other 
groups used the to investigate the impact of CBF reduction on synapses. Bilateral 
common carotid artery occlusion (BCCAO or 2VO) is frequently used in rats and mice. 
Permanent BCCAO in rats has been shown to result in an acute CBF reduction of ~55-
65% in the cortex and white matter, and ~20-40% reduction in the hippocampus, with 
recovery to baseline level over the following 2-6 months (Otori et al. 2003; Choy et al. 
2006).  
A number of studies have published evidence that BCCAO surgery results in cognitive 
decline (Farkas et al. 2007). The MWM and RAM tests have been the most widely used 
to show that BCCAO surgery results in hippocampal-dependent memory impairment in 
rats, as early as 7 days after surgery (Farkas & Luiten 2001; Murakami et al. 2000; Sopala 
et al. 2000; Liu et al. 2005). BCCAO surgery has also been found to impact other non-
spatial forms of memory, such as impairment in an object recognition test at 60 and 90 
days after surgery (Sarti et al. 2002). 
57 
Histological analysis has revealed that hippocampal CA1 neurons are damaged 2 weeks 
after surgery, and their condition worsens over time (Ohtaki et al. 2006; J. Liu et al. 
2006). BCCAO also induces white matter disruption and neuroinflammation in the corpus 
callosum, optic tract and internal capsule (Cho et al. 2006). Ligation of both common 
carotid arteries in mice resulted in progressive spatial memory impairment, and neuron 
loss in the hippocampus and cortex (Wang et al. 2016).  
1.5.2 Focal ischaemia models 
The majority (~70%) of human strokes occur within the MCA and its branches (Koizumi 
et al. 1986). Models of middle cerebral artery occlusion (MCAO), therefore, resemble the 
majority of human ischaemic strokes (Tamura & Teasdale 1981). There are a number of 
different approaches to achieve MCAO through the use of an intraluminal suture, 
electrocoagulation, microanerurysn clip, micro embolism, vasoconstriction or 
photothrombosis (Fluri 2015). The results of these different methods are differing 
severity and locations of ischaemia damage. The majority of these procedures have 
MCAO performed in mice and rats; however, some studies using higher organisms such 
as gerbils and non-human primates have been used for these studies.  
1.5.2.1 Intraluminal suture MCAO 
Intraluminal suture MCAO is a widely-used method for induced focal ischaemia in rats 
and mice, and was used in the studies presented in Chapters 5 and 6 of this thesis. This 
method involves ligating the CCA and ECA, then introducing a silicone-coated 
monofilament through a small incision in the ECA and moving it up to occlude the 
entrance of the MCA. This approach can be used for transient and permanent occlusion. 
The maximum occlusion time for transient MCAO in mice is 60 minutes, whilst longer 
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occlusion times of 60, 90 and 120 minutes occlusion are most commonly used for rats. 
This surgery has a high success rate of 88-100% (Tsuchiya et al. 2003; Liu et al. 2009). An 
advantage of intraluminal suture MCAO is that is does not require a craniotomy, making 
the procedure less invasive compared to other MCAO methods.  
The type of intraluminal suture MCAO surgery used in the present study was previously 
described by Hata et al. (Hata et al. 1998). In this model, ischaemic cell injury first occurs 
within the striatum, with delayed damage expanding to the overlying frontoparietal and 
temporal cortices, which will often result from longer occlusion times. The striatum is 
vulnerable to ischaemia following MCAO, as the end arteries branching from the MCA 
are end-arteries and do not form collaterals (see Figure 1.1A). This is supported by 
observations that the striatal CBF remains reduced, whilst cortical CBF recovers to its 
baseline value 2 hours after reperfusion in rat MCAO (Takagi et al. 1995; Fluri 2015). The 
cell damage that occurs in the striatum is mostly rapid, necrotic and irreversible, and 
reaches its maximum volume by 24 hours post-occlusion. In the cortex, however, the 
changes tend to be delayed and apoptotic, making up the penumbra or peri-lesion. The 
extent of damage is largely dependent on the duration of the occlusion. A study by 
Pedrono et al. demonstrated that there was a fivefold increase in lesion volume between 
mice after 15 minutes and 30 minutes of MCAO. The smallest duration of MCAO that will 
result in ischaemic damage is 15 minutes, while 10 minutes or less result in no 
detectable lesion (Pedrono et al. 2010).  
Alongside the advantages previously mentioned about the physiological relevance of the 
model, the surgical procedure is also relatively quick and easy to perform with good 
reproducibility. It success rate is high, although sometimes premature reperfusion can 
occur. Moreover, there can be variations in the pathological outcome, such as 
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inadequate MCAO leading to no evidence of ischaemia damage, or excessive injury. An 
adverse side effect of the surgery can be subarchnoid haemorrhage (SAH), although this 
can be improved by the use of silicone-coated filaments, which adhere better to the 
endothelium (Bouley et al. 2007). In addition, Laser Doppler imaging can be used to 
guide the placement of the filament (Schmid-Elsaesser et al. 1998). Another early 
adverse effect of the surgery can be difficulty with eating and weight loss, as ischaemia 
can occur in the muscles that control mastication and swallowing (Dittmar et al. 2003). 
There are a number of different types of MCAO surgery, which are described below, as 
these models were used in publications discussed later in this thesis. 
1.5.2.2 Distal MCAO 
There are two main models of distal MCAO, which involve exposing the MCA via a 
narrow craniectomy and an incision into the dura mater. The first method permanently 
occluded the MCA by electrocoagulation, application of a microaneurysm clip, vessel 
ligation or photothromobosis using Rose Bengal (Fluri 2015). The main regions of 
damage are in the striatum, subcortical white matter and ipsilateral cortex. The second 
approach is known as the three-vessel model (3VO), which involves the first method plus 
bilateral common carotid artery occlusion. Permanently or transiently occluding the 
MCA or CCA is a common method for inducing focal ischaemia (Yanamoto et al. 2003). 
This model results in injury predominately in the cortex and underlying white matter, 
with limited damage in the striatum (Desk et al. 1992). Although these techniques are 
much more invasive than the intraluminal suture model, they enable much better 
targeting of the occlusion site leading to more restricted regions of damage. The main 
disadvantage of this model is that it requires a craniectomy, which could be damaging 
for the brain and induce a neuroinflammatory response. Application of the 
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vasoconstrictor endothelin-1 is another method used to induce distal MCAO or injected 
into specific brain regions (Fluri 2015). 
Kristian Doyle and colleagues use a modified version of distal MCAO; after dMCAO 
surgery the mice are placed in a hypoxic chamber for an hour. They call this model Distal 
Hypoxia Stroke model (DH stroke). They found that the addition of hypoxia created a 
lesion that is larger than the usual dMCAO lesion, and has better reproducibility (Doyle 
et al. 2012). The model also resulted in acute motor and neurological deficits, with 
impaired hippocampal long-term potentiation and cognitive decline appearing at 7 
weeks after surgery (Doyle et al. 2015). The authors propose that this is an appropriate 
model for studying post-stroke dementia.  
1.5.2.3 Cognitive Impairment following MCAO 
A number of studies have investigated whether MCAO surgery in rats induces spatial 
learning and working memory impairment, assessed with the RAM or MWM tests. 
Although some studies did find a significant impairment (Okada et al. 1995; Yonemori et al. 
1996; Markgraf et al. 1992), the results may be confounded as there is an abundance of 
evidence indicating that MCAO surgery impacts motor ability which could affect their 
performance in the MWM and RAM tests. Bingham et al. adapted the analysis for their 
MWM experiment, by which they compared the ‘accuracy in crossing the platform 
location’ between sham and MCAO animals (Bingham et al. 2012). This is calculated by the 
number of times the rats cross the platform in the target quadrant, minus the number of 
crossings in equivalent locations in the other three quadrants, thus the result is not 
dependent on escape latency. This study found that one month after permanent MCAO, 
the rats only had a minimal deficit in spatial memory compared to sham and un-operated 
animals (Bingham et al. 2012). Novel object recognition (NOR) task has also been used to 
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assess non-spatial memory impairment after MCAO surgery. Fréchou et al. found that 60 
days of permanent MCAO in mice resulted in impairment in recognition memory, in the 
novel object recognition test (Fréchou et al. 2019). Whereas, Nguyen et al. using the DH 
stroke mouse model discovered that young mice experienced memory impairment in the 
NOR task at 7 weeks after surgery, whilst older mice experienced memory impairment 
earlier at 4 weeks (Nguyen et al. 2018). 
1.5.2.4 Photothrombosis  
Another popular model for inducing focal ischemic lesions is photothrombosis. Light-
sensitive Rose Bengal is injected intravenously injected in rodents and illuminated 
through the skull, to cause the generation of singlet oxygen, focal endothelial damage, 
platelet activation and focal clotting (Dietrich et al. 1986). The result is the formation of a 
focal ischaemic lesion in the cortex at the location of illumination. This method enables 
the researcher to have high control over where the lesion forms, however, the lesions 
are restricted to the cortex. Moreover, the pathological process of the lesion formation 
is different to that in human stroke, which is characterised by cyotoxic edema. In this 
model the lesion forms rapidly from cytotoxic (intracellular) and vasogenic (extracellular) 
edema from endothelial injury  (Lee et al. 1996). Experiments were undertaken to 
optimise an approach for Rose Bengal photothrombosis, as described in Chapter 4.  
Photothrombosis in rats and mice has been shown to induce motor impairment, 
however, far fewer studies have investigated the impact this has on cognition. Sadigh-
Eteghad et al. showed that a photothrombotic lesion in the medial prefrontal cortex 
leads to longer escape latencies in the Barnes maze (Sadigh-Eteghad et al. 2018). The 
Barnes maze is a land version of the MWM, with the maze being an open circular surface 
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with holes around the perimeter, and one hole leading to a plastic box enabling the mice 
to escape the maze (Barnes 1979). Similarly to the MWM, the Barnes maze requires the 
mice to use external visual cues to learn and remember which hole leads to the escape 
box and the longer escape latency is an indication of worsened spatial memory. Sadigh-
Eteghad et al. also demonstrated that the locomotion activity was unchanged between 
the ischaemic mice and the sham mice, suggesting that the Barnes maze experiment was 
not confounded by motor deficits (Sadigh-Eteghad et al. 2018). Another study using Rose 
Bengal photothrombosis to induce a large unilateral cortical lesion found that these mice 
had longer escape latencies and fewer crossings of the hidden platform in the MWM 
compared to sham animals, whilst ischaemic animals that had environmental 
enrichment in their cages had shorter escape latencies and more platform crossings, 
indicating improved spatial memory (Wang et al. 2016).    
1.5.3 Mouse strains 
There are a number of mouse strains used in basic research, and the genetic variations 
between them can result in differing success of surgery to reduce CBF. C57Bl/6J are 
frequently used in models of VCI, as they have poor posterior communicating arteries 
and the majority of them have an incomplete circle of Willis, so their collateral blood 
supply is reduced (McColl et al. 2004). When compared to Sv129 mice, following 
permanent MCAO, C57Bl/6J mice have been found to have larger lesions (Doyle et al. 
2012; Maeda et al. 1999). The present studies used C57Bl/6J mice for BCAS and MCAO 
surgeries. As well as differences in the cerebral vascular architecture between strains, 
the weight and age of the animals will influence the outcome of the surgery, as older and 
heavier animals tend to have more fat around vessels (Hata et al. 1998; Spratt et al. 
2006; Fluri 2015). 
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1.6 Models of β-amyloid pathology  
As previously discussed, there is a large body of evidence indicating that β-amyloid 
pathology and vascular pathology interact and exacerbate each other. Advancements in 
understanding this interaction have largely resulted from the use of transgenic mouse 
models that mimic aspects of Alzheimer’s disease.  
Numerous transgenic mouse lines have been generated to express elements of 
Alzheimer’s pathology, although none of them exhibit all of the pathological features of 
the disease. The most widely used types of Alzheimer mouse models are ones that 
express mutated versions of human amyloid precursor protein (APP), which were 
identified in patients with familial forms of Alzheimer’s disease. The different APP 
mutations lead to variations in the resulting pathology. One of the first transgenic lines 
developed is the PDAPP mice, which overexpress APP harbouring the Indiana mutation 
V717F, leading to early cognitive impairment and synaptic depression (Games et al. 
1995; Larson et al. 1999). The Swedish double mutation (K670N/M671L) is the most 
common mutation in APP transgenic mouse lines, which increases β-amyloid production 
by changing the β-secretase cleavage site (Sasaguri et al. 2017). This mutation can be 
expressed alone in some APP models, such as Tg2576 (Hsiao et al. 1996), whilst others 
combine it with another mutation. J20 mice express the Swedish double mutation and 
the Indiana mutation (Mucke et al. 2000) and Thy1-hAPPLond/Swe combines the Swedish 
mutation with the London mutation (Rockenstein et al. 2001). The human mutated APP 
mouse model used for the studies in this thesis expressed the Swedish, Dutch (E22Q) 
and Iowa (D23N) mutations (TgSwDI) (Davis et al. 2004). Some transgenic mouse lines 
also include mutations in presenilin-1 (PSEN 1), a subunit of γ-secretase, an enzyme 
complex that processes APP into β-amyloid. These transgenic lines include APP-PS1, 
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which harbours the Swedish mutations plus PSEN1 L166P (Radde et al. 2006); and 
PS/APP, which harbours Swedish APP mutation and PSEN1 M146L (A>C) (Holcomb et al. 
1998). Whilst PS/APP induces early (3 months old) cognitive decline, with delayed β-
amyloid deposition and gliosis (Gordon et al. 2002); APP-PS1 has very early β-amyloid 
deposition and gliosis (1 month old), with delayed cognitive decline (Radde et al. 2006; 
Bittner et al. 2012). 
Research described in the present thesis used TgSwDI mice. The Dutch and Iowa 
mutations causes CAA in humans, therefore, expression of these in mice results in 
vascular β-amyloid accumulation (Davis et al. 2004). TgSwDI tend to have diffuse β-
amyloid deposition in the parenchyma with some more compact aggregation around the 
vessels (Davis et al. 2004; Xu et al. 2007; Duncombe et al. 2017). The TgSwDIAPP 
transgene is under the control of the thymocyte differentiation antigen 1 (Thy-1) 
promoter, which drives neuron-specific expression. The benefits of this type of promoter 
are that it does not switch on expression until around postnatal day 7, avoiding 
development complications (Hall & Roberson 2012). Moreover, the expression of the 
transgene is around the level of endogenous mouse APP (Davis et al. 2004). Many 
studies in the field have used over-expression APP mouse models with transgenes 
controlled by the prion protein (PrP) promoter, such as Tg2576. The PrP promoter causes 
a 15-fold human APP expression level increase compared to the endogenous level, and 
induces this expression in both neurons and glia, culminating in severe pathological 
changes that may not be relevant to the human disease (Hall & Roberson 2012).  
TgSwDI is an appropriate mouse model to use to investigate changes related to CVD, as it 
develops β-amyloid deposition in the microvasculature. Previous work conducted by our 
lab demonstrated that chronic cerebral hypoperfusion, induced by BCAS surgery, 
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resulted in an increase in soluble and insoluble Aβ40 pools at 1 month and 3 months, 
respectively (Salvadores et al. 2017). This study also found an increase in the burden of 
β-amyloid in the microvasculature after 3 months of hypoperfusion. To date, there is no 
evidence indicating whether focal ischaemia induces an increase in β-amyloid burden in 
this model. Moreover, it is unknown whether synaptic loss occurs in this model. There is 
evidence that homozygous TgSwDI have memory impairment starting at 3 months of age 
(Xu et al. 2007), however, it remains to be seen whether this is the result of synaptic 
degeneration. 
1.7 Synaptic changes in Vascular Cognitive Impairment and 
Alzheimer’s disease 
1.7.1 Normal synaptic structure and function 
Synapses are neurochemically complex structures that facilitate the transfer of information 
between neurons within networks. A synapse consists of a presynaptic terminal from one 
neuron apposing with a postsynaptic terminal on a dendrite from another neuron (see 
Figure 1.5). These structures are supported by a cytoskeleton that is predominately made 
of filamentous actin (F-actin). The gap between the pre- and postsynaptic terminals is 
~20nm wide and is known as the synaptic cleft (Stewart et al. 2013). In chemical synapses, 
an action potential arriving at the presynaptic terminal stimulates the release of 
neurotransmitter from synaptic vesicles into the synaptic cleft, which diffuses to the 
postsynaptic terminal and binds to receptors, which stimulates the opening of ion channels 
for the next neuron to become activated. 
Presynaptic terminals contain synaptic vesicles, which are packed full of neurotransmitter. 
The majority of CNS presynaptic terminals have an active zone (AZ) where vesicles fuse 
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with the presynaptic membrane and release neurotransmitter into the synaptic cleft 
(Landis et al. 1988). This region is rich with proteins specialised for facilitating vesicle 
docking, priming and fusing with the presynaptic membrane (Dresbach et al. 2001; 
Gundelfinger & Dieck 2000). Synaptic vesicles exist and move between different pools 
within the presynaptic terminal, mediated by the actin cytoskeleton and Ca2+ -dependent 
protein-protein interactions (Sankaranarayanan & Ryan 2000; Doussau & Augustine 2000; 
Ashery et al. 2014). At the presynaptic terminals, vesicles detach from the actin 
cytoskeleton and become docked at the AZ where they are then primed ready for fusion. 
Synapsins are a key family of presynaptic proteins that help cluster vesicles in the 
presynaptic terminal, whilst the SNARE family are essential for vesicle priming and fusion 
(Ashery et al. 2014; Söllner et al. 1993; Ferreira et al. 2000). Priming refers to the process 
of tethering the vesicles to the presynaptic membranes. The SNARE protein, 
synaptobrevin, is expressed on the surface of the vesicles, whilst other SNAREs, syntaxin 
and SNAP-25, are expressed on the presynaptic membrane, and interact with another key 
protein called Munc18 (de Wit et al. 2009; Sinha et al. 2011). The vesicular and presynaptic 
membranes SNARE proteins become tightly interwoven in a complex, pulling the vesicle to 
the presynaptic membrane and merging the membranes, priming the vesicle for fusion 
(Baumert et al. 1989; Hanson et al. 1997; Lin & Scheller 1997; Ashery et al. 2014). When an 
action potential arrives at the nerve terminal and the presynaptic membrane becomes 
depolarised, presynaptic voltage-gated calcium channels open enabling an influx of Ca2+ 
ions (Barnett & Larkman 2007; Catterall 2011; Mahapatra et al. 2012). The increase in 
presynaptic Ca2+ levels activates vesicular fusion, as another vesicular protein, 
synaptotagmin, joins the complex and the vesicle is opened into the synaptic cleft, and 
enabling the neurotransmitter to diffuse out and across to the postsynaptic terminal 
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(Ashery et al. 2014). Synaptic vesicles are recycling by clathrin-mediated endocytosis, to 
maintain the size of the presynaptic membrane (Ashery et al. 2014). 
The released neurotransmitter diffuses across the synaptic cleft and binds to receptors on 
the postsynaptic membrane. This in turn causes either depolarisation or hyperpolarisation 
of the postsynaptic membrane, depending on the type of neurotransmitter, leading to 
excitatory (e.g. glutamate, epinephrine, acetylcholine) or inhibitory (e.g. GABA, 
norepinephrine) transmission, respectively. Excitatory postsynaptic terminals have a 
postsynaptic density (PSD), which is a ~30-40nm thick, protein-rich structure where various 
neurotransmitter receptors, transmembrane proteins, scaffold proteins, regulatory 
enzymes and signalling proteins. The complexes present in the PSD are specialised for 
signal transduction. Moreover, these proteins are modifiable by phosphorylation, local 
translation, ubiquidation, degradation and subcellular redistribution, enabling synaptic 
strengthening and weakening according the activity of the synapse (reviewed by Verpelli et 
al. 2013) .  
The majority of excitatory synapses are glutamatergic synapses. Ionotrophic receptors for 
glutamate, NMDA-, AMPA- and kainate receptors, cluster within the PSD. An important 
protein for PSD function is postsynaptic density-95 (PSD95), which has roles in organising 
signal complexes, such as linking NMDA-receptor subunits to intracellular signalling 
proteins (Bresler 2004). PSD95 (also known as synapse-associated-protein-90, SAP90) 
comes from a larger family of membrane-associated guanylate kinases (MAGUKs), which 
also includes PSD93/chapsyn-110, SAP107 and SAP97 (Elias & Nicoll 2007; Sheng & Sala 
2001). When glutamate binds to these receptors on the postsynaptic membrane, it causes 
the opening of cation channels and enabling the influx of calcium and sodium ions, 
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resulting in a wave of depolarisation and, if the threshold is reached, continuation of an 
action potential onto the next neuron (Michael-Titus et al. 2010; Kusano et al. 1975). In 
addition, increased intracellular calcium levels can activate enzymes within the PSD and 
modify intracellular signalling. An example of this is the tethering of neuronal nitric oxide 
synthase (nNOS) to NMDA-receptors via PSD95, which can then be more easily activated 
by the influx of Ca2+ ions, resulting in increased nitric oxide production; which has roles in 
neuronal signalling and excitotoxicity (Lai et al. 2014).  
Once glutamate has been released from the presynaptic terminal and activated the 
postsynaptic receptors, it is important that the neurotransmitter is ‘mopped-up’ to prevent 
excessive cation influxes into the postsynaptic terminal. Astrocytic processes that closely 
appose the synaptic terminals in the ‘tripartite synapse’ have a key role here, as they take 
up glutamate with excitatory amino acid transports (EAATs) (Shigeri et al. 2004; Tzingounis 
& Wadiche 2007). When inside the astrocytes, glutamate is converted to non-signalling 
glutamine with glutamine synthetase, which is then transported to the presynaptic 
terminal where it is converted back to glutamate (Hertz & Zielke 2004). Vesicular 
glutamate transports (VGLUTs) are a family of proteins that package glutamate into 
synaptic vesicles in the presynaptic terminals, and exist in three isoforms (VGLUT1-3) 
(Montana 2004).  
Historically, synapses are classified by the type of neurotransmitter they release, such as 
glutamatergic, GABAergic, dopaminergic, serotonergic, cholinergic and adrenergic. 
Glutamate is the main excitatory neurotransmitter, whilst GABA is the main inhibitory 
neurotransmitter. Proteomic studies in rodents have revealed that more than 3000 
proteins are expressed in the synaptic terminals, with roles in scaffolding, vesicular 
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transporters, adhesion proteins and receptor subunits (Filiou et al. 2010; Schrimpf et al. 
2005; O’Rourke et al. 2013). Furthermore, there is now a greater understanding about the 
breadth of synaptic proteomic “intra-type” diversity within classes of synapses, and how it 
affects aspects of synaptic function, including strength, kinetics and plasticity (O’Rourke et 
al. 2013). Molecular diversity will partly result from multiple isoforms of synaptic proteins, 
which may be expressed in different parts of the brain or in different cell types (Gong et al. 
2003; Lein et al. 2007). For example, this type of diversity occurs the three isoforms of 
VGLUTs (VGLUT1-3). These isoforms vary in their expression levels in different brain 
regions, and have distinct protein-protein interactions that affect the functionality of the 
Figure 1.5 Schematic of glutamatergic synapse. VGLUT1 is a presynaptic protein that 
transports glutamate into synaptic vesicles. Glutamate binds to AMPA- and NMDA-
receptors 
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synapses (Vigneault et al. 2015; Zhang et al. 2018; De Gois et al. 2006). Another example of 
this is the diversity within the subunits for AMPA-receptors (GluR’s) and NMDA-receptors 
(GluN’s), as the assembly of subunits vary for different brain regions and cell types (Isaac et 
al. 2007; Cull-Candy & Leszkiewicz 2004).  
Synaptic transmission is critical for cognitive function; and dysfunction or degeneration 
of synapses is a primary feature in many brain diseases, including forms of dementia 
(Clare et al. 2011; Bayés et al. 2011). The concept that synaptic degeneration underpins 
cognitive decline in dementia was first proposed by Santiago Ramon y Cajal: 
“dementia could result when synapses between neurons are weakened as a result of 
more or less pathological condition, that is, when processes atrophy and no longer form 
contacts, when cortical mnemonic or association areas suffer partial disorganization” 
(Cajal 1928). 
1.7.2 Synaptic loss in human post-mortem studies 
There is considerable evidence that synapse loss occurs at an early stage of the 
pathological progression to dementia. This is based on the demonstration that synapse 
loss predates neuronal loss in post mortem brain tissue from elderly individuals, MCI and 
AD patients (Davies et al. 1987; Masliah et al. 1989; Terry et al. 1991; Scheff et al. 2006; 
DeKosky & Scheff 1990). In Alzheimer’s post-mortem brain tissue, there is a significant 
reduction in synaptic terminals in cortical layer V whilst the neuron density remains 
unchanged compared to control samples (Davies et al. 1987). Additional studies have 
shown that in Alzheimer’s brain tissue, the densities of presynaptic terminals are 
reduced in specific brain regions, including the parietal, temporal, midfrontal cortices 
(Masliah et al. 1989; Terry et al. 1991) and the hippocampus; whilst in the densities 
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remained unchanged in other brain regions (Perdahl et al. 1984). These findings indicate 
that there is a selective vulnerability of synapses in specific brain regions. Moreover, 
they demonstrate that the synaptic changes are not homologous between different 
types of dementia, as the reduction in presynaptic terminals the hippocampus found in 
AD brains was not present in the samples from multi-infarct dementia patients (Perdahl 
et al. 1984). Another important finding in these studies was that synapse loss correlated 
with cognitive decline, more strongly than any other pathological feature of AD (DeKosky 
& Scheff 1990; Scheff et al. 2006; Terry et al. 1991). Furthermore, they found that 
synapse loss occurs in MCI and proposed that progressive synapse loss converts a normal 
cognitive state to MCI, and MCI to AD (Scheff et al. 2006). The methods used for 
detecting synapses in these publications were immunohistochemistry of abundant 
presynaptic protein synaptophysin (Terry et al. 1991; Masliah et al. 1991), and electron 
microscopy (Scheff et al. 2006; DeKosky & Scheff 1990), which do not distinguish 
between different types of synapses.  
Synapses have diverse neurochemical composition depending on the type of 
neurotransmitter they release, which can elicit selective vulnerability in pathological 
conditions. In AD, the networks most susceptible to damage include glutamatergic and 
cholinergic transmission (Bell & Claudio Cuello 2006). The glutamatergic presynaptic 
proteins vesicular glutamate transport (VGLUT) -1 and -2 were shown to be reduced in 
protein levels and terminal density in the prefrontal cortex of Alzheimer’s patients 
(Kashani et al. 2008). This study also investigated the levels of these proteins in tissue 
from patients with MCI, which showed a smaller reduction in VGLUT2 levels and no 
change in VGLUT1 levels compared to controls; reinforcing the theory that mild cognitive 
impairment is a precursor state to AD, and progressive synapse loss is part of the 
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pathological process. Importantly, this paper indicates that VGLUT1 protein levels 
correlate with the clinical dementia rating score from the individual patients, highlighting 
that VGLUT1 in the prefrontal cortex is crucial for cognitive function. Postsynaptic 
density 95 (PSD95) is an abundant scaffolding protein in excitatory postsynaptic 
densities. There is conflicting evidence as to whether there are changes in PSD95 in AD, 
as reviewed in (Savioz et al. 2014). Taken together, there is substantive evidence that 
glutamatergic presynaptic terminals and proteins are reduced in AD, whilst conflicting 
evidence for postsynaptic changes may indicate resilience in these structures. 
Less attention has been given to investigating synaptic changes in VCI and VaD (Clare et 
al. 2010). Synaptic protein levels were analysed in tissue from the superior temporal 
gyrus from vascular dementia patients, as infarcts have been shown to be prevalent in 
this region (Sinclair et al. 2015). The study found that levels of the presynaptic protein 
SNAP-25 were significantly reduced, whereas synaptophysin levels were unchanged. 
Conversely, the postsynaptic protein drebrin increased, whilst PSD95 was unchanged. 
This is an interesting result, as it indicates that vascular pathology may stimulate 
different mechanisms for pre- and postsynaptic structures, and the authors hypothesise 
that the increase in drebrin could be involved in a compensatory response following 
ischaemia. Reductions in levels of the glutamatergic presynaptic protein VGLUT1 have 
been found in the in the frontal and temporal cortices of VaD, AD, and mixed dementia 
brains (Kirvell et al. 2010). Interestingly, the protein levels of VGLUT1 correlated with the 
pre-mortem mental health and memory scores from these patients, further indicating 
that glutamatergic presynaptic loss results in cognitive decline. Overall, there is evidence 
that in VCI there is some selective vulnerability of some presynaptic proteins, whilst 
postsynaptic proteins appear to be more resilient.  
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Studies using post-mortem human brain tissue have enabled end-stage analysis of 
synapse density, however, it remains a challenge to investigate progressive synapses 
changes and the underlying mechanisms. Recently technological advancements have 
been made enabling synaptic density to be measured in the living human brain (Finnema 
et al. 2016), which could be applied to understand synaptic changes during the 
development of VCI and dementia. The use of rodent models, however, has enabled 
huge advancements to be made in understanding the mechanisms underlying synapse 
dysfunction and loss. 
1.7.3 Synapse changes in models of Alzheimer’s pathology 
The amyloid cascade hypothesis of AD was proposed by John Hardy and Gerald Higgins 
in 1992, stating that β-amyloid is the causative agent of AD, leading to downstream 
NFTs, synaptic and neurodegeneration, vascular degeneration and dementia (Hardy & 
Higgins 1992). Previous to this, β-amyloid had been discovered as the main component 
of plaques in the human AD brain (Glenner & Wong 1984), which was later identified as 
a product of amyloid precursor protein (APP), the gene for which is localised on 
chromosome 21 (Tanzi et al. 1987). The link between β-amyloid and AD was further 
solidified by the discovery that mutations in the APP gene, or in genes encoding the 
enzymes that process APP to β-amyloid, were present in patients with early-onset 
familial AD. Furthermore, trisomy of chromosome 21 causes Down’s syndrome and is 
associated with early-onset AD (Tanzi et al. 1987; St. George-Hyslop et al. 1987). In 
transgenic mouse lines expressing human mutated APP, there was evidence reduced 
densities of hippocampal dendrites and dendritic spines with age, and coinciding with an 
increase in β-amyloid burden (Lanz et al. 2003; Moolman et al. 2004). Furthermore, 
dendrites and axons become swollen within an area of ~15μm around fibrillar amyloid 
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plaques, indicating that β-amyloid exerts neurotoxicity only within nearby neurons (Tsai 
et al. 2004). However, the hypothesis that β-amyloid plaques drive synapse 
degeneration was further scrutinised, as studies failed to find a relationship between 
synaptic loss and β-amyloid plaque burden (Mucke et al. 2000). 
The amyloid cascade hypothesis was then refined, as later research has indicated that 
soluble oligomers of β-amyloid is a driver for synaptic and neurodegeneration in 
Alzheimer’s disease (Selkoe 2002). Seminal work conducted by Dominic Walsh showed 
that cerebral microinjections of soluble human β-amyloid oligomers and monomers into 
rats resulted in inhibited hippocampal long-term potentiation (Walsh et al. 2002). It was 
later shown by Koffie et al. that amyloid plaques have a ‘halo’ of oligomeric β-amyloid 
around dense core plaques, which is associated with synaptic degeneration immediately 
around the plaque (Koffie et al. 2009). They then went on to discover a similar finding in 
human post-mortem tissue (Koffie et al. 2012). These studies indicate that oligomeric β-
amyloid is the main synaptotoxic form of β-amyloid, but it may be seeded from around 
dense plaques.  
It is unclear by which mechanisms β-amyloid can induce synapse dysfunction and 
degeneration, however, there is evidence that it can inferere with a number of processes 
affecting both pre- and post-synaptic terminals. An increase of β-amyloid may result 
from clustering of BACE1 enzyme at presynaptic terminals, as observed in J20 mice (Ye et 
al. 2017). β-amyloid can disrupt presynaptic processes, such as axonal transport, 
synaptic vesicle cycling and neurotransmitter release (Chen et al. 2019). There is 
evidence that β-amyloid oligomers can induce calcium ion influxes into presynaptic 
terminals by co-localising with voltage gated calcium channels (VGCC), which can impair 
axonal transport (Gan & Silverman 2015). Furthermore, oligomeric β-amyloid-induced 
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presynaptic calcium influxes can promote release of glutamate into the synaptic cleft 
and enhance postsynaptic activity (Brito-Moreira et al. 2011). Another proposed 
mechanism came from a study by Fogel and colleagues, which indicated that Aβ40 
peptides can bind to APP dimers in the presynaptic membrane, stimulating intracellular 
signalling through APP/Go-protein complex to cause calcium influxes and 
neurotransmitter release (Fogel et al. 2014). There is evidence that oligomeric β-amyloid 
can bind to distal axons and induce local synthesis of a number of proteins including 
transcription factor ATF4, which was shown to have roles in neurodegeneration 
(Baleriola et al. 2014).  
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There also is a growing body of evidence indicating that β-amyloid can cause dysfunction 
through mechanisms affecting the postsynaptic terminals. Publications by Shankar and 
colleagues have revealed that β-amyloid can induce postsynaptic dysfunction through 
NMDA-receptors. The application of naturally secreted β-amyloid dimers and trimers to 
rat organotypic slices lead to progressive loss of dendritic spines, and reduced the 
number and strength of active excitatory synapses in the hippocampus (Shankar et al. 
2007). They found that β-amyloid oligomers diminished calcium influxes through NMDA-
receptors, and later showed that they inhibited glutamate uptake, culminating in long-
term depression (LTD) (Li et al. 2009). In another study they found that β-amyloid 
Figure 1.6 Mechanisms of β-amyloid – induced synaptic dysfunction and loss.               
(A) Underlying mechanisms of synaptic dysfunction and degeneration by β-amyloid 
binding to synaptic receptors on presynaptic and postsynaptic terminals. (B) β-amyloid -
activated microglia inducing synaptic dysfunction by releasing cytokines, and physically 
stripping and engulfing synaptic terminals. Based on figures from Chen et al. 2019; 
Rajendran & Paolicelli 2018. 
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oligomers extracted from human AD cortices enhanced LTD and caused spine loss in rat 
hippocampal slices, as well as resulting in learning deficits when injected into the lateral 
ventricles of normal rats (Shankar et al. 2008). Moreover, when β-amyloid peptides were 
administered with antibodies against them this prevented the activity deficits. There is 
evidence that increased levels of β-amyloid can lead to a removal of AMPA-receptors 
from postsynaptic terminals, particularly receptors containing GluR3 subunits, 
contributing to synaptic depression (Guntupalli et al. 2016; Chang et al. 2006; Hsieh et al. 
2006; Reinders et al. 2016). A number of additional mechanisms have been proposed 
whereby β-amyloid induces synapse dysfunction by binding to other receptors on 
postsynaptic terminals, as reviewed by (Chen et al. 2019). Selective neuronal 
hyperactivity and seizures has emerged as an early pathological process in AD (Selkoe 
2018; Zott et al. 2019; Palop & Mucke 2016; Busche et al. 2012). A recent study has 
found compelling evidence that β-amyloid induces hyperactivation by blocking 
glutamate reuptake, leading to synapse dysfunction and neurodegeneration (Selkoe 
2018; Zott et al. 2019). 
β-amyloid may also act indirectly to drive synaptic dysfunction, through activation of the 
immune system. As previously described, microglia and astrocytes are very sensitive to 
changes in the brain environment and stimulated by the build-up of β-amyloid, and 
activated glia are observed clustered around amyloid plaques in AD post-mortem tissue 
(Serrano-Pozo et al. 2011). There is evidence that pro-inflammatory cytokines released 
by neuroinflammatory cells, such as TNFα and IL-1β, can elicit excitotoxic effects on 
synapses (Wang et al. 2015). More recently it has been proposed that in 
neurodegenerative diseases microglia physically strip away synaptic terminals. Hong and 
colleagues found evidence that β-amyloid-activated microglia colocalise with synaptic 
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terminals which appear to be engulfed by the cells (Hong et al. 2016). Taken together, 
the evidence implies that β-amyloid oligomers drive can directly or indirectly cause 
synapse dysfunction and loss. 
1.7.4 Synaptic changes in models of VCI 
1.7.4.1 Global cerebral blood flow reduction and synapse changes 
Compared to the vast body of literature that has focused on synaptic dysfunction and 
Alzheimer’s pathology, there is limited evidence regarding synaptic changes in models of 
VCI. Of these few studies, the majority of them have investigated the effect of global 
ischaemia, with permanent BCCAO in rats. This model results in gradual decrease of 
presynaptic protein synaptophysin and dendritic protein MAP2 in the hippocampus, over 
20 weeks after surgery (Liu et al. 2005). Reduced levels for both of these protein levels 
correlated with memory deficits probed by the Morris Water Maze, indicating that 
ischaemia-induced degeneration of dendrites and presynaptic terminals in the 
hippocampus directly relates to cognitive decline. There is evidence that dendrites and 
dendritic spines in layer 3 of the medial prefrontal cortex have selective vulnerability to 
ischaemia-induced degeneration as well (Jia et al. 2012). A similar finding was made in 
another study investigating the effect of transient global ischaemia, using a model of 
bilateral common carotid artery ligation (BCAL) on YFP mice. The researchers found that 
induction of BCAL caused blebbing of the dendrites and dendritic spines, however, when 
reperfusion was induced at 20 minutes or 1 hour after ligation, considerable restoration 
followed over the next three hours. For mice ligated for 3 or 6 hours, the dendrites 
remained blebbed and irreversibly damaged (Zhu et al. 2017).  
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Glutamatergic synapses are particularly vulnerable to ischaemia. Excessive glutamate 
levels are released from metabolically challenged neurons (Dawson et al. 2001; Drejer et 
al. 1985), whilst glutamate clearance systems are impaired (Rothstein et al. 1993); 
leading to glutamate spillover and over-activation of AMPA- and NMDA- receptors. This 
causes disruption to calcium homeostasis, which can initiate many pathological 
cascades, such as the breakdown of synaptic proteins from calpain activation (Lai et al. 
2014). Proteins involved in excitatory transmission were found to more vulnerable than 
those with inhibitory functions; vesicular glutamate transporters, VGLUT1 and 3, were 
reduced in the hippocampus 3 days after BCCAO in rats, whilst their GABAergic 
counterpart, VGAT, remained unchanged (Cao et al. 2016). Whilst glutamatergic 
transmission has acute vulnerability, delayed deficits in GABAergic may contribute to 
excitotoxic degeneration (Schwartz-Bloom & Sah 2001). A recent study investigated the 
protein changes in synaptosome fractions from the cortex of BCCAO rats 7 weeks after 
surgery, and found that proteins involved in glutamatergic and GABAergic transmission 
were reduced (Völgyi et al. 2017). This is supported by the observation that a GABAB 
receptor agonist, baclofen, ameliorated cognitive impairment after BCCAO in rats (Li et 
al. 2014; Lu et al. 2016; Luo et al. 2016).  
Global ischaemia also impacts post-synaptic terminals, largely as a result of glutamate 
spillover and overactivation of postsynaptic glutamate receptors. A study investigating 
the protein levels of different AMPAR and NMDAR subunits demonstrated that some 
subunits are more vulnerable than others in the CA1 in the sub-acute stage following 
transient global ischaemia (Han et al. 2016). In particular, AMPAR subunit GluR2 levels 
were decreased, while GluR1 levels remained unchanged; and while NMDAR subunits 
NR2A and NR2B were both reduced, the effect was more pronounced in the case of 
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NR2A. Interestingly, the researchers did not find any changes in AMPAR or NMDAR 
subunits in the CA3 compared to sham controls, indicating that this region is not 
susceptible to ischaemic damage, unlike the neighbouring CA1. Their interpretation was 
that the CA3 has greater inhibitory innervation than the CA1 (Yao et al., 1996), therefore 
it has greater resistance to excitotoxcity; there are higher levels of AMPAR and NMDAR 
subunits in the CA3 compared to the CA1 under normal conditions (Coultrap et al. 2005; 
Butler et al. 2010) and CA3 express hamartin an endogenous neuroprotective factor, 
which protect against ischaemic injury (Papadakis et al. 2013). 
AMPAR and NMDAR are crucial for synaptic morphology and plasticity, thus changes in 
their expression will impact synapse function. A recent study showed that the density of 
GluR2-positive termials was reduced in the CA1 at 1-24 weeks post-BCCAO in rats, whilst 
NR1 density increased (Wang et al. 2016). They theorised that this was a result of 
converting functional AMPAR-rich postsynaptic terminals, into AMPAR-silent non-
functional synapses, linking this to the fact that their rats showed evidence of impaired 
spatial and working memory. Other research indicates that the mechanism underlining 
this change in synapse functionality is due to internalization of GluR2 AMPA-receptor 
subunits during ischaemic conditions (Liu et al. 2006). In another study, however, BCCAO 
resulted in reductions of hippocampal PSD95 and NMDAR subunit NR2B protein levels, 
LTP deficits and spatial memory impairment, as found 4 weeks after surgery (Yang et al. 
2017). Conversely, in a model using unilateral common carotid artery occlusion (UCCAO), 
PSD95 protein levels was slightly increased in the cortex at 2.5 months after surgery 
(Zhao et al. 2014). UCCAO surgery induces an acute CBF reduction, which is statistically 
indistinct at day 15 from the before-surgery recording (Guo et al. 2011). This model, 
therefore, has modest blood flow changes compared to BCCAO surgery, and instead of 
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inducing postsynaptic degeneration it may stimulate compensatory mechanisms 
resulting in a PSD95 increase.  
Taken together, these papers indicate that dendritic, and glutamatergic pre- and 
postsynaptic loss occurs at acute and long-term stages after global ischaemia. To the 
best of my knowledge, to date there are no studies that have investigated whether 
modest, sustained, global hypoperfusion induced by carotid artery stenosis results in 
synaptic changes.  
1.7.4.2 Focal ischaemia and synapse changes 
A number of publications have investigated predominantly acute impact of focal 
ischaemia on synapses. Publications by Tim Murphy and colleagues have demonstrated, 
with in vivo multiphoton imaging through cranial windows, that cortical 
photothrombosis results in focal blebbing of dendrites and dendritic spines, which 
postsynaptic densities project from (Brown et al. 2007; Zhang et al. 2005; Zhang & 
Murphy 2007; Li & Murphy 2008; Enright et al. 2007). Their studies have shown that 
dendrites and spines are rapidly disrupted near the occlusion site, leading to a reduction 
in the activity of the forelimb response of the somatosensory cortex. An interesting 
finding was that if the clots broke up and reperfusion occurred between 20-50 minutes 
after activation, there is partial restoration of the dendrites and spines, whilst prolonged 
ischaemia resulted in irreversible damage (Zhang et al. 2005). In a focal ischaemic lesion, 
there is a lesion core of irreversible neuron death, whilst the tissue immediately 
surrounding the lesion is a region of delayed damage, known as the penumbra or peri-
lesion. An additional study from Tim Murphy’s group demonstrated that the ~50-100 μm 
surrounding the core had delayed dendrite and spine loss, which gradually occurred over 
5-6 hours post-activation (Zhang & Murphy 2007). They further investigated the effect of 
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vessel occlusion on local dendritic structure by applying transient MCAO to the YFP mice. 
In this study they showed that 60 minutes of MCAO resulted in a lesion core of 
irreversible dendritic damage, however, the penumbra region experienced some 
recovery, 3 hours after reperfusion (Li & Murphy 2008). These studies demonstrated 
that dendrites and spines are vulnerable to focal ischaemia, but undergo some recovery 
if the blockage is removed or within the peri-lesion at the acute stages following 
ischaemia.  
To date there have been few studies that have investigated the sub-acute and chronic 
stages of focal ischaemia on synapses. A study analysing the protein levels of VGLUT 
isoforms following transient MCAO in rats showed that VGLUT1 is increased above the 
control level at day 1 in the striatum and day 3 in the cortex, which then drops below the 
control level by day 7 (Sánchez-Mendoza et al. 2010). This result indicates that an 
increase in VGLUT1+ synaptic terminals could be an early response to focal ischaemic 
damage, with delayed synaptic degeneration occurring at sub-acute and chronic stages. 
This finding is contradicted by another study which found gradually increasing levels of 
synaptophysin from 8 days to 30 days in the lesion and peri-lesion cortex using the 
photothrombotic model in mice (Madinier et al. 2013). The discrepancy between these 
papers may result from the differences in the model, as others have reported that 
photothrombosis stimulates synapse reorganisation in the peri-lesional cortex. Among 
these studies is a recent paper by Stokowska et al, who found a long-term increase of 
synapsin I+ and VGLUT1+ terminals in the peri-lesional cortex, compared to the 
contralateral hemisphere, 21 days after photothrombosis (Stokowska et al. 2016). 
Cooperrider et al. demonstrated that the protein levels of PSD95 and synaptophysin 
were increased in the peri-lesion, 5 weeks after inducing a small ischaemic lesion in the 
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motor cortex with ET-1 (Cooperrider et al. 2014). They also found that these protein 
levels were increased with deep cerebellar stimulation, indicating that electrical activity 
can stimulate synaptogenesis in the peri-lesion. Furthermore, multiphoton imaging 
captured the reorganisation of dendrites and blood vessels in the peri-lesion of a 
photothrombotically-induced lesion (Brown et al. 2007). Overall, these studies 
demonstrate that whilst focal ischaemia induces synaptic degeneration within the lesion 
site, it can also stimulate recovery processes that include a delayed increase in synaptic 
terminal densities in the peri-lesions. 
Focal ischaemia can induce neurodegeneration in distal brain regions, connected to the 
occlusion territory, by secondary neurodegeneration. This is based on evidence from 
animal models that demonstrated that activity dysfunction and cell damage occurs in 
brain regions connect to the lesion site, known as diaschisis (Carrera & Tononi 2014). 
MCAO surgery causes ischaemic lesions to occur within the striatum, which is connected 
to the substantia nigra, thalamus and cortex (see Figure 1.7), therefore, pathological 
changes have been identified in these regions in this model. MCAO surgery in rats 
induced a decrease in synaptic activity in the ipsilateral substantia nigra (Nakanishi et al. 
1997). Distal MCAO or Rose Bengal photothrombosis induce ischaemic lesion 
predominantly in the cortex, therefore, leads to secondary pathological changes in the 
thalamus (Doyle et al. 2015; Kluge et al. 2018; Jones et al. 2018)and hippocampus 
(Sopala et al. 2000). Interestingly, there is also evidence of focal ischaemia stimulating 
recovery processes in diaschisis sites, as it induced a delayed increase in hippocampal 
synaptophysin levels (Madinier et al. 2013) and activate neurogenesis in the dendate 
gyrus subgranular zone (Lichtenwalner & Parent 2006). Taken together, these studies 
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demonstrate that focal ischaemia can induce secondary neurodegenerative changes in 
connected brain regions, as well as stimulating some recovery changes. 
Most studies of experimental models of hypoperfusion/ischaemia have not taken into 
consideration the heterogeneity of the human condition where multiple comorbidities in 
addition are normally present. There is a gap in our knowledge as to whether multiple 
comorbidities have an exaggerated impact on synapses. There is evidence that the 
comorbidities of focal ischaemia and age resulted in significant synapse protein loss in 
the thalamus, compared to the young mice (Kluge et al. 2018). As previously mentioned, 
Figure 1.7 Neuronal network connecting the striatum to the internal capsule, substantia 
nigra pars reticulate and thalamus; regions that are vulnerable to primary and secondary 
neurodegeneration in rodent MCAO model. The striatum receives glutamatergic projections 
from the thalamus and cortex. Inhibitory neurons project from the striatum to the substantia 
nigra pars reticulata (SNR) in the direct pathway, whilst in the indirect pathway, inhibitory and 
excitatory projections connect the striatum, globus pallidus (GPe) and subthalamic nucleus 
(STN) and SNR (Benarroch 2016). These projections run through the internal capsule white 
matter tract (Reinius et al. 2015).  
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the Nun study showed that the presence of Alzheimer’s pathology and vascular 
pathology result in worsened functional outcome, compared to patients with only 
vascular pathology (Snowdon et al. 1997). A recent publication, demonstrated that DH 
stroke model induced more exacerbated cholinergic degenerated in the cortex of APP-SL 
transgenic mice (Nguyen et al. 2018). There is also evidence that focal ischaemia in 
Tg2576 results in larger infarcts than in WT mice (Milner et al. 2014). Moreover, previous 
work from our group demonstrated that hypoperfusion induced more microinfarcts in 
TgSwDI mice than in WT mice (Salvadores et al. 2017). These studies imply that 
comorbidities of hypoperfusion/ischaemia and β-amyloid induce worsened pathology 
when present together, and remains to be seen whether they exacerbate synaptic 
degeneration. 
1.8 Hypothesis  
The over-arching hypothesis of this thesis is the chronic impact of reduced CBF is the 
degeneration of glutamatergic pre- and post-synaptic terminals in specific brain regions. 
Second to this, these changes are exacerbated when concurrent β-amyloid pathology is 
also present. To address this, the impact of different models of CBF reductions, BCAS and 
MCAO, were studied in WT and TgSwDI mice with the following aims. 
1.9 Aims 
1. To establish whether chronic cerebral hypoperfusion (induced by BCAS surgery) 
results in degeneration of dendrites and glutamatergic pre- and postsynaptic 
terminals, in brain regions that are associated with spatial working memory. 
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2. To elucidate whether transient focal ischaemia (induced by MCAO surgery) 
causes long-term focal degeneration of glutamatergic pre- and post-synaptic 
terminals in the ischaemic territory in WT mice, related to impaired motor 
function. And whether these changes are exacerbated in TgSwDI mice. 
 
3. To determine whether transient MCAO causes long-term degeneration of 
glutamatergic pre- and post-synaptic terminals in remote brain regions that 
connect with the primary lesion site and to elucidate whether these changes are 
exaggerated in TgSwDI mice. 
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Chapter 2:  Materials and Methods 
2.1 Animals 
All procedures were authorised under the project licence number 60/4350 held by Prof. 
Horsburgh, approved by the UK Home Office and the University of Edinburgh's Ethical 
Review Committee and adhered to regulations specified in the Animals (Scientific 
Procedures) Act (1986).  
All mice used in the studies were male. In the studies of wild-type mice, the strain used 
was C57BL/6J mice purchased from Charles River. Transgenic mice used were all on a 
C57Bl/6J background. This strain is appropriate to use for our investigations, as unlike 
other strains, they mostly have an incomplete circle of Willis and poor collateral supply, 
which increases the chances of successful surgically induced CBF reductions.  
The mice were housed in groups of up to 6, on a 12-hour light/dark cycle, with a constant 
temperature and free access to food and water. The ages and the ‘n’ numbers for the mice 
are stated in the methods section for each results chapter.  
2.1.1 TgSwDI mice 
TgSwDI mice express human neuronal amyloid precursor protein (APP), harbouring the 
Swedish (K670N/M671L), Dutch (E22Q) and Iowa (D23N) mutations, under the control of 
the Thy1.2 promoter (Figure 2.1). The Swedish mutation causes increased burden of Aβ40 
and Aβ42 peptides (Kalaria & Hedera 1996), whereas the Dutch and Iowa mutations lead to 
increased Aβ40 deposition in the vasculature (Levy et al. 1990; Grabowski et al. 2001). 
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TgSwDI is not an overexpression model, as the expression of human APP is about 50% less 
than that of the endogenous mouse APP (Davis et al. 2004). Heterozygous TgSwDI 
transgene causes progressive β-amyloid deposition in the parenchyma and 
microvasculature, starting at approximately six months of age. The brain regions which 
exhibit β-amyloid burden in older mice are the thalamus and cortex (Miao et al. 2005).  
2.1.2 PSD95:eGFP x TgSwDI 
Male homozygous PSD95:eGFP mice on a C57BL/6J background were supplied by our 
collaborator Prof. Seth Grant, Edinburgh. PSD95 is a stable scaffold protein involved in the 
assembly of receptors and signalling proteins in the postsynaptic densities (Zhu et al. 
2018). This model has enhanced green fluorescent protein (eGFP) fused onto endogenous 
PSD95 (Figure 2.2). The male homozygous PSD95:eGFP mice were bred in house with 
Figure 2.1 Schematic of the TgSwDI mutant human APP construct, expressed by the mice. 
TgSwDI contains the Swedish (K670N/M671L), Dutch (E693Q) and Iowa (D694N) mutations 
under the Thy1.2 promoter. Taken from (Davis et al. 2004). 
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homozygous TgSwDI females on C57BL/6J background, to result in PSD95:eGFP+/- x 
TgSwDI+/-  and PSD95:eGFP+/- x TgSwDI-/- (referred to as WT littermates) offspring.  
2.1.3 Arc-Venus 
Arc-Venus mice on a C57BL/6J background were also supplied by Prof. Seth Grant. Arc is 
localised in postsynaptic sites and its mRNA is rapidly transcribed following synaptic activity 
(Link et al. 1995). Tagging endogenous Arc with Venus fluorescent protein enables the 
detection of synaptic activity (Fernández et al. 2017). 
2.2 Surgery 
2.2.1 Bilateral common carotid artery stenosis 
Chronic cerebral hypoperfusion was induced surgically by bilateral common carotid artery 
stenosis (BCAS). This model has been well-characterised by our group (Coltman et al. 2011; 
Reimer et al. 2011; Kitamura et al. 2017; Holland et al. 2011; McQueen et al. 2014). Mice 
were anaesthetised initially with 5% isofluorane, then with 1.5% isofluorane during 
surgery. A midline cervical incision was made and the common carotid arteries were 
exposed. Microcoils with an internal diameter of 0.18 mm or 0.16mm (Sawane Spring Co. 
Japan) were permanently fitted onto both common carotid arteries, with a 30 minute 
interval between application of each microcoil (Figure 2.3). The wound was sutured up and 
the mice were placed in an incubator (30° C) until fully recovered from the anaesthesia. 
The same surgical procedure was performed on the sham animals, but without the 
Figure 2.2 Schematic of PSD95:eGFP transgene. Image provided by Noboru Komiyama.  
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application of the microcoils. Following surgery, the weight and general health of the mice 
were closely monitored. The surgery was performed by Prof. Karen Horsburgh.  
Figure 2.3 Schematic representation of bilateral common carotid artery stenosis (BCAS) 
surgery used to induce cerebral hypoperfusion. (A) Microcoil schematic with internal 
diameter of 0.18mm or 0.16mm, for modest or severe hypoperfusion, respectively. (B) 





2.2.2 Middle cerebral artery occlusion 
Focal ischaemia was induced by 15 minutes of middle cerebral artery occlusion (MCAO). 
The mice were anaesthetised, initially with 5% isofluorane, then with 1.5% isofluorane 
during surgery. A midline cervical incision was made to expose the left common carotid 
(CCA), external carotid (ECA) and internal carotid (ICA) arteries and their branches. A 6-0 
silk suture was tied around the CCA proximal to the bifurcation of the ECA and ICA, then a 
second suture was tied around the ECA distal to the superior thyroid artery (STA). The STA 
and occipital artery (OA) was closed by electrocoagulation.  A silicone-coated 
Figure 2.4 Schematic presentation of middle cerebral artery occlusion (MCAO) surgery 
used to induce focal ischaemia. (A) The common carotid artery (CCA) and external 
carotid artery (ECA) are permanently ligated with sutures and a monofilament is inserted 
into an incision in the internal carotid artery (ICA) and advanced to occlude the entrance 
of the middle cerebral artery (MCA). (B) Schematic showing the anatomical location of 
the MCA on a mouse brain and the lenticulostriate ‘end arteries’ that supply the 
striatum, plus the location of a striatal ischaemic lesion caused by MCAO surgery. 
Adapted from (Morris et al. 2016). 
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monofilament (diameter 220 µm) was introduced into the CCA via a small incision and 
advanced 10 mm distal to the carotid bifurcation, to occlude the MCA.  The wound was 
then closed with one suture. The mice were placed in an incubator (30° C) for the duration 
of occlusion time (15 minutes) and recovered from anaesthesia during this period. 
Following this, the mice were re-anaesthetised with isofluorane; the suture was removed 
to reopen the wound and the monofilament was withdrawn. The ECA remained 
permanently ligated. The wound was closed and the mice were placed in an incubator for 2 
hours to recover. The mice were monitored 2-3 times a day for the first week, and 
regularly monitored thereafter.   
2.2.3 Rose Bengal photothrombosis  
Experiments were performed to optimise an approach that induces the formation of a 
cortical ischaemic lesion with Rose Bengal photothrombosis. See experiment details in 
Chapter 4. 
2.3 Laser speckle imaging  
Laser speckle imaging was used to assess the cortical cerebral blood flow following Rose 
Bengal photothrombosis and MCAO surgery. The mice were anaesthetised with 5% 
isofluorane. Once fully anaesthetised, the mice were placed on a stereotaxic frame, with 
the head secured with ear and tooth bars, and ventilated through a nose cone with 1.5% 
isofluorane and 100% oxygen, at a rate of 150 breaths per minute. A midline incision was 
made and the scalp was held open by clips to expose the skull. The skull was cleaned from 
fur using ultrasound gel and sterile cotton buds, then a layer of gel was spread over it to 
prevent the skull from drying. The cortical cerebral blood flow was recorded for 3 minutes 
using a Laser Speckle Contrast Imager (Moor FLPI2 Speckle Contrast Imager, Moor 
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Instruments, UK). The wound was then sutured and the mice were recovered in an 
incubator. The laser speckle images were analysed using MoorFLPI-2 Review software. 
2.4 Behaviour 
2.4.1 Radial arm maze 
To determine whether mild chronic cerebral hypoperfusion affected the spatial working 
memory, the animals underwent behavioural experiments in an eight-arm radial arm maze 
(RAM), as previously described (Coltman et al. 2011). One week prior to starting the RAM 
experiment (eight weeks after surgery), animal food consumption was restricted to reduce 
the animals by 10-15% of their initial weight. A former member of the group, Dr Yasmina 
Manso Sanz, carried out the RAM experiment, and I did the statistical analysis and 
interpretation of the data.  
The RAM procedure commenced with two days of pre-training, in which the mice were 
allowed to freely explore the maze and collect food pellets from the ends of the maze 
arms, to become habituated to the apparatus and the task. Following this, the spatial 
working memory of the mice was probed. The eight arms of the RAM were baited with 
food pellets. Each mouse was placed in the central platform of the maze and allowed to 
choose an arm to receive the food pellet at the distal end and return to the centre, ready 
to choose again. The task was completed when the mouse had visited all eight different 
arms to retrieve the food pellet, or after 25 minutes of the test. Each mouse received 1 
trial per day for 16 consecutive days. The number of revisiting errors was recorded for each 
trial; higher errors indicated a greater deficit in spatial working memory. The data was 
expressed as averages for each block: Block A is averaged data from day 1-4; Block B, day 
5-8; Block C, day 9-10; Block D, day 11-12; Block E, day 13-14; and Block F, day 15-16. The 
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data was analysed by comparing the average revisiting errors between sham and BCAS 
mice over-time, with repeated measures two-way ANOVA.  
2.4.2 Ladder-rung test and neurological score 
A modified version of the ladder-rung test was used to probe for motor deficits following 
MCAO (Farr et al. 2006). A clear Perspex ladder (35cm long, 8cm wide, with 1.5cm gap 
between rungs) was suspended between two stacks of cages on a flat tabletop. The ladder 
started on the lid of a neutral cage containing only clean bedding, and ended on the lid of 
the mice’s homecage. Both cage were stacked on top of upturned cages so there was 
enough space for a camcorder to be placed underneath. The mice were placed on the start 
cage and had to walk across the ladder to their home cage, whilst their limb placements on 
the rungs were recorded with the camcorder below. On each day, they did one practice 
trial and three experimental trials. The contralateral limb placements were analysed by 
watching the recordings at half speed and counting how many times the mice made a 
correct limb placement, partial limb placement or slipped. Partial placement was when the 
mouse would place one or two digits on the rung. At each time point for each mouse, the 
sum of the number of partial placements and slips for all 3 trials was divided by the total 
Figure 2.5 Schematic of the ladder-rung test. (A) Apparatus set up for the ladder-rung test. 
(B) Types of limb placement recorded. 
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number of limb placements, and multiplied by 100 to get a limb placement % error (Figure 
2.5).  
2.5 Tissue harvesting and processing  
2.5.1 For histology 
2.5.1.1 Transcardial perfusion  
Mice were placed in an anaesthetic chamber containing 5% isoflurane. Once deeply 
anesthetised, they were transferred to an operating table and maintained under 3% 
anaesthesia during the procedure.  A midline incision was made and the diaphragm and 
ribcage were cut to expose the heart. A butterfly needle connected to a cannula was 
inserted into the left ventricle and clamped into place, followed by a small incision in the 
right atrium for blood to drain out. The mice were perfused by pumping 30 mL of 0.1% 
heparinised phosphate buffered saline (PBS) (pH 7.4) through the cannula, at a rate of 2 
mL/minute.  
2.5.1.2 Cryostat cutting 
Brains were removed from the skull and immersion fixed in 4% paraformaldehyde (PFA) 
and stored at 4°C for 24 hours. The brains were then transferred to 30% sucrose (Sigma 
S9378) solution for 72 hours. Following this, the brains were frozen in isopentane at -42˚C 
and kept at -80˚C before cutting on a cryostat (Leica CM1950). The brains were cut into 30 
µm coronal sections, and slide-mounted or placed in cryoprotective medium (30% glycerol, 
30% ethylene glycol in PB) in 24 well plates, and stored in -20˚C freezer. 
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2.5.1.3 Vibratome cutting 
As before, each brain was removed from the skull and immersion fixed in 4% 
paraformaldehyde (PFA) and stored at 4°C for 24 hours. The brains were then transferred 
into PBS and cut on a vibratome. The brains were cut into 30 µm coronal sections, using 
frequency of 70, amplitude of 0.9 and velocity of 18. The sections were stored at -20˚C in 
cryoprotective medium (30% glycerol, 30% ethylene glycol in PB) in 24 well plates.   
2.5.2 For biochemistry 
Mice were culled by schedule 1 cervical dislocation, followed by decapitation. The brains 
were removed and sectioned into 2 mm slices using a mouse brain matrix; the slices were 
taken from around 0.38mm to -1.62mm from bregma was identified. The slices were cut 
into hemibrains and frozen in liquid nitrogen and stored in the -80˚C freezer. 
2.6 Histology 
2.6.1 Haematoxylin and eosin staining 
Before staining, the sections were washed in PBS pH 7.4 (3 x 15minutes) and TB pH 7.6 (2 x 
15minutes) to remove the cryoprotective medium; mounted on superfrost plus slides 
(VWR International) and left to air-dry overnight. Sections were dehydrated starting from 
running tap water and taken through serial alcohols (70%, 90%, 100%) and then in xylene 
for 10 minutes; then rehydrated by the reverse. Sections were stained with filtered 
haematoxylin (Thermo Fisher, UK) for 3 minutes, rinsed in running water and placed in 1% 
Acid Alcohol for 10 minutes and rinsing in running water again for 2 minutes. The sections 
were then placed in Scott’s tap water for 2 minutes, stained with EosinY Alcoholic (Thermo 
Fisher, UK) for 20 seconds, and rinsed in running water again. Finally, the sections were 
97 
dehydrated again via the same procedure and incubated in xylene for 15 minutes before 
mounting the cover-glass with DPX.  
2.6.2 Cresyl violet staining 
Sections were mounted on slides, dried, dehydrated and rehydrated as described in 
Section 2.6.1 for Haematoxylin and Eosin staining. After rinsing in running water for 5 
minutes, the sections were stained with filtered cresyl violet solution for 20 minutes. The 
sections were then dipped into the serial alcohols (70%, 90%, 100%) and incubated in 
xylene for 15 minutes for mounting with DPX. 
2.6.3 Immunohistochemistry 
All primary and secondary antibodies used in immunohistochemistry are listed in Table 2.1. 
Optimisation experiments were undertaken to determine the primary antibody 
concentrations, retrieval types and whether to use direct or indirect secondary labelling in 
protocols. For each experiment there was a negative control of an additional section that 
did not receive primary antibody incubation.  
2.6.3.1 Immunoperoxidase labelling 
The sections were washed in PBS pH 7.4 (3 x 15minutes) and TB pH 7.6 (2 x 15minutes) to 
remove the cryoprotective medium; mounted on superfrost plus slides (VWR International) 
and left to air-dry overnight. Sections were dehydrated from running tap water, through 
serial alcohols (70%, 90%, 100%) and in xylene for 10 minutes. 
The sections were then rehydrated in 100% ethanol and endogenous peroxidase was 
quenched using 3% hydrogen peroxide solution for 30 minutes. For Iba1 and GFAP 
detection, antigen retrieval was performed by incubating the slides in 10mM citric acid 
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(pH6) and heating to 95˚C for 10minutes, in Decloaking Chamber NxGen (Biocare Medical). 
For 6E10 detection, the sections were placed in 70% formic acid for 20 minutes. Following 
retrieval, the sections were washed in PBS and incubated in blocking solution (10% horse 
or goat normal serum, 0.5% bovine serum albumin (Sigma A7030) in PBS) for 2 hours at 
room temperature. The primary antibodies in blocking solution were incubated on the 
sections overnight at 4˚C. Following this, the sections were washed in PBS and incubated 
with the secondary biotinylated antibody for 1 hour at room temperature. Signal 
amplification was performed using a Vector ABC Elite Kit (Vector Labs, UK) for 1 hour at 
room temperature. The sections were washed with PBS and peroxidase activity was 
detected with 3 minute incubation with 3,3’ diaminobenzadine tetrahydrochloride (DAB, 
Vector Labs, UK). The sections were rinsed in running water and dehydrated through serial 
alcohols (70%, 90%, 100%), then kept in xylene for 15 minutes before mounting with DPX. 
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2.6.3.2 Immunofluorescent labelling, slide mounted method 
The sections were washed, mounted on slides and dehydrated as described above in 
Section 2.6.3.1. Sections for PSD95 detection underwent citrate antigen retrieval, at 110°C 
for 10 minutes, then were rinsed in running water and washed with in PBS with 0.2% triton 
X for 15 minutes each. Sections for GluR1 detection did not require antigen retrieval. The 
sections were blocked in 10% horse or goat normal serum, 0.5% bovine serum albumin 
(Sigma A7030) in PBS with 0.2% triton-x for 2 hours at room temperature. The primary 
antibodies in blocking solution were incubated on the sections overnight at 4˚C. Following 
this, the sections were washed in PBS and incubated with the secondary biotinylated 
antibody in PBS (1:100) for 2 hours. This was followed by PBS washes and application of 
streptavidin alexa flour 488 in PBS (1:100) for 2 hours. Finally, the sections were washed 
twice in PBS, then once in TB for 10 minutes each, and air-dried in the dark. The cover-
glasses were applied with vectashield hardset with DAPI (Vector H-1500), sealed with nail 
varnish and stored at 4˚C to await imaging. 
2.6.3.3 Immunofluorescent labelling, free-floating method 
The protocol was carried out on sections in 24 well plates placed on a shaker. The sections 
were washed in PBS (3 x 15minutes). For the sections immunostained for TMEM119, 
antigen retrieval was performed by microwaving a flask of citric acid (10mM, pH6) to 
boiling (5 minutes) and pouring it into the well plate for 30 minutes, before removing the 
solution and washing with PBS. In all protocols, the sections were wash in PBS with 0.1% 
triton-x (3 x 15 minutes) and then blocked for 2 hours with 10% horse or goat normal 
serum, 0.5% bovine serum albumin (Sigma A7030) in PBS. Next, the sections were 
incubated overnight at 4˚C with primary antibodies in blocking solution. The sections were 
returned to room temperature and washed in PBS. For direct staining (MAP2 and 
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TMEM119 IHC), the sections were incubated for 2 hours with fluorescent conjugated 
antibodies in PBS (1:500), then washed in PBS and TB, and mounted onto superfrost plus 
slides (Thermo Scientific). For indirect staining (VGLUT1 IHC), biotinylated secondary 
antibodies in PBS (1:100) were applied to the tissue for 1 hour, washed with PBS and 
incubated with streptavidin alexa fluor 488 in PBS (1:100) for 2 hours at room temperature. 
The sections were dried in the dark, cover glasses applied with vectashield hardset with 
dapi (Vector H-1500), sealed with nail varnish and stored at 4˚C. 
2.6.4 Analysis of histology  
2.6.4.1 Confocal imaging 
Laser scanning confocal microscopy system used was LSM 710 (Carl Zeiss Microscopy, 
Cambridge, UK). Image analysis was performed with ImageJ software (v1.46, NIH Bethesda, 
MD, USA). See chapter methods for specific analysis details.  
2.6.4.2 Slide scanner imaging  
Zeiss Axio Scan.Z1 slide scanner was used to capture tiled images of entire tissue sections 
and the images were converted into tiff files with ZEN imaging software by Zeiss. Image 
analysis was performed with ImageJ software (v1.46, NIH Bethesda, MD, USA). See chapter 
methods for specific analysis details.  
2.7 Biochemistry 
2.7.1.1 Tissue homogenisation 
After harvesting and freezing tissue (Section 2.5.2), the sections were removed from -80°C 
freezer. The sections were placed on a lid of a plastic petri dish in a tub of wet ice and 
allowed to thaw slightly. Using a scalpel, the striatum was cut away from each section and 
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weighed in fresh eppendorf tubes and put on wet ice. The tissue was homogenised in a 
buffer of: 20mM Tris Base; 1mM EDTA; 1mM EGTA; 250mM sucrose; 1:100 protease 
inhibitors (Calibiochem, 53913) and 1:50 phosphatase inhibitors (Merck, 524629). The 
volume of buffer used was 5x the weight of the tissue and added to the eppendorf tube. 
Fifteen strokes of a plastic plunger tip was used to homogenise the tissue, then a 
motorised homogeniser was used with same plunger tip for a count of 4. The homogenate 
was centrifuged at 3000 rpm for 5 minutes at 4°C and the supernatant was taken off and 
aliquoted for protein concentration analysis and western blotting. 
2.7.1.2 Protein concentration 
The protein concentrations were analysed with the Pierce BCA Protein Assay Kit (Thermo 
Scientific) and performed according to the manufacturer’s instructions. The absorbances 
were measured at 562nm on a FilterMax microplate reader (Molecular Devices, CA, USA). 
2.7.1.3 Western blot 
Optimisation experiments were performed to determine the protein concentration, 
primary antibody concentration, and whether to use direct or indirect secondary labelling 
in these protocols.   
NuPage western blot products were sourced from Invitrogen. Samples were prepared to 
15μg in 10μl in NuPage LDS sample buffer (4x) and NuPage reducing agent (10x), and 
denatured at 90°C for 10 minutes. 12μl of the sample solutions were run on NuPage 4-12% 
Bis-Tris 1.0mm x 15 well gels, in with NuPage Mes SDS running buffer. The gels were run 
for 1.5 hours at 80V. Proteins were transferred onto PVDF membranes (Immobilon-FL, 
Millipore) in transfer buffer (192mM glycine; 25mM pH8.3 trizma base; 20% v/v methanol), 
at 70V for 2 hours. Afterwards, the membranes were blocked for an hour in Odyssey 
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blocking buffer (Licor, 927-40000), made up in PBS at 1:1. The membranes were then 
incubated overnight at 4°C with primary antibodies (see Table 2.2) in 1:1 Odyssey blocking 
buffer: PBS 0.1% Tween, on a shaker. The next day, the membranes were washed with PBS 
0.1% Tween and then incubated secondary antibody dilutions (see Table 2.2) at room 
temperature for an hour, in a black box on a shaker. For targets that required signal 
amplification with indirect labelling, the membranes were washed again in PBS 0.1% 
Tween, and fluorescent streptavidin solution was applied for an hour. Following 





2.8 Statistical analysis 
All statistical analysis was performed on GraphPad Prism software (v5.01, GraphPad 
Software Inc., La Jolla, USA). Details for the specific statistical analysis details are stated in 
the chapter methods. All data is presented as mean ± standard deviation, and p<0.05 was 
considered to be statistically significant. 
2.9 ARRIVE and IMPROVE guidelines 
ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines are designed to 
improve the reporting of studies that use animal models. The present studies were 
designed according to ARRIVE recommendations. The number of experimental and control 
groups for each study are stated in the methods section for each results chapter. To 
minimise experimental bias, the animals were randomly allocated to sham-operated or 
BCAS/MCAO-operated groups. The experiments and analysis were performed in a blinded-
manner: the animals were randomly assigned a numerical code and the data was recorded 
under this code, without knowing the surgery or genotype status of the animals. After the 
data sets from all experiments had been finalised, the codes were broken and the data was 
statistically analysed between the experimental groups. 
The MCAO studies followed IMPROVE (Ischaemic Models: Procedural Refinements Of in 
Vivo Experiments) guidelines, which promotes experimental design that improves animal 
welfare and reduces their suffering, while maintaining the value of the research (Percie du 
Sert et al. 2017). Firstly, the present studies followed the IMPROVE guidelines by the 
choice of MCAO model: 15 minutes of intraluminal filament MCA occlusion. As these 
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studies were investigating the chronic impact of focal ischaemia and required the animals 
to be recovered for 3 months after surgery, a relatively short occlusion time was chosen to 
reduce the animals’ suffering and increase their chances of surviving for that long. 
Furthermore, the animals were closely monitored after surgery, by checking their body 
weight and condition every day for the first week and regularly thereafter.  
The IMPROVE guidelines stipulate the importance of pre-surgery acclimatisation (Percie du 
Sert et al. 2017). The mice used in these studies were bred in-house and were acclimatised 
to the animal unit prior to surgery. The condition of the mice was observed before surgery, 
checking their body weight and coat condition; one mouse was culled before surgery as it 
was the runt of the litter. IMPROVE guidelines were followed in that the mice were housed 
with the same groups before and after surgery. The cages contained the same 
environmental enrichment as each other, consisting of two cardboard tunnels and nesting 
material; ‘super-enrichment’ was not used to prevent neurorestorative effects. As 
recommended by IMPROVE, the animals were randomised so each cage contained both 
sham- and MCAO-operated animals. The diet was kept the same for the animals before 
surgery and throughout the experimental period, and they had a plentiful supply.  
All surgical procedures were performed with aseptic techniques. Sham-operated animals 
received the same anaesthetic and surgical treatment as MCAO-operated animals, apart 
from insertion of the intraluminal filament. The mice were checked to be deeply 
anaesthetised prior to surgical incisions being made. The animals’ body temperatures were 
regulated throughout surgery with a rectal thermometer and heated mat. The animals’ 
respiratory rates were also regulated throughout surgery. Immediately after surgery, the 
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mice were pre-emptively given a 500mL subcutaneous injection of sterile saline solution to 
help prevent dehydration. 
The animals were closely monitored after surgery and the vet was consulted about animals 
that were losing too much weight or appeared to be in pain. The animals were checked 
three times a day for 48 hours after surgery, then 2 times a day for the rest of the week. 
These checks included observing whether the mice were eating and drinking, their coat 
quality and movement abilities. Their body weight was recorded every morning for the first 
week after surgery, and then once a week thereafter. For the first week after surgery the 
animals were given ‘mash’, which was their diet pellets soaked in drinking water. Animals 
that lost 18% of their pre-surgery body weight were given a 500mL subcutaneous injection 
of sterile saline solution to help them become rehydrated and improve their condition. If 
the animals’ weight decreased by 20% of their pre-surgery body weight, they would be 
culled to prevent suffering. Thanks to rigorous animal monitoring only 3 mice out of a total 
of 80 that underwent MCAO (or sham) surgery had to be culled due to significant weight 
loss. None of the animals were found dead. Notes were taken to record the conditions of 





Chapter 3:  The impact of chronic cerebral 
hypoperfusion on dendrites and glutamatergic 
synapses 
3.1 Introduction  
Chronic cerebral hypoperfusion has been proposed as a central common mechanism, 
contributing to cognitive decline and degenerative processes leading to dementia. This is 
based on evidence that global reductions in blood flow are associated with increased risk 
of progression from mild cognitive impairment to dementia, with the degree of CBF 
reduction correlating with the severity of cognitive impairment (Alsop et al. 2010; Chao et 
al. 2010; Huang et al. 2002; Ruitenberg et al. 2005). Moreover, investigations in rodent 
models have shown that hypoperfusion can induce pathological changes relevant to VCI 
and dementia. Previous studies from our group and others have shown that surgically 
induced hypoperfusion leads to long-term deficits in spatial working memory (Coltman et 
al. 2011; Kitamura et al. 2017; Shibata et al. 2004; Holland et al. 2015). A number of 
mechanisms have been proposed that link hypoperfusion to cognitive decline, however, it 
is unclear whether these include synaptic dysfunction and loss. Synaptic loss is the 
strongest correlating factor with cognitive decline in Alzheimer’s disease (Terry et al. 1991). 
It may also underpin cognitive decline in VCI, however, there have only been a few studies 
investigating changes in synaptic protein levels in this disease (Sinclair et al. 2015; Kirvell et 
al. 2010). A number of studies have shown that global ischaemia models in rodents results 
in synapse and dendritic loss, with selective vulnerability to excitatory, glutamatergic 
terminals in the CA1 of the hippocampus (Jia et al. 2012; Wang et al. 2016). It is unknown, 
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however, whether modest chronic cerebral hypoperfusion, indicative of early stages of VCI 
and dementia, contributes to synaptic degeneration. This study was designed to 
investigate whether chronic cerebral hypoperfusion (induced by BCAS surgery) would lead 
to progressive dendritic and glutamatergic synaptic degeneration, culminating in impaired 
spatial working memory.  
3.1.1 Hypothesis  
Chronic cerebral hypoperfusion leads to progressive degeneration of dendrites and 
glutamatergic pre- and postsynaptic terminals, culminating in cognitive decline and 
dementia. 
3.1.2 Aims 
The aim of this study was to establish whether chronic cerebral hypoperfusion (induced by 
BCAS surgery) results in degeneration of dendrites and glutamatergic pre- and postsynaptic 
terminals, in brain regions that are associated with spatial working memory. 
3.2 Methods 
3.2.1 Animals 
Male C57Bl/6J mice (4-5 months old) were used for a chronic cerebral hypoperfusion 
study. The mice were maintained on a 12:12 hour light/dark cycle, with ad libitum food and 
water access. All experiments were conducted in accordance with the Animals (Scientific 
Procedures) Act 1986 and local ethical approval at the University of Edinburgh and were 
performed under personal and project licenses granted by the Home Office. The data was 
collected and analysed in a blinded manner.  
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3.2.2 Bilateral common carotid artery stenosis (BCAS) 
Cerebral hypoperfusion was induced with BCAS surgery, according to Section 2.2.1. The 
microcoils of 0.18mm diameter were used. This study had two cohorts; one with 1 month 
recovery from sham or BCAS surgery, and the other had 3 months recovery from sham or 
BCAS surgery.  
The animal cohorts used for this study had been previously processed before I started in 
the lab. The tissue from the 1 month BCAS cohort was from an unpublished study, and the 
tissue 3 month cohort came from animals used in this published study (Kitamura et al. 
2017). Kitamura et al. were investigating whether the drug cilostazol alleviates white 
matter pathology after 3 months of BCAS surgery. Therefore, both 3-month sham and 
BCAS groups used in the present study were actually vehicle-treated controls. 
The present study did not use all of the animals in the 1 and 3 months cohorts; instead 8 
mice per group were randomly selected. This group size was chosen to make the 
experimental procedure more manageable, enabling all the tissue from all selected animals 
to be immunostained at once and for all the slides to be imaged in one session. This 
approach was chosen to try to reduce experimental variation between animals. Power-
calculations were not used to determine the group size. The animals had been given an 
experimental code. To select the 8 mice per group to use for the study, the total list of 
animal codes for each group were copied and pasted into an online randomiser 
(www.random.org), which then randomised the list of animal codes and the top 8 codes 
from each list were selected for the study. 
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3.2.3 Radial arm maze (RAM) 
Eight-arm RAM was used to probe for spatial working memory deficit in the 3-month 
cohort, see Section 2.4.1. The mice were trialled for 16 consecutive days. Number of 
revisiting errors were averaged and blocked, as previously described. Former lab member 
Dr Yasmina Manso conducted the RAM experiment. 
3.2.4 Tissue harvesting and processing 
Mice were transcardially perfused, as described in Section 2.5.1.1, and the tissue was 
processed, cut and stored according to Section 2.5.1.2. The tissue was cut into 30μm 
coronal sections, taken from throughout the striatal and hippocampal levels, and stored at 
-20˚C as free-floating sections in cryoprotective medium (30% glycerol, 30% ethylene glycol 
in PB) in 24 well plates.   
3.2.5 Detection of ischaemic neuronal pathology 
Tissue sections from level 0.14mm and -1.70mm from bregma were stained with 
haematoxylin and eosin (Section 2.6.1). The stained sections were viewed with a brightfield 
microscope, and areas of ischaemic neuronal pathology were imaged and measured with 
ImageJ. 
3.2.6 Detection of dendrites and synaptic terminals with 
immunohistochemistry 
For each mouse in both 1- and 3-month cohorts, a section was taken from level 0.14mm 
and -1.70mm from bregma. Dendrites, glutamatergic pre- and postsynaptic terminals were 
detected with immunofluorescent labelling for MAP2, VGLUT1, PSD95 and GluR1, as stated 
in Section 2.6.3.2-3 and Table 2.1.  
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3.2.7 Confocal microscopy and Image analysis 
Laser scanning confocal microscopy system used was LSM 710 (Carl Zeiss Microscopy, 
Cambridge, UK), to capture immunofluorescent detection of MAP2, VGLUT1, PSD95 and 
GluR1. The brain regions imaged were the CA1 hippocampus, VPM thalamus, and layer 3 of 
the somatosensory cortex (at level -1.70mm) and layer 3 of the motor cortex (at level 
0.14mm) (see Figure 3.1). 
In each brain regions of interest, two z-stacks were captured. The z-stacks were captured 2 
µm from the tissue surface and were 1.04 µm deep. The images were taken with 63x 
objective (1.4 NA) resulting in each slice having the dimensions of 43.53 x 43.53µm. 
Framesize was 1024 x 1024 pixels and the interval between each image was 0.13 µm. The 
two stacks were taken 50 µm apart from each other. Stereotactic maps and DAPI staining 
were used to locate the regions of interest. The images were taken and analysed in a 
blinded manner, as each animal was given a code to conceal which experimental group 
they were from. 
Figure 3.1 Brain regions where the densities of MAP2, VGLUT1, PSSD95 and GluR1 were 
imaged and analysed. 
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Image analysis was performed with ImageJ software (v1.46, NIH Bethesda, MD, USA). An 
autothreshold to cover the area of positive staining was used to measure the %density of 
MAP2, VGLUT1, PSD95 and GluR1 at each plane in the image stacks. The %density of each 
marker was averaged for each stack and then an average from the two stacks were 
calculated, to result in one %density value for each marker for each brain regions, per 
mouse. 
3.2.8 Statistical analysis 
The RAM data was analysed by comparing the average revisiting errors between sham and 
BCAS mice over-time, with repeated measures two-way ANOVA. Plus, the average of 
Blocks E and F was compared between sham and BCAS mice with Mann-Whitney test. The 
%densities of MAP2, VGLUT1, PSD95 and GluR1 were compared between sham and BCAS 
mice at 1 month and 3 months post-surgery, with Mann-Whitney test. A significance level 
of p<0.05 was considered to be statistically significant. 
3.3 Results 
3.3.1 BCAS did not result in long-term spatial memory working deficits. 
Previous results from our group and others have demonstrated that chronic cerebral 
hypoperfusion leads to an impairment in spatial working memory (Coltman et al. 2011; 
Holland et al. 2015; Shibata et al. 2007). In the current study, spatial working memory was 
probed by the 8-arm radial arm maze. The mice were trialled for 16 consecutive days 
before being culled, 3 months after BCAS surgery. The average revisiting errors from each 
block was compared between sham and BCAS mice over-time, with repeated two-way 
ANOVA (Figure 3.2). Statistical analysis showed a significant effect of time (F(5,70) = 17.37, 
p <0.0001), as the average revisiting errors have decreased over time as the mice learnt 
115 
the task. However, there was no significant effect on surgery (F(1,14) = 0.600, p = 0.452, 
with no factor interaction (F(5,70) = 1.171, p = 0.332). This result contradicted previous 
findings from our group. The next stage was to investigate whether BCAS surgery induced 
pathological changes related to spatial working memory impairment. 
3.3.2 CA1 dendrites and glutamatergic synaptic structures were resilient to the 
effects of BCAS surgery. Dendrites were vulnerable to ischaemic damage.  
Following the finding that BCAS surgery causes a trend of spatial memory impairment, the 
underlying pathological alterations were investigated with a focus on the hippocampus, 
which is important in memory processes and is also vulnerable to global cerebral blood 
flow reductions (Cassel et al. 1998; Kril et al. 2002; Ordy et al. 1993; Hatakeyama et al. 
1988; Nishio et al. 2010). Haematoxylin and eosin staining was used to identify whether 
BCAS surgery induced ischaemic neuronal pathology in the CA1. There was no evidence of 
ischemic neuronal damage in any of the 16 sham mice and the majority of BCAS mice did 
not show evidence of ischemic neuronal damage (12 out of 16). However, a subset of 
Figure 3.2 BCAS surgery did not result in significant spatial working memory impairment. There 
was no significant difference in the average number of revisiting errors over blocks A-F between 
sham and BCAS mice. Repeated two-way ANOVA. Data presented as mean ± SD, n = 8 per group. 
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hypoperfused animals had ischaemic damage in the CA1 (4 out of 16), which included 3 
animals in the 1 month hypoperfused group had CA1 ischaemic damage of the following 
areas: 0.030 mm2, 0.036 mm2 and 0.026 mm2; whilst 1 animal in the 3 month 
hypoperfused group had CA1 ischaemic damage of 0.056 mm2 (Figure 3.3). This provided 
evidence that BCAS surgery can lead to heterogeneity in neuronal pathology. 
The next aim of the study was to address whether chronic cerebral hypoperfusion resulted 
in the degeneration of dendrites and glutamatergic pre- and postsynaptic terminals. Since 
BCAS surgery resulted in heterogeneous pathology, the subset of animals with CA1 
ischaemic neuronal pathology were highlighted on the graphs in red (Figures 3.4 and 3.5). 
The dendrites and synaptic densities in the CA1 were compared between sham and BCAS 
mice, at 1 and 3 months post-surgery, with Mann-Whitney test. MAP2 
immunohistochemistry was used to visualise dendrites in the CA1 after sham or BCAS 
surgery (Figure 3.4). In the 1 month cohort, there was no significant difference in the MAP2 
%density CA1 in the between the sham and BCAS (p = 0.104) (Figure 3.4B). Although there 
was no overall effect of BCAS surgery, there was a trend for a decrease in the BCAS group, 
with the lowest dendritic densities occurring in the animals with CA1 ischaemic damage 
Figure 3.3 BCAS surgery with 0.18mm microcoil resulted in no ischaemic neuronal 
damage in the CA1 of sham mice and in the majority (12/16) of BCAS mice. Only a subset 
of BCAS mice (4 out of 16) had ischaemic neuronal damage in the CA1. Scale bar = 100μm. 
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Figure 3.4 Dendrites and glutamatergic presynaptic terminals in the CA1 were resilient to 
BCAS surgery, although there was indication that dendrites were vulnerable to ischaemic 
damage. (A) MAP2 and VGLUT1 immunohistochmistry to detect dendrites and glutamatergic 
presynaptic terminals in the CA1. (B) At 1 month and (C) 3 months after surgery, there was no 
significant different in MAP2 %densities between sham and BCAS mice. The mice with CA1 
ischaemic damage (red points) had the lowest MAP2 %densities, indicating that dendrites 
were vulnerable to ischaemic damage. (D) At 1 month and (F) 3 months after surgery, there 
was no significant different in VGLUT1 %densities between sham and BCAS mice. Data 
presented as mean ± SD, n = 8 per group. Scale bar = 10 μm. Mann-Whitney test. 
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 (marked red). In the 3 month cohort, there was no significant effect of BCAS surgery on 
CA1 MAP2 density (p = 0.777) (Figure 3.4C), however, the dendritic density in the animal 
with CA1 ischaemic damage had the lowest value. Taken together, this data showed that 
BCAS induced hypoperfusion does not cause significant loss of dendrites in the CA1 at 1 or 
3 months post-surgery, however, there was indication the CA1 ischaemic damage does 
cause some degeneration of dendrites. 
Glutamatergic transmission is known to be vulnerable in cognitive decline and dementia; 
therefore, the densities of glutamatergic pre- and postsynaptic terminals were measured in 
the CA1 after hypoperfusion. VGLUT1, an abundant marker of glutamatergic presynaptic 
terminals was analysed (Figure 3.5). The CA1 VGLUT1 %densities were compared between 
the sham and BCAS mice, 1 month after surgery, and found no significant difference (p = 
0.232) (Figure 3.5D). For the 3 month cohort, there was also no significant difference in 
CA1 VGLUT1 %densities between sham and BCAS mice (p = 0.275) (Figure 3.5E). Unlike the 
MAP2 %densities, the VGLUT1 %densities from the BCAS mice with CA1 ischaemic damage 
were not obviously lower than the values from mice without ischaemic damage. Overall, 
the results showed that hypoperfusion from BCAS surgery did not cause a loss of 
glutamatergic presynaptic terminals in the CA1. 
Next, the impact of BCAS surgery of glutamatergic post-synaptic densities was investigated, 
by immunostaining for PSD95 and GluR1 (Figure 3.5A). PSD95 is an abundant protein in the 
postsynaptic densities of excitatory synapses. PSD95 %densities in the CA1 were 
unchanged between the sham and BCAS mice at both 1 month (p = 0.275) (Figure 3.5B) 
and 3 month (p = 0.275) (Figure 3.5C) post-surgery. GluR1 is a subunit of AMPA-receptors. 
Similarly, the %densities of GluR1 in the CA1 were unchanged between sham and BCAS, at 
1 month (p = 0.130) (Figure 3.5D) and 3 months (p = 0.560) (Figure 3.5E) after surgery.
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Figure 3.5 Glutamatergic postsynaptic terminals in the CA1 were unchanged with 
BCAS surgery. (A) PSD95 and GluR1 immunohistochemistry to detect dendrites and 
glutamatergic presynaptic terminals in the CA1. There were no differences in the 
%density of PSD95 at (B) 1 month and (C) 3 months after BCAS surgery. There were 
no differences in the %density of GluR1 at (D) 1 month and (E) 3 months after BCAs 




There was also no indication that ischaemic damage in the CA1 lead to lower values of 
glutamatergic post-synaptic densities, apart from in one mouse in the 1 month cohort. 
Taken together, the data showed no effect of chronic cerebral hypoperfusion on the 
densities of glutamatergic postsynaptic terminals in the CA1. 
Overall, the data indicated that dendrites and glutamatergic pre- and postsynaptic 
terminals in the CA1 were resilient to the effects of chronic cerebral hypoperfusion; and 
although there was indication that CA1 dendrites were vulnerable to ischaemic damage, 
there was no evidence of it causing synapse loss. 
3.3.3 Dendritic and synaptic structures in the thalamus were resilient to BCAS 
surgery. 
The thalamus is another brain region that has been found to be vulnerable following 
chronic cerebral hypoperfusion and subcortical microinfarcts have been identified at 
6months post-BCAS (Holland et al. 2015). In the present study, however, there was no
Figure 3.6 There was no ischaemic neuronal damage in the 
thalamus after sham or BCAS surgery. Scale bar = 100 μm. 
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Figure 3.7 Dendrites and glutamatergic presynaptic terminals were unchanged with BCAS 
surgery in the thalamus. (A) MAP2 and VGLUT1 immunohistochemistry to detect dendrites 
and glutamatergic presynaptic terminals in the thalamus. There were no differences in the 
%density of MAP2 at (B) 1 month and (C) 3 months after BCAS surgery. There were no 
differences in the %density of VGLU1 at (D) 1 month and (E) 3 months after BCAS surgery. 
Data presented as mean ± SD, n = 8 per group. Scale bar = 10 μm. Mann-Whitney test. 
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evidence of ischaemic neuronal damage in the thalamus at 1 and 3 months post-BCAS 
(Figure 3.6). Next, the densities of dendrites and glutamatergic presynaptic and 
postsynaptic terminals were investigated in the VPM thalamic nuclei (Figure 3.7A). The 
%densities of MAP2 in the thalamus were unchanged between the sham and BCAS mice, at 
1 month (p = 0.151) (Figure 3.7B) and 3 month (p = 0.275) (Figure 3.7C) after surgery. 
Similarly, there were no differences in the VGLUT1 %densities between the sham and BCAS 
mice, at 1 month (p = 0.230) (Figure 3.7D) and 3 months (p = 0.854) (Figure 3.7E) after 
surgery.   
The densities of PSD95 and GluR1 were also measured in the thalamus at 1 month and 3 
months after BCAS surgery (Figure 3.8). Interestingly, there was a small but significant 
increase in PSD95 %density in the BCAS mice at 1 month after surgery (p = 0.0379) (Figure 
3.8B). In the 3 month cohort, however, there was no significant difference in PSD95 
%densities between sham and BCAS mice, (p = 0.932) (Figure 3.8C). GluR1 %densities in the 
thalamus were unchanged between sham and BCAS mice at 1 month (p = 0.854) (Figure 
3.8D) and 3 months (p = 0.160) (Figure 3.8E) after surgery. Overall, BCAS surgery did not 
impact the densities of dendrites and glutamatergic pre- and post-synaptic terminals in the 
thalamus, apart from causing a small increase in PSD95+ terminals after 1 month.  
The %densities of MAP2, VGLUT1, PSD95 and GluR1 were also measured in the motor and 
somatosensory cortex, as these are other brain regions associated with spatial working 
memory function and VCI. The densities of the dendritic and synaptic markers were 
unchanged between sham and BCAS mice, at 1 and 3 months after surgery; apart from a 
small significant increase in MAP2 %density in the motor cortex after 3 months of BCAS 
(see Supplementary Figure S3.1 and S3.2).  
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Figure 3.8 Glutamatergic postsynaptic terminals in the thalamus were unchanged with 
BCAS surgery, apart from a small increase in PSD95 %density. (A) PSD95 and GluR1 
immunohistochemistry to detect dendrites and glutamatergic presynaptic terminals in the 
thalamus. (B) There was a small increase in PSD95 %density, 1 month after BCAS surgery 
compared to sham mice. (C) PSD95 %densities were unchanged between sham and BCAS 
mice at 3 months. There were no differences in the %density of GluR1 at (D) 1 month and 
(E) 3 months after hypoperfusion. Data presented as mean ± SD, n = 8 per group. Scale bar = 
10 μm. Mann-Whitney, *p<0.05. 
 
124 
Overall, this study demonstrated that glutamatergic pre- and postsynaptic terminals were 
robust and were largely unchanged after 1 and 3 months of BCAS-induced hypoperfusion. 
The dendrites were also largely resilient to change, although there was some implication 
that ischaemic neuronal pathology in the CA1 caused some degeneration of dendrites.  
3.4 Discussion 
The purpose of this investigation was to determine whether chronic cerebral 
hypoperfusion, which is a key feature of cerebral vascular disease and a predictor for 
dementia, causes a loss of dendrites and glutamatergic synaptic terminals in the 
hippocampus and thalamus, culminating in a decline in spatial working memory. In this 
study, there was no significant difference in the spatial working memory abilities of mice at 
3 months after sham or BCAS surgery. Furthermore, there was no evidence of synaptic loss 
with hypoperfusion, and instead dendritic loss was only evident in cases with ischaemic 
damage in the CA1. Taken together, this data rejects the original hypothesis that chronic 
cerebral hypoperfusion leads to progressive degeneration of dendrites and glutamatergic 
pre- and postsynaptic terminals, culminating in cognitive decline and dementia. 
3.4.1 Chronic cerebral hypoperfusion caused a trend towards spatial working 
memory impairment. 
Vascular cognitive impairment is diagnosed based on the presence of vascular pathology 
and decline in four cognitive domains: executive/attention, memory, language and 
visuospatial functions (Gorelick et al. 2011). Clinical studies have revealed that mild 
cognitive impairment, related to subcortical vascular pathology, is characterised by deficits 
in executive function (Breteler et al. 1994; O’Brien et al. 2003). Key aspects of executive 
function include working memory and problem solving (Chan et al. 2008). In preclinical 
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studies, chronic cerebral hypoperfusion (induced by BCAS surgery) results in impairment in 
spatial working memory (Shibata et al. 2007; Holland et al. 2015; Coltman et al. 2011; 
Saggu et al. 2016), as well as in other hypoperfusion rodent models (Hattori et al. 2015; 
Hattori et al. 2014; Kitamura et al. 2012). The radial arm maze test is designed to probe for 
spatial working memory deficits in rodents (Olton et al. 1980) and was used in the current 
study and previous hypoperfusion studies (Holland et al. 2015; Coltman et al. 2011; Shibata 
et al. 2007). In this test the mice are required to enter each arm of the maze to obtain a 
food pellet and use visuospatial clues to work out which arms they have yet to enter. The 
number of errors they make by revisiting an arm is recorded, and the higher number of 
revisiting errors is a sign of impaired spatial working memory.  
In the present study, both sham and BCAS mice initially made many errors as they were 
learning the task, which is consistent with previous publications. However, unlike our 
previous findings, there was no overall surgery effect on the average number of revisiting 
errors over the trial. In the 3-month cohort, there was only one mouse with any ischaemic 
neuronal damage in the brain regions analysed, and this only occurred in the CA1 of the 
hippocampus. There is a large body of evidence from preclinical studies showing that the 
CA1 of the hippocampus is particularly vulnerable to global reductions in CBF, resulting in 
ischaemic neuronal damage and atrophy in this region (Ordy et al. 1993; Hatakeyama et al. 
1988; Farkas et al. 2007a; Keiko Nishio et al. 2010), as will be discussed in more detail in 
the following section. Moreover, it is widely accepted that the hippocampus is a key brain 
region in memory formation processes. The hippocampus has been shown to have a role in 
spatial working memory, as animals with lesions in the hippocampus or fimbria-fornix 
(output nerve bundles from the hippocampus) resulted in worsened scores for the RAM 
test (Cassel et al. 1998; Warburton et al. 2000). Moreover, a number of studies have shown 
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that BCCAO in rats leads to ischaemic neuronal damage in the CA1 of the hippocampus. As 
reviewed by Farkas et al., at 2 weeks post-BCCAO, 6-29% of animals have CA1 ischaemic 
neuronal injury; at 4 weeks, this has been exhibited by 55% of animals; and at 8-13 weeks, 
67% of BCCAO rats had total hippocampal destruction (Farkas et al. 2007a; Farkas et al. 
2006; Ohtaki et al. 2006; Schmidt-Kastner et al. 2001; Liu 2006). There is evidence of 
hippocampal ischaemic injury occurring in animals with spatial working memory deficits, as 
shown in BCCAO rat models (Bennett et al. 1998; Ni et al. 1994) and BCAS mouse models 
(Nishio et al. 2010). Taken together, this may indicate that hypoperfusion-induced 
ischaemic injury contributes to spatial working memory deficits and may explain why the 
present study did not find spatial working memory deficits, as only one animal in the 3-
month BCAS group had CA1 ischaemic pathology. This would suggest that pathological 
changes as a result of ischaemia leads to cognitive impariment, rather than hypoperfusion 
directly.  
3.4.2 Chronic cerebral hypoperfusion resulted in heterogeneous hippocampal 
pathology. 
The present study found evidence of ischaemic neuronal pathology in the CA1 
hippocampus of only a subset of hypoperfused mice. Hippocampal atrophy and CA1 
neuronal loss has been shown to be a feature of human vascular dementia (Kril et al. 2002; 
Du et al. 2002). This is consistent with observations of selective ischaemic damage and 
atrophy in rodent models of chronic global ischaemia (Ordy et al. 1993; Hatakeyama et al. 
1988) and hypoperfusion (Nishio et al. 2010). Transient global ischaemia in monkeys also 
resulted in loss of CA1 and CA2 neurons (Zola-Morgan et al. 1992). 
In the present study, a subset of the hypoperfused animals showed evidence of ischaemic 
neuronal damage in the CA1. This finding is consistent with previous results from our 
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group, which has found varying degrees of ischaemic neuronal damage post-BCAS. For 
example, in one particular study Coltman et al. found that in different cohorts post-BCAS 
there was evidence of ischaemic neuron damage in 2 out of 17 hypoperfused animals in 
cohort 1 one month after surgery; 4 out of 14 hypoperfused animals in cohort 2 and 17 out 
of 24 hypoperfused animals in cohort 3, both 2 months after surgery (Coltman et al. 2011). 
Another group reported that the CA1 neurons remained intact 30 days after BCAS surgery 
(Shibata et al. 2007). Furthermore, Nishio et al. showed that there was significant 
hippocampal atrophy and frequent signs of ischaemic damage in mice 8 months after BCAS 
(Nishio et al. 2010). Taken together, our results and these publications indicate that 
chronic cerebral hypoperfusion can result in long-term ischaemic damage in the CA1. 
Ischaemic neuron damage occurs when cerebral blood flow drops to 30% that of baseline 
levels (Heiss & Rosner 1983; Baron 2001), whereas previous work from our group has 
shown that the acute cortical blood flow in the BCAS is only 60-70% of the baseline, and 
then recovers to ~80% over a month after surgery (McQueen, et al. 2014). Although these 
studies refer to cortical CBF measurements, and CBF reductions have been shown to be 
less severe in the cortex (Hattori et al. 2016), it may be that for the majority of mice post-
BCAS the subcortical CBF is not reduced enough to induce CA1 ischaemic damage. CBF was 
not measured in the present study, however, an improvement to this study would be to 
use Arterial Spin Labelling (ASL) to measure CBF in subcortical regions and to determine 
whether hippocampal CBF related to the extent of ischaemic neuronal pathology in these 
animals. 
In the present study, ischaemic neuronal pathology was present in the CA1 of a subset of 
mice post-BCAS, whilst the other hippocampal regions remained intact. Previous studies 
have found selective vulnerability of CA1 neurons compared to other CA hippocampal 
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regions, as shown in a range of neurological disorders (Bartsch et al. 2015), including 
Alzheimer’s disease (Hyman et al. 1984; Braak & Braak 1991; Terry et al. 1991). It has been 
proposed that selective vulnerability of CA1 neurons is a consequence of genomic 
differences increasing the sensitivity to oxidative stress and excitotoxicity (Wang & 
Michaelis 2010). The sensitivity of CA1 neurons to oxidative stress was shown in an 
experiment where superoxide-generating compound, duroquinone, was applied to 
organotypic hippocampal slice cultures, resulting in extensive CA1 cell death whilst sparing 
the CA3 neurons (Wang et al. 2005). Furthermore, they found that cortical neurons were 
also resilient to oxidative stress (Wang et al. 2009), which is consistent with the present 
study as there was a lack of cortical ischaemic damage whilst some mice had ischaemic 
CA1 damage. The selective vulnerability of CA1 may result from higher endogenous levels 
of reactive oxygen species in these neurons compared to CA3 (Mattiasson et al. 2003); and 
genes related to ROS-generation, anti-oxidants and cellular stress are more highly 
expressed in CA1 neurons (Wang et al. 2005; Wang et al. 2007). CA1 neurons may have 
higher reactive oxygen species as it is required for long-term potentiation in this region 
(Klann et al. 1998). The increased levels of reactive oxygen species in the CA1 neurons may 
predispose this region to neurodegeneration through oxidative stress (Wang et al. 2007). 
Selective CA1 neuronal vulnerability may be linked to the activation of glutamate 
receptors. In oxygen-glucose deprived hippocampal sections, the CA1 neurons more 
rapidly released glutamate and in greater quantities than CA3 (Uchino et al. 2001). 
Excessive glutamate release and glutamate receptor activation can cause downstream 
excitotoxicity via the ischaemic cascade, Section 1.4.1.1. This pathway generates reactive 
oxygen species, as activation of NMDA-receptors by glutamate can induce activation of 
neuronal nitric oxide synthase (Lai et al. 2014). The greater release of glutamate and 
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increased oxidative stress, therefore, may underpin the selective CA1 damage seen in the 
current study.  
3.4.3 CA1 dendrites and glutamatergic pre- and postsynaptic terminals were 
resilient to chronic cerebral hypoperfusion.  
The next task in this study was to investigate whether hypoperfusion resulted in 
degeneration of dendrites and glutamatergic pre- and postsynaptic terminals in the CA1. 
Dendrites were detected with immunohistochemistry for microtubule-associated protein-2 
(MAP2), an abundant cytoskeletal phosphoprotein associated with dendritic microtubules 
(Friedrich & Aszódi 1991). The analysis showed that dendritic density in the CA1 was 
unchanged with hypoperfusion, however, there was indication that dendrites were 
vulnerable in animals with CA1 ischaemic neuropathology. This is also supported by reports 
that MAP2 loss is a sensitive marker for ischaemic lesions (Dawson & Hallenbeck 1996). 
Previous studies of global ischaemia found a loss of hippocampal dendrites. In a model of 
permanent global ischaemia in rats, MAP2 protein and mRNA levels were gradually 
reduced in the hippocampus over 4 weeks after surgery (Liu et al. 2005). This study also 
reported that the loss of MAP2 correlated with deficits in spatial memory of the rats, which 
suggest that hippocampal dendrite degeneration is a cause of cognitive impairment after 
global ischaemia. Another study demonstrated that dendritic branching in the CA1 is 
progressively reduced from 2 to 16 weeks after BCCAO in rats (Jia et al. 2012).  
The mechanism by which dendrite degeneration occurs in the CA1 after cerebral 
hypoperfusion is unclear. It may occur as a result of progressive ATP depletion and 
oxidative stress, which could cause downstream blockage of dendritic and axonal 
trafficking by binding of cofilin-1 to ADP-actin (Won et al. 2018). This mechanism may exist 
to save energy in metabolically challenged neurons, yet it inhibits the processes needed for 
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dendrites to function and dendritic degeneration may ensue. Another proposed 
mechanism could be the dysregulation of autophagy in dendrites, which is the cell’s 
method of removing dysfunctional or redundant proteins and organelles. Excessive 
autophagy could be stimulated by deficits in dendritic transport and accumulation of 
proteins and organelles. Oxidative stress and energy deprivation has been shown to 
increase autophagy (Filomeni et al. 2015), and global ischaemia causes autophagosomes to 
become concentrated in CA1 synaptic terminals and dendrites, 48 hours after surgery 
(Ruan et al. 2012). The increase in autophagy may be a self-destructive mechanism, as in 
Drosophila heterozygous for Nmnat, blocking autophagy prevented hypoxia-induced 
dendritic degeneration (Wen et al. 2013). These studies may suggest that ischaemia in the 
CA1 results in dendritic degeneration by over-activation of autophagy (Yang et al. 2013). 
In the current study, the density of glutamatergic presynaptic protein, VGLUT1, and 
postsynaptic proteins, PSD95 and GluR1, were also measured in the CA1 to identify 
whether chronic cerebral hypoperfusion causes degeneration of these structures. 
However, the data did not find significant differences in the densities of any of these 
markers, showing that 1 and 3 months of hypoperfusion does not cause degeneration of 
glutamatergic pre- or postsynaptic terminals in the CA1. To the best of our knowledge, this 
is the first study that has investigated whether modest chronic cerebral hypoperfusion 
causes synaptic loss. Previous studies have shown hippocampal synaptic degeneration 
occurs with global ischaemia, most commonly with bilateral common carotid artery 
occlusion (BCCAO) in rats. There are reports that BCCAO in rats causes a progressive loss of 
CA1 dendritic spines between 2 and 16 weeks post-surgery (Jia et al. 2012), and gradual 
reductions of hippocampal synaptophysin protein levels, over 20 weeks post-surgery (Liu 
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et al. 2005). The functional impact of these changes have been measured as reduction in 
CA1 synaptic plasticity, 3 weeks after BCCAO in rats (Xu et al. 2012).  
VGLUT1 was used as a marker for glutamatergic presynaptic terminals, as it is a transporter 
for packaging glutamate into synaptic vesicles in presynaptic terminals (Fujiyama et al. 
2001). VGLUT1 appears to have a important roles in cognition, as there was a significant 
reduction in its protein levels in the cortex from vascular dementia patients, compared to 
cortices from stroke patients who had not experienced dementia (Kirvell et al. 2010). 
Furthermore, VGLUT1 protein levels positively correlated with a pre-mortem cognitive 
score, further indicating that decreased VGLUT1 is associated with cognitive decline. In 
another study, CA1 levels of VGLUT1 and its isoform VGLUT2, were reduced 7 days after 
transient BCCAO in mice (Khan et al. 2018). The data presented in Section 5.3.3 
demonstrates that focal ischaemia induced by transient MCAO leads to loss of VGLUT1+ 
terminals within the ischaemic lesion. Taken together, the results indicate that VGLUT1 is 
resilient to modest hypoperfusion and more vulnerable to ischaemic damage. In the 
present study, however, there was no evidence of VGLUT1+ terminal loss in the animals 
with ischaemic CA1 damage, even though there was evidence of dendritic damage. This 
was a recurrent theme with the other synaptic markers, PSD95 and GluR1. For a discussion 
on mechanisms of ischaemia-induced VGLUT1 loss see Section 5.4.2.  
PSD95 is commonly used as a marker for excitatory postsynaptic terminals, as it is an 
abundant scaffolding protein expressed in postsynaptic densities (Migaud et al. 1998). The 
present study did not show any changes in the densities of PSD95+ terminals in CA1 after 1 
or 3 months of cerebral hypoperfusion. Previous work has shown that PSD95 protein levels 
in the hippocampus are significantly reduced long-term in rats after BCCAO (Nie et al. 
2016; Hu et al. 2019). In a study of unilateral common carotid artery occlusion (UCCAO), 
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PSD95 protein levels were unchanged in the ipsilateral hippocampus and actually increased 
in the ipsilateral cortex (Zhao et al. 2014). This latter result is consistent with the data in 
the present study and indicates that PSD95 can be resilient to hypoperfusion.  
GluR1 is a subunit of AMPA-receptors, abundantly expressed in the postsynaptic densities 
of glutamatergic synaptic terminals (Angulo et al. 1997). The present study did not find a 
difference in the densities of GluR1+ terminals between sham and BCAS mice, at 1 and 3 
months after surgery. A previous study showed that the densities of terminals positive for 
another AMPA-receptor subunit, GluR2, were significantly reduced in the hippocampus, 1-
24 weeks after BCCAO in rats (Wang et al. 2016). They also reported that the density of 
terminals positive for NMDA-receptor subunit NR1 and colocalised NR1-synaptophsyin 
terminals increased, which they theorise is to show an increase in the number of non-
functional, ‘AMPAR-silent’ synapses, which do not respond to presynaptic stimulation 
(Hanse et al. 2013). GluR1 was used in the present study, as this is the dominant AMPA-
receptor subunit in activity-dependent subunit recruitment and long-term potentiation 
induction. Protein levels of both GluR1 and GluR2 were reduced in the CA1, CA3 and 
dentate gyrus, 2 days after transient global ischaemia (Dos-anjos et al. 2009), indicating 
that both subunits are acutely vulnerable to ischaemia. In another study, however, they 
found that whilst immunoreactivity of GluR2 was reduced in the CA1 after 6-48 hours after 
transient four vessel occlusion, GluR1 levels remained stable (Han et al. 2016). This may 
suggest that GluR2 subunits are more vulnerable than GluR1. 80% of synaptic AMPARs in 
the CA1 are composed of GluR1-GluR2 heteromers (Lu et al. 2009), yet these can be 
replaced with GluR2-GluR3 heteromers especially in the absence of activity (Shi et al. 
2001). The current study could be developed to detect whether chronic cerebral 
hypoperfusion has an impact on GluR2, to determine whether this subunit is more 
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vulnerable than GluR1. Taken together, the results showed that modest chronic cerebral 
hypoperfusion does not cause loss of glutamatergic pre- and postsynaptic terminals in the 
CA1, even in cases with some ischaemic neuronal pathology in this region. 
A surprising finding in this study was the significant loss of MAP2 dendrites occurred in 
mice with CA1 ischaemia neuronal, whilst there was no significant differences in the pre- 
and postsynaptic markers in the same regions. Previous studies have shown that 
ischaemia-induced dendritic blebbing includes loss of dendritic spines, which post-synaptic 
densities project from (Zhang et al. 2005; Brown et al. 2007; Zhu et al. 2017). Therefore, 
the expectation was that that synaptic degeneration would occur in regions of dendritic 
degeneration. The lack of synaptic changes in these animals could be the result of different 
mechanisms governing dendritic and synaptic degeneration, or due to a lack in sensitivity 
in the methods used for their detection, as discussed below. It has been reported that 
dendrites contain particularly high densities of reactive mitochondria compared to axons 
and spines (Kageyama & Wong-Riley 1982), which could make dendrites even more 
vulnerable to ischaemia and energy depletion than these other structures.  
As previously discussed, PSD95 has been shown to be resilient to hypoperfusion, 2.5 
months after UCCAO (Zhao et al. 2014). This study also investigated the density of 
degenerating neurons in the CA1, CA3 and dentate gyrus with fluoro-jade staining. In the 
ipsilateral CA1 and CA3, there was a small but non-significant increase in 
neurodegeneration, whilst there was a significant increase in the dentate gyrus. Although 
the hippocampal protein levels of PSD95 were significantly indistinct between the 
contralateral and sham hippocampi, there was a trend towards a small increase in 
ipsilateral PSD95 (Zhao et al. 2014). Although these changes were small, the data may 
indicate that whilst neurodegeneration occurs in the hippocampus, the synapses may be 
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stable or may even increase in density. There is a growing body of evidence focused on 
neuronal plasticity and rewiring after ischaemic injury (Carmichael et al. 2017). Increased 
expression of VGLUT1 has also been found in ischaemia-induced synaptogenesis in a focal 
ischaemia model (Stokowska et al. 2017). In animals with ischaemic damage in the present 
study, ischaemia may have promoted synaptogenesis in the CA1, which may have resulted 
in synaptic densities that were indistinct from sham animals. Immunostaining of GAP43 
could be used to detect whether there has been CA1 synaptogenesis following BCAS 
(Stokowska et al. 2017; Carmichael 2003). 
As previously mentioned, the methods used for the analysis of synaptic density may lack 
sufficient specificity and sensitivity for detecting small changes. All of the structures were 
analysed with immunohistochemistry, which can be susceptible to cross-reactivity of 
antibodies with other proteins especially if there are isoforms of the target proteins. The 
specificity of the VGLUT1 antibody used in the present study had previously been checked 
by other groups, as discussed in Section 5.4.2. The antibody used to detect PSD95 was 
recommended to us by members of Seth Grant’s lab, as they had previously checked the 
specificity by immunostaining tissue from PSD95 KO mice and found no signal. We did not 
check the specificity of the GluR1 antibody. A concern may be that GluR1 is also expressed 
by astrocytes, as some AMPA-receptors are, however, the evidence indicates that GluR2 is 
the predominant subunit of astrocytic AMPA-receptors (Zhang et al. 2014; Mölders et al. 
2018; Rusnakova et al. 2013). Taken together these results suggest that the antibodies 
used for this study are specific to the proteins of interest.  
Insufficient sensitivity in the microscopy and image analysis approaches used may also 
result in the inability to detect small differences in synaptic density in this study. Confocal 
microscopy was used to capture stacks of planar images through the tissue, as described in 
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Section 3.2.7. The images were taken with a 63x objective and 3.1 zoom, so punctate 
immunostaining was visible. The original plan for this study was to use a new analysis 
method developed by the Grant lab, which uses a machine learning algorithm to count the 
number of synaptic terminals in the confocal images (Zhu et al. 2018). This method 
requires the images to be of high resolution and in stacks, in order to count the synaptic 
terminals within 3D space. In the present study, the images were taken as z-stacks of 
1.04μm, with an interval of 0.13μm. On attempting the analysis with the method, it 
became obvious that this method needed images of even higher resolution. We tried to 
deconvolve the images using Hugyens software, however, this raised concerns that it 
would create artefacts that looked like synaptic terminals (Sibarita 2005; Monici 2005). 
Furthermore, it became clear that the machine learning algorithm takes a long time to 
process the images, which would have impacted on the ‘n’ numbers of the study, as it 
would not have been possible to analyse n = 8/group using this method. Instead, the 
decision was made to analyse the images as %density of positive signal, with an 
autothreshold on ImageJ. This approach, however, may lack sensitivity and is still liable to 
issues caused by suboptimal resolution. As %density measurement does not need z-stacks 
to terminals number in 3D, it may have been more beneficial to image multiple regions on 
one plane or making a tiled image to cover the whole of the CA1. The current method may 
be under-sampling as it is captured from a small area in the CA1. An improvement of this 
method was to use a Zeiss Axio Scan.Z1 slide scanner microscope in the studies for Chapter 
5 & 6, which takes tiled images of entire coronal brain sections. 
The present study focused on whether chronic cerebral hypoperfusion resulted in 
structural changes of synapses and dendrites, however, it does not provide any insight into 
the functional state. As hypoperfusion leads to impairment in spatial working memory, 
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there may have been dysfunction of the synapses in the hippocampus and cortex, even 
though there was no sign of synaptic loss. Previous work has demonstrated that BCCAO 
surgery in rats leads to deficits in spatial learning and memory processes and impaired 
long-term potentiation in the CA1 from 4-12 weeks after surgery (Luo et al. 2015). The 
present study could be developed to investigate the changes to long-term potentiation in 
hippocampal slices taken from mice 1 and 3 months after BCAS surgery, to identify 
whether there are changes in the synaptic function in the absence of synaptic loss. 
An alternative approach would be to use transgenic mice that express fluorescent signals 
when their neurons are active. Arc-Venus and Arc-dVenus mice would be appropriate for 
Figure 3.9 Severe hypoperfusion surgery (BCAS, 0.16mm) resulted in activation of Arc-
Venus after 24 hours. Arc-Venus mice underwent sham, modest (0.18mm microcoil) and 
severe (0.16mm microcoil) BCAS surgery. Arc-Venus signal was greatly increased after 
severe hypoperfusion, compared to after sham or modest hypoperfusion surgery. 
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such an experiment. Arc is a postsynaptic protein that interacts with PSD95 and is 
upregulated during excitatory synaptic activity (Fernández et al. 2017). Venus and the 
destabilised version (dVenus) are fluorescent yellow proteins that have been tagged onto 
Arc to track its expression; with dVenus signal fading quicker than Venus (Eguchi & 
Yamaguchi 2009). Rudinskiy et al. used the Arc-dVenus model to show that neuronal 
activity was reduced around amyloid plaques in the cortex of APP/PS1 mice (Rudinskiy et 
al. 2012). Arc-Venus or dVenus mice could be used to develop on the work of the current 
study to determine whether chronic cerebral hypoperfusion causes a reduction in neuronal 
activity in the CA1. Before culling the mice, the specific brain region would need to be 
stimulated, similar to Rudinskiy et al. using light to stimulate neurons in the visual cortex 
(Rudinskiy et al. 2012). For the current study, the radial arm maze task could be used to 
stimulate the brain regions relevant to spatial working memory and show where there is 
less activity in dysfunctional neurons. A pilot study, conducted by my colleagues Juraj 
Koudelka and Karen Horsburgh, investigated the acute effect of BCAS surgery on Arc-Venus 
mice, supplied by the Grant Lab. They compared the effect of using the normal 0.18mm 
microcoils and thinner 0.16mm microcoils, to result in modest and severe hypoperfusion, 
respectively. After 48 hours, there was no Arc-Venus signal in the modest hypoperfused 
mice, however, there was clear neuronal activation in the hippocampus and cortex in the 
severely hypoperfused mice (Figure 3.9). Histological analysis showed evidence of 
ischaemic neuronal damage in the hippocampus in severe hypoperfused animals but not in 
the modest hypoperfused animals. Severe hypoperfusion alone was sufficient to acutely 
activate neurons, most likely through ischaemia-induced hyperexcitability, whilst modest 
hypoperfusion did not. This method could be applied to a chronic study, although it would 
require a method for stimulating the CA1 neurons just before culling the animals, such as 
with a hippocampal-dependent behavioural task. This approach could be used to 
138 
determine whether chronic cerebral hypoperfusion results in long-term neuronal 
dysfunction in the hippocampus. Moreover, the findings in the Arc-Venus pilot study 
support the data in the present study, as there was no evidence of neurodegenerative 
changes in mice without CA1 ischaemic pathology, whilst severe hypoperfusion resulted in 
CA1 ischaemic damage and degenerative changes. 
3.4.4 Dendrites and synapses in the thalamus were unaffected by chronic 
cerebral hypoperfusion. 
The thalamus appears to be another key brain region involved in spatial working memory 
(Hallock et al. 2016). Previous work by our group showed that 6 months after BCAS surgery 
resulted in ischaemic and haemorrhagic lesions in the thalamus, whereas these were 
absent at 1 month after surgery (Holland et al. 2015). The present study also showed no 
evidence of ischaemic neuronal damage in the thalamus 1 month and 3 months after 
surgery. The expectation was that ischaemic damage would occur in the thalamus by 3 
months, as the number of ischaemic lesions increased over time in the data by Holland et 
al. The lack of thalamic ischaemic neuropathology detected in the present study may result 
from the thickness of the tissue sections; they were quite thick at 30µm, which could affect 
the sensitivity of detecting small ischaemic lesions, whilst Holland et al. used sections of 
6µm thick. Alternatively, other environmental factors may have reduced the extent of 
neuropathology in the 3 month cohort, such as inconsistencies in the animal unit and cold 
temperatures having neuroprotective affects (Talma et al. 2016). 
The impact of chronic cerebral hypoperfusion on dendrites and glutamatergic pre- and 
postsynaptic terminals in the thalamus was investigated, at 1 and 3 months after surgery. 
There was no significant difference in any of the markers, apart from a small significant 
increase in PSD95 %density in the 1 month hypoperfused thalamus. This was a surprising 
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finding, as we would have expected to see synaptic degeneration induced by 
hypoperfusion. This result may indicate the new postsynaptic terminals have formed in the 
hypoperfused thalamus. There is evidence of thalamocortical circuits undergo rewiring 
after ischaemic stroke (Tennant et al. 2017), therefore, there may be small amounts of 
rewiring in the thalamus after chronic cerebral hypoperfusion. Interestingly, in the study 
presented in Chapter 6, there was a small significant increase in PSD95 %density also in the 
VPM thalamic nuclei. This data could indicate that there was a small increase in PSD95+ 
terminals in the hypoperfused thalamus to compensate for pathological changes 
elsewhere, however, this is a puzzlingly finding as there does not appear to be many 
neuropathological changes to stimulate restoration mechanisms. There is substantial 
evidence to support that synaptic rewiring occurs in the cortex following a brain injury, 
whilst less attention has been given to subcortical reorganisation. As previously stated, 
GAP43 can be used as a marker for axon sprouting and synaptic plasticity (Frey et al. 2000), 
therefore, increased immunostaining in the hypoperfused thalamus would indicate that 
restoration mechanisms had been activated.  
There were no significant differences in the %densities of MAP+ dendrites, VGLUT1+ and 
GluR1+ terminals in the hypoperfused thalamus. As previously discussed, the data 
indicates that the modest cerebral blood flow changes in this BCAS model are insufficient 
to result in loss of glutamatergic pre and postsynaptic terminals. The expression of GluR1 is 
limited in the thalamus under normal conditions (Ibrahim et al. 2000). 
The somatosensory and motor cortices are additional brains regions known to be 
vulnerable to vascular pathology. Dysfunction of the frontal lobe is linked to vascular multi-
infarct lesions in humans (Wolfe et al. 1990). Furthermore, the somatosensory cortex is 
considered to be important for working memory processes (Linden 2007). MEG data 
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collected from VCI patients showed changes in somatosensory evoked magnetic fields that 
correlated with cognitive decline (Sun et al. 2013), indicating alterations in the 
somatosensory system in VCI. In the present study, however, there was no evidence of 
ischaemic neuronal pathology, dendrite degeneration or synaptic loss in either the motor 
or somatosensory cortices. Although there was an increase in dendritic density in the 
motor cortex after 3 months of BCAS, which may result from compensatory mechanisms. 
Völgyi et al. performed proteome analysis on synaptosomes fractions from the cortex of 
rats, 5 weeks after BCCAO and found significant reductions in proteins involved in 
presynaptic vesicle cycling and in postsynaptic assembly (Völgyi et al. 2017), although 
VGLUT1 and PSD95 were not among the list of specific proteins. The present study 
demonstrated that modest chronic cerebral hypoperfusion was insufficient to cause 
reductions in the densities of dendrites, and glutamatergic pre- and post-synaptic 
terminals in the motor and somatosensory cortices.  
Overall, the results in this study, and others, have implicated that chronic cerebral 
hypoperfusion leads to impairment in spatial working memory; however, this is not related 
to a loss of glutamatergic synaptic terminals or dendrites. A number of studies by our 
group and others have identified alternative mechanisms that can lead to downstream 
functional impairment and cognitive decline. White matter tracts are very sensitive to 
cerebral blood flow changes, and BCAS surgery has been shown to cause diffuse myelin 
damage in the corpus callosum, fimbria, internal capsule and optic tract, by 1 month after 
surgery (Shibata et al. 2004; Reimer et al. 2011; Holland et al. 2015; Holland et al. 2011; 
Sigfridsson et al. 2018). The extent of white matter damage in dementia is related to the 
decline in cognitive processing speed and executive function (Cohen et al. 2002; Mungas et 
al. 2001), as white matter disruption prevents communication between different brain 
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regions. A number of studies published from our group have demonstrated that white 
matter pathology occurs by 2 months after BCAS surgery (Coltman et al. 2011), and loss of 
white matter integrity relates to impairment in spatial working memory (Kitamura et al. 
2017; Manso et al. 2018). Furthermore, there is evidence that hypoperfusion reduces 
efficient conduction of white matter tracts by disrupting paranodal axon-glial junctions 
(Reimer et al. 2011). 
Mechanisms related to hypoxia are also considered to be important in hypoperfusion-
induced pathology. BCAS surgery has been shown to greatly reduce oxygen levels in the 
corpus callosum at 3 days, 1 and 6 weeks after surgery (Duncombe et al. 2017). Moreover, 
hypoxia-related genes were expressed in the white matter 3 days post-BCAS (Reimer et al. 
2011). Another study by our group showed that densities of oligodendrocytes and their 
precursors are reduced in the corpus callosum at 3 days post-BCAS (McQueen et al. 2014). 
It may be that hypoperfusion induces hypoxic mechanisms in the white matter, causing the 
degeneration of oligodendrocytes and disruption in axon-glial integrity, leading to reduced 
signal conducted in the white matter tract (Duncombe et al. 2017). Neuroinflammation 
appears to be another key player in the pathological changes following hypoperfusion, 
based on evidence that BCAS stimulates increases in microglia/macrophage and astrocyte 
densities, particularly in the white matter (Shibata et al. 2004; McQueen et al. 2014; 
Reimer et al. 2011; Holland et al. 2011). There is evidence that the level of 
microglia/macrophages relates to the slowing of conduction velocity in the corpus 
callosum, and therapeutic intervention with anti-inflammatory drugs improved conduction 
velocity (Fowler et al. 2018; Manso et al. 2018). Furthermore, white matter 
neuroinflammation may cause impairment in axon-glial integrity and conduction velocity, 
by the release of pro-inflammatory cytokines and chemokines (Reimer et al. 2011). Pro-
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inflammatory cells also release matrix metalloproteinases (MMPs), which can degrade the 
myelin sheath, as well as the proteins in the extracellular matrix and tight junction proteins 
between endothelial cells, which have been associated with BBB breakdown (Seo et al. 
2013; Chandler et al. 1995). Moreover, the release of reactive oxygen species (ROS) from 
activated microglia may also contribute to endothelial dysfunction (Freeman & Keller 
2012).  
Neurovascular coupling may also be impacted by hypoperfusion. As described in Section 
1.2.3., neurovascular coupling is the fine-tuning of CBF in response to neuronal activity, 
that is mediated through the NVU and vasoactive neurotransmitter release. There is 
evidence that hypoperfusion, induced by UCCAO, results in a loss of vascular response to 
neuronal activity (Nishino et al. 2016). Furthermore, previous analysis from our group also 
found a smaller increase in CBF upon neuronal activation (by whisker stimulation) in BCAS 
mice compared to shams (Duncombe et al. 2017). This may result from uncoupling of the 
NVU, based on evidence that chronic hypoperfusion caused activation of astrocytes and 
displacement of their end-feet; although this finding was associated with thalamic 
ischaemic injury (Holland et al. 2015). Collectively, these studies indicate that chronic 
cerebral hypoperfusion results in a number of mechanisms that can cause functional 
impairment and cognitive decline, without inducing glutamatergic synapse loss in the 
hippocampus, thalamus and cortex. 
3.4.5 Conclusions 
Chronic cerebral hypoperfusion by BCAS surgery did not result in long-term spatial working 
memory impairment. Hypoperfusion leads to heterogeneous ischaemic neuronal 
pathology, as only a small subset of animals had CA1 ischaemic neuronal damage. 
Dendrites are resilient to hypoperfusion, but there was implication of their vulnerability to 
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CA1 ischaemic injury. Glutamatergic pre- and postsynaptic terminals were resilient to 
hypoperfusion. The overall implications of the study were that hypoperfusion may not be 
the main driver of degeneration and decline in VCI; and that hypoperfusion does not cause 
glutamatergic synaptic loss in VCI and VaD. It may be that ischaemic injury, which can 
result from hypoperfusion, is the initiator for degenerative mechanisms leading to VCI and 
dementia.  
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3.5 Supplementary figures 
 
  
Figure S3.1 MAP2, VGLUT1, PSD95 and GluR1 %densities in the motor 
cortex were unchanged after 1 or 3 months of BCAS surgery, apart from a 





Figure S3.2 MAP2, VGLUT1, PSD95 and GluR1 %densities in the 
somatosensory cortex were unchanged after 1 or 3 months of BCAS 




Chapter 4:  Optimisation of photothrombosis and 
multiphoton microscopy 
4.1 Introduction 
The previous study demonstrated that glutamatergic pre- and postsynaptic terminals and 
dendrites are resilient to loss from chronic cerebral hypoperfusion, however, there was 
indication that dendrites were vulnerable to ischaemic damage. The development of this 
work, therefore, would be to investigate whether focal ischaemia leads to degeneration of 
glutamatergic pre- and postsynaptic terminals.  
Publications by Tim Murphy, Shengxiang Zhang and colleagues have shown that cortical 
focal ischaemia caused by photothrombotic occlusion leads to rapid blebbing of dendrites 
and dendritic spines, the structures which excitatory postsynaptic terminals project from, 
within minutes (Zhang et al. 2005; Zhang & Murphy 2007). These studies used multiphoton 
in vivo microscopy and mice expressing YFP+ in layer VI cortical neurons, to capture 
dynamic changes. Furthermore, they found that these changes can be reversible, as timely 
reperfusion restored the dendrites and spines (Zhang et al. 2005). Furthermore, Zhu et al. 
demonstrated that global ischaemia also results in quick dendritic degeneration which can 
be reversed if reperfusion occurs 20 minutes later, whereas longer occlusion times lead to 
minimal or no recovery (Zhu et al. 2017). These studies focus on acute time-points and do 
not determine the chronic outcome of focal ischaemia on dendrites, spines or synapses.  
There is a large body of literature supporting that β-amyloid has synaptotoxic effects, as 
described in Section 1.7.1. In cases with both vascular and Alzheimer’s pathology, there is 
evidence of worsened cognitive outcome, compared to patients with just vascular 
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pathology (Snowdon et al. 1997), although the mechanism behind this is unclear. The 
current study sought to determine whether concurrent focal ischaemia and β-amyloid 
deposition would lead to worsened postsynaptic terminal loss, in comparison to focal 
ischaemia alone. To investigate this, mice harbouring APPTgSwDI transgene or WT controls 
were subject to focal ischaemia. These mice also expressed PSD95:eGFP to enable analyse 
of excitatory postsynaptic terminals to be analysed with multiphoton in vivo microscopy. 
The photothrombotic occlusion model with Rose Bengal is a commonly used method for 
inducing a small focal ischaemic lesion in the cortex. Rose Bengal is activated when it is 
illuminated, leading to the generation of singlet oxygen, focal endothelial damage, platelet 
activation and focal clotting (Dietrich et al. 1986). It is also advantageous as it allows for 
targeting a specific area for occlusion. In the initial stages of my research, it was considered 
that this model may be beneficial to use to investigate the longitudinal effect of focal 
ischaemia and concurrent β-amyloid on postsynaptic terminals, as captured with 
multiphoton in vivo microscopy. This short chapter describes the optimisation experiments 
and preliminary results for Rose Bengal photothrombosis and multiphoton microscopy, 
how this informed the experimental plan for the following investigations.  
4.2 Methods and Results 
The experimental animals were all adult C57Bl/6J and PSD95:eGFP x TgSwDI. Both male 
and female mice were used for photothrombosis optimisation. The mice were housed on a 
12-hour light/dark cycle, with a constant temperature and free access to food and water. 
4.2.1 Optimisation of markers for multiphoton microscopy. 
The aim was to optimise markers for multiphoton microscopy for detection of synaptic 
terminals, blood vessels and β-amyloid, with for the purpose of using this technique to 
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investigate the dynamic changes of postsynaptic terminals after an ischaemic lesion in the 
presence of β-amyloid.  
4.2.1.1 Cranial window implantation 
To enable dynamic changes in the brain to be visualised by in vivo imaging, the mice had 
cranial windows implanted and a head-plate fitted. This procedure was carried out by Dr 
Koudelka. The mice were anaesthetised in a chamber with 3% isoflurane, transferred to a 
stereotactic frame and maintained with 1.5-2.5% isoflurane. The fur from the top of the 
head was shaved off and eye ointment was applied. A cotton bud soaked in 70% ethanol 
was used to sterilise the exposed skin and a midline incision was made running from 
between the eyes to the top of the ears. Vetbond was applied to the edges of the skull, to 
seal the skin on the sides and prevent leakage underneath the head-plate. Once this has 
dried, Superglue Precision Max was applied to cover the Vetbond. The window was made 
in the skull by drilling as close to the midline as possible and just posterior to bregma, to 
expose the somatosensory cortex above the hippocampus: burr size 5 (0.5 mm) and drill 
speed of 2x1000 rpm. The part of the skull to be lifted was drilled more thinly, whilst the 
other side was left thicker and acted like a hinge. A sterile glass cover glass was cut to size, 
3 x 3mm. A drop of saline was placed on the craniotomy and let soak into the skull for 10 
minutes. Forceps were used to lift the skull fragment and with some saline on the back the 
cover glass was placed over the craniotomy and glued in place. Following this, the 
headplate was glued to the skull so it sits flat on the head, and the glue was allowed to dry 
for 20 minutes. Dental cement was applied to the outside of the headplate and covering 
the skull to make the craniotomy watertight. Finally, the animals were injected with 0.5mL 
of saline and allowed to recover in an incubator.  
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4.2.1.2 Multiphoton microscopy imaging 
The first multiphoton imaging session took place at 24 hours after cranial window 
implantation, with follow up imaging up to 2 months afterwards. The mice were 
anaesthetised in a chamber and then transferred to a platform and maintained with 1.5-
2.5% isofluorane with a mask. The dextran dye for vasculature detection was introduced 
through the tail vein (see below), before placing the mouse on its front on a moveable 
platform and securing its head-plate to it with screws. The success of the tail vein injections 
were checked under a fluorescent microscope before transporting the mice to the 
multiphoton microscope. Eye ointment was applied and the cover glass over the 
Figure 4.1 Multiphoton microscopy of the cerebrovasculature, with Texas Red detection. 
Multiphoton images from two mice, imaged at 1 day, 28 days and 5 weeks after cranial window 
implantation. Scale bar = 50μm.  
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craniotomy was cleaned with distilled water. The mouse’s body temperature was 
monitored with a rectal thermometer and heated mat under its body, plus probes to 
monitor heart and breathing rates were used. The platform was placed in the chamber of 
the multiphoton and positioned with the objective above the cranial window for imaging. 
4.2.1.3 Vasculature detection 
Blood vessels were visualised with fluorescent dextran dyes, which were injected into the 
tail vein just before imaging. Initially, Texas Red dextran (Molecular probe, D1830) was 
used for this. Figure 4.1 shows the two examples of multiphoton imaging of the 
vasculature in mice 24 hours, 28 days and 5 weeks after cranial window implantation. At 24 
hours after surgery, the vasculature was clearly detectable and could be imaged up to a 
depth of 400μm from the surface of the cortex. At the follow-up imaging sessions, many 
bright fluorescing cells were observed around the vasculature at 28 days and 5 weeks after 
cranial window surgery. We speculated that the cranial window surgery had caused a 
localised inflammatory response, and these cells were ‘mopping up’ any Texas Red dextran 
that had leaked from the vessels. This would be a major caveat for use in future studies, as 
local inflammation reduced the clarity of the images and the depth of successful imaging, 




4.2.1.4 PSD95:eGFP synaptic terminals 
The multiphoton system used is LaVision TrimScope III with ImSpector for image 
acquisition. PSD95:eGFP mice were used to detect postsynaptic densities. The eGFP signal 












from the surface of the cortex. An issue we found with this approach was that large blood 
vessels on the cortex created shadows on the synaptic terminals, which would make it 
difficult to measure the density of synaptic terminals and determine whether they had 
changed between imaging sessions. Furthermore, the resolution of the eGFP signal was not 
good enough to see individual terminals or clusters (see Figure 4.4). 
Vessels, synapses & β-amyloid  
Figure 4.4 Detection of vessels, PSD95+ postsynaptic terminals and β-amyloid, 
captured by multiphoton microscopy. Scale bar = 50μm. 
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4.2.1.5 β-amyloid deposits 
Methoxy-XO4 is a dye for detecting β-amyloid deposits. PSD95:eGFP x TgSwDI mice were 
injected with Methoxy-XO4 via intraperitoneal injection 24 hours before imaging. Figure 
4.4 shows multiphoton image detecting Methoxy-XO4, Texas Red Dextran, and 
PSD95:eGFP in the somatosensory cortex, 120μm below the surface.  
4.2.2 Optimisation of focal ischaemia by photothrombosis  
4.2.2.1 LED light source 
Experiments to optimise Rose Bengal photothrombotic occlusion were undertaken with 
the intention of using this approach to investigate the longitudinal effect of ischaemia and 
β-amyloid on postsynaptic terminals. Rose Bengal is activated by wavelength 532nm. 
Initially the approach was performed by illuminating the cortex with a LED/HBO fibre 
focused into the tissue with a 25x, 40x or 63x objective in the multiphoton microscope. 
Rose Bengal solution was prepared a day prior to injections (25 mg/mL in sterile PBS) and 
kept in the dark thereafter. As Rose Bengal dissipates quickly, there is only a window of 10-
15 minutes between intravenous injection and illumination. Once the dextran dye was 
injected and the clarity of the window checked, the anaesthetic rig was moved to the 
multiphoton microscope and the mouse’s headplate was attached to the platform. The 
platform was placed in the chamber, immediately putting the second anaesthetic mask 
over the mouse’s nose, and arranging the position of the stand and mask with the 10x 
objective needed for imaging over the cranial window, and to check for the location of the 
vasculature. The mask was secured with tape and more tape was used to mark out the 
location of the platform. The platform was then removed back to the anaesthetic rig and 
the first mask used to maintain the aesthesia. Then 100μl of Rose Bengal solution was 
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Figure 4.5 Lesions at 24 hours after Rose Bengal 
photothrombosis, using 25x objective lens for illumination, 100% 




Figure 4.6 Lesions at 24 hours after Rose Bengal photothrombosis, using 
40x and 63x objective lens for illumination, 100% and 50% strength and 




area of lesion and the length of the lesion on the brain surface. As the cranial window was 
3x3mm in size, the lesions had to be smaller to be able to capture the changes within the 
lesion and peri-lesion, however, the method here mostly resulted in lesions that were too 
large, this may have resulted from too much light scattering. The next stage was to modify 
this approach to get a more focal lesion, which was done using a fibre optic cable. 
4.2.2.2 Fibre optic 
A different approach was tried, using a fibre optic to target the region with stereotactic 
frame. This method was performed on C57Bl/6J without cranial windows, and laser speckle 
imaging was used to identifying regions of low cerebral blood flow. This procedure was 
conducted by myself with the assistance of Jessica Duncombe. 
Rose Bengal solution was prepared as before (25 mg/mL in sterile PBS). The mice were 
anaesthetised in a chamber and then transferred to the stereotactic frame and maintained 
with 1.5-2.5% isofluorane with a mask. Their body temperature was monitored with a 
rectal thermometer and a heated mat. The skull was exposed and laser speckle imaging 
was used to record the baseline blood flow (Section 2.3). One end of a fibre optic cable 
(0.75mm diameter) was attached to the arm of the stereotactic frame and set to the 
coordinates of: 1.50mm right from the midline, and -1.70mm from Bregma; to target the 
somatosensory cortex above the CA1. The fibre optic was positioned so the end was 
touching the exposed skull, to reduce lateral light scattering. 100μl of Rose Bengal solution 
was injected via the tail vein, keeping the room as dark as possible to prevent its activation. 
Once the solution had been injected, a surgical lamp was turned on away from the mouse, 
with the other end of the optical fibre cable held to it to illuminate it and the skull in the 
targeted area. Illumination durations of 2 and 3 minutes were tried for different mice. 
Laser speckle imaging was performed immediately after to capture the acute blood flow 
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change. The midline incision was closed up with a suture and the mice were recovered in 
an incubator. 4 hours later, laser speckle imaging procedure was repeated to measure 
blood flow changes. Mice were culled by schedule 1. Figure 4.7 shows the laser speckle 
images after 2 and 3 minute illumination. The laser speckle images at 0 hours already start 
to show a region of low CBF in the ipsilateral cortex, which increased in size by 4 hours 
post-photothrombosis. Although these images were not quantified and there was only 1 
mouse for either 2 or 3 minute illumination, there was concern that the mouse that had 
received 2 minute illumination had a far larger region of low CBF than after 3 minute 
illumination. As longer illumination duration should increase the size of the ischaemic area, 
Figure 4.7 Laser speckle images showing in cortical cerebral blow flow changes at baseline, 
immediately after photothrombosis and 4 hours after photothrombosis. 
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this was indication that this approach may have poor reproducibility and an alternative 
model of focal ischaemia was chosen for future studies. 
4.3 Discussion 
4.3.1 Multiphoton microscopy  
The use of multiphoton in vivo imaging through a cranial window in the skull is a beneficial 
approach for capturing dynamic real-time changes and to enable re-imaging of the same 
animals at different time-points. This could be particularly useful in the stroke field, as 
there is a disconnect in understanding how focal ischaemia can cause progressive damage, 
culminating in cognitive decline and dementia. The techniques described in this chapter 
were being optimised for a study to investigate the changes in density in excitatory 
postsynaptic terminals, at acute and chronic time points after a focal ischaemic lesion in 
the cortex of WT and TgSwDI mice. These procedures were very technically demanding and 
eventually we decided to change the approach to use the MCAO model, as presented in 
the following chapters.  
The disadvantages of multiphoton imaging through a cranial window is that only a small 
area of the brain can be analysed, as the window size was 3x3mm, and the depth of 
imaging was 450μm, at best. These limitations could be overcome by adapting the cranial 
window techniques, such as using silicone-based polydimethylsiloxane (PDMS), which is 
flexible, transparent and allows better light penetration (Heo et al. 2016). This publication 
reported that their PDMS cranial windows for mice could be 18mm2, and they could image 
to 550μm from the surface of the brain. Another benefit of PDMS window is that a 
micropipette can be used to inject through it, therefore, ion-sensitive dyes or 
pharmacological substances could be applied directly on to the brain. This would also allow 
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for measuring electrical activity with electrodes, to determine whether the synapses 
undergo functional changes. 
The initial plan for this study was to use multiphoton in vivo microscopy to detect changes 
in PSD95:eGFP+ terminals, however, the resolution was too poor to see individual 
terminals or clusters of them. Studies by Tim Murphy and colleagues frequently used this 
technique to capture dendritic spines, however, they used a 60x objective and a mouse 
model with YFP expressing in cortical layer V neurons. The highest objective we had 
available for imaging was the 40x lens. Plus, the fluorescent labelling in heterozygous 
PSD95:eGFP is on half of the PSD95 proteins, rather than a specific population of neurons. 
These issues made it challenging to resolve individual terminals. An alterative approach 
could be to use a transgenic mouse model which produces a fluorescent signal for 
neuronal activity, such as Arc-Venus or Arc-dVenus (Fernández et al. 2017; Rudinskiy et al. 
2012). As previously described (Section 3.4.3), Arc is an excitatory postsynaptic protein that 
is produced on activation, and tagging it with fluorescent Venus or dVenus signifies when 
the neurons are active. This approach of detecting a change in the fluorescent intensity of 
Arc-(d)Venus signal may be more sensitive than measuring the density of PSD95:eGFP+ 
terminals, which would require high microscopy resolution. 
Another problem that was encountered was that the cranial window appeared to induce 
long-term elevation of inflammatory cells, and these cells were made visible by engulfing 
Texas Red. Heo et al. stated that there were no clear differences in the density of 
microglia/macrophages or astrocytes at 10 weeks in the ipsilateral hemisphere of a rat 
with PDMS window compared to a naïve rat (Heo et al. 2016). There was, however, a clear 
increase in microglial density at 1 week in Cx3CrGFP+/- mice. It is likely that any cranial 
window surgery is going to cause some acute inflammatory response, and the best way 
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around it is to use the correct controls and to image at time points before and after the 
inflammation. In the present study, these cells were still present up to 2 months after 
window implantation. As these cells were not visible with use of the larger molecule 
weight dye, FITC dextran, it indicated that the smaller Texas Red dextran was leaking from 
the vessels and being taken up by these cells. FITC dextran is a green dye so it could not be 
used in mice expressed PSD95:eGFP, as the signals would be indistinguishable from each 
other. An alternative approach could be to use an even larger red fluorescent dextran, such 
as Tetramethylrhodamine, which can be imaged with PSD95:eGFP and would be too large 
to leak from the vessels and be engulfed by inflammatory cells. Taken together, we 
experienced a number of technical challenges with optimising multiple markers for 
multiphoton detection, and decided to instead use histological approaches for improved 
microscopy resolution in future studies (Chapters 5 and 6). 
4.3.2 Rose Bengal photothrombosis 
Previous publications have used Rose Bengal photothrombosis to induce a small cortical 
ischaemic lesions, in order to investigate the acute impact on dendrite and dendritic spines 
(Zhang et al. 2005; Zhang & Murphy 2007). In the present case, experiments were 
undertaken to optimise Rose Bengal photothrombosis for use in a future study, sought to 
determine whether focal ischaemia leads to long-term postsynaptic degeneration, and 
whether this would be exacerbated in TgSwDI mice. Initially, activation of Rose Bengal was 
trialled using a LED/HBO light source focussed through the 25x and 40x objectives, 
however, this resulted in large lesions that extended beyond the area exposed by the 
cranial window. This was improved somewhat by the use a 63x dipping objective, although 
this presented additional challenges as this objective could be used to focus the light for 
Rose Bengal activation, but it was not compatible for imaging with this microscope. As the 
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brain could not be imaged with this objective, it was very difficult to precisely illuminate 
the same area of the cortex between each mouse. The technique was made even more 
challenging by the speed required, as Rose Bengal dissipates after 10-15 minutes. The best 
method to overcome these issues would be to use a laser, at wavelength 561nm, to 
activate Rosen Bengal, as used by (Porritt et al. 2012; Stokowska et al. 2016). This should 
result in a small, precise cortical lesion. Plus, this approach would enable imaging to occur 
whilst the occlusion is being formed.  
Further to this, a fibre optic cable was used to activate Rose Bengal by illuminating the skull 
as specific stereotactic coordinates, for either 2 or 3 minutes. As described, laser speckle 
imaging was used to capture the cortical CBF at the baseline, 0 hours and 4 hours after the 
procedure. Although this approach enabled a precise area of the skull to be targeted, there 
still appeared to be large areas of low CBF in the ipsilateral hemisphere. Histological 
analysis of the tissue was not performed, however, so we do not know how large the 
resulting lesion was. Moreover, as previously described, the mouse with shorter 
illumination duration had a larger area of low CBF, which implied that even with this 
approach there may be issues with reproducibility.  
Overall, the results of these experiments indicated that this approach of Rose Bengal 
photothrombosis was too variable and presented too many challenges for a study. 
Moreover, there were concerns that the limited resolution of the multiphoton microscope 
would be insufficient to detect changes in the densities of synaptic terminals. It was 
decided, therefore, that an alterative model of focal ischaemia would be used, middle 
cerebral artery occlusion (MCAO), which was then established by Dr. Jill Fowler. 
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Chapter 5:  The long-term impact of focal ischaemia 
and concurrent TgSwDIAPP expression on 
glutamatergic synapses and glial responses within the 
ischaemic territory 
5.1 Introduction 
The previous study determined that glutamatergic pre- and post-synaptic terminals and 
dendrites are resilient to modest hypoperfusion. There was implication that ischaemic 
injury caused some degeneration of dendrites, indicating that greater structural changes 
would occur in a model of focal ischaemia. As described in Section 1.7.3., there is evidence 
that focal ischaemia results in acute changes in glutamatergic synaptic protein levels and a 
loss of dendrites and dendritic spines. In remains unclear, however, what long-term impact 
focal ischaemia has on glutamatergic pre- and postsynaptic terminals.  
There is a considerable body of literature indicating that an interplay between vascular and 
Alzheimer’s pathology exists, and that patients with concurrent vascular and Alzheimer’s 
pathology have worsened cognitive outcome compared with patients with just vascular 
pathology (Snowdon et al. 1997). The mechanisms underpinning this interaction, however, 
remain ill-defined. As well as the impact of ischaemia on glutamatergic transmission, there 
is evidence that β-amyloid causes downstream dysfunction and degeneration of 
glutamatergic pre- and postsynaptic terminals. Our prediction was, therefore, that in cases 
of mixed vascular and Alzheimer’s pathology, there would be exaggerated synaptic 
dysfunction and degeneration, culminating in worsened cognitive decline. Furthermore, as 
both ischaemia and β-amyloid are known to trigger glial responses, we predicted that in 
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conditions of mixed pathology there would be an exacerbated glial response, which would 
contribute to degenerative processes. A limited number of studies have investigated the 
effect of focal ischaemia surgery on mice with β-amyloid pathology and found exaggerated 
tissue damage and glial responses (Milner et al. 2014; Amtul, Shawn N Whitehead, et al. 
2015), however, the impact of these comorbidities on glutamatergic pre- and postsynaptic 
terminals is unknown. 
The present study was designed to further elucidate the long-term outcome of focal 
ischaemia and concurrent β-amyloid pathology on neurons and glutamatergic synapses 
within the occlusion territory in relation to the glial response and functional outcome. 
Transient focal ischaemia was induced with 15 minutes of MCAO in TgSwDI mice and in WT 
littermates. Protein markers to of glutamatergic synapses were analysed. The mice used in 
the study expressed PSD95:eGFP so their postsynaptic densities could be readily imaged 
with fluorescent microscopy. Finally, glial cells, microglia/macrophages and astrocytes 
were investigated.  
5.1.1 Hypothesis 
Focal ischaemia leads to long-term degeneration of glutamatergic pre- and post-synaptic 
terminals and neuronal structures, plus chronic neuroinflammation, within the occlusion 
territory, culminating in functional impairment. In cases with concurrent focal ischaemia 
and β-amyloid this results in exaggerated long-term degeneration of these structures, 
exacerbated chronic neuroinflammation, and worsening functional impairment.   
5.1.2 Aims 
The aim of this study was to elucidate whether transient MCAO causes worsened outcome 
for neuronal and synaptic degeneration in the ischaemic territory in TgSwDI mice 
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compared to WT mice, and whether these changes are related to differences in chronic 
glial responses.  
5.2 Materials and Methods 
5.2.1 Animals 
Male WT and heterozygous TgSwDI littermates (on a heterozygous PSD95:eGFP 
background, Section 2.1.2) underwent either 15 minutes of sham or MCAO surgery. The 
mice were 4-6 months old at the time of surgery. Three mice were culled in the first week 
after surgery as they had adverse side effects. Five mice were excluded from the study for 
not meeting the inclusion criteria of having a diffuse ischaemic lesion in the striatum; as 
three of these mice had large striatal and cortical infarcts, whereas the other two had no 
ischaemic pathology. The final group numbers were WTxPSD95:eGFP sham n = 6; 
TgSwDIxPSD95:eGFP sham n = 5; WTxPSD95:eGFP MCAO n = 7 and TgSwDIxPSD95:eGFP 
MCAO n = 6. These mice were recovered for 3 months after surgery before harvesting the 
tissue for histological analysis. An additional three cohorts were included for generating 
tissue for biochemical analysis. These cohorts were composed of C57Bl/6J and 
heterozygous TgSwDI mice on C57Bl/6J background. 15 minutes MCAO surgery was 
performed on these mice at ages 4-6 months. The brains were harvested at three time 
points: 24 hours (WT MCAO n = 9, TgSwDI MCAO n = 8), 1 month (WT MCAO n = 8, TgSwDI 
MCAO n = 8) and 3 months (WT MCAO n = 8, TgSwDI MCAO n = 10). The animal group 
numbers chosen for this study were based on the breeding constraints, rather than power 
calculations. For the histology cohort, the mice were assigned so the cages contained both 
sham- and MCAO-operated animals. The mice in the histology cohort are the same mice as 
used for the study in Chapter 6. 
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The mice were maintained on a 12:12hr light/dark cycle and had access to food and water 
ad libitum. All experiments were conducted in accordance with the Animals (Scientific 
Procedures) Act 1986 and local ethical approval at the University of Edinburgh and were 
performed under personal and project licenses granted by the Home Office. The 
experiments and data analysis were conducted in a blinded manner, so the genetic and 
surgical status of the mice were unknown until the data sets were finalized and statistically 
compared between groups.  
5.2.2 Middle cerebral artery occlusion surgery  
MCAO and sham surgery was performed when the mice were 4-6 months old. The details 
of the surgery are described in full in Section 2.2.2.  
5.2.3 Laser speckle imaging 
Cortical CBF was analysed with a Laser Speckle Contrast Imager (Moor FLPI2 Speckle 
Contrast Imager, Moor Instruments, UK), at 24 hours and 4 weeks after MCAO surgery, for 
the biochemistry cohorts (Section 2.3). CBF was recorded for 3 minutes. The recordings 
were analysed using MoorFLPI-2 Review software (version 4.0). Regions of interest were 
placed over the contralateral and ipsilateral cortices, in region supplied by the MCA (see 
Figure 5.2). Ipsilateral CBF was normalised to the contralateral CBF for each mouse, and 
compared between WT and TgSwDI mice. 
5.2.4 Ladder rung test  
At 3 days, 6 weeks and 11 weeks following sham or MCAO surgery, the mice underwent 
the ladder-rung test to probe motor function (Section 2.4.2).  
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5.2.5 Tissue collection and tissue processing  
Mice for histological analysis were transcardially perfused with PBS according to Section 
2.5.1.1, 3 months after surgery. The brains were sectioned using the vibratome (Section 2. 
5.1.3); the sections were cut to 30μm thick and every section was taken between coronal 
levels +2.58 and -2.92 from bregma, and stored in a 24 well plate in cryoprotective 
medium.  
Mice for biochemical analysis were culled at 24 hours, 1 month and 3 months after 
surgery, by schedule 1 cervical dislocation, followed by decapitation (Section 2.5.2). As 
previously stated, the brains were sectioned into 2mm slices, divided into hemispheres, 
and frozen in liquid nitrogen. The middle slice (~0.38mm to -1.62mm from bregma) was 
thawed and the striatum was dissected from each hemisphere and homogenised, as stated 
Section 2.7.1.1. Protein concentration analysed was performed (Section 2.7.1.2) and the 
samples were prepared for western blotting.  
5.2.6 Detection of ischaemic neuronal pathology 
For each mouse a section was taken from the following coronal levels: +2.58, +1.54, +0.98, 
+0.74, -0.10, -1.06, -2.06 and -2.92, and stained with cresyl violet (Section 2.6.2). The areas 
of ischaemic neuronal pathology were visible as regions with selective neuronal loss 
(absence of large neuronal somas). These areas were manually mapped out on line 
drawings of each coronal levels (Figure 5.3B) and the areas were scaled and measured 
using ImageJ. The areas of ischaemic neuronal pathology at each coronal level were 
compared between WT and TgSwDI mice. The volumes of ischaemic neuronal pathology 
were measured as the area under the curve and the volumes were compared between WT 
and TgSwDI mice.  

171 
5.2.9 Detection of microglia/macrophages and astrocytes 
Microglia/macrophages were detected with immunostaining for Iba1, whilst astrocytes 
were detected with immunostaining for GFAP, using the protocol described in Section 
2.6.3.1. Neighbouring coronal sections were taken from -0.10mm from bregma coronal 
level. The entire sections were imaged with the Zeiss Axio Scan.Z1 slide scanner, using 
brightfield acquisition and 20x objective. 
5.2.10 Analysis of %density within lesion and peri-lesion 
5.2.10.1 Lesion and peri-lesion regions of interest 
The %density of VGLUT1, PSD95, Iba1 and GFAP was measured in the lesion and peri-
lesion. The lesion area was delineated using the cresyl violet stained sections. The cresyl 
violet stained sections from coronal level -0.10mm were imaged with the slide scanner, 
using brightfield acquisition and 20x objective. 
VGLUT1 and PSD95 were detected with fluorescent microscopy and the resulting images 
had different pixel densities to the brightfield images taken of the cresyl violet stained 
sections. The brightfield images had to be scaled to fit the fluorescent images, so regions of 
interest delineated on the brightfield images could be superimposed on the fluorescent 
images. The scaling method used required the brightfield cresyl violet images and 
fluorescent PSD95:eGFP images from the same mouse to be opened together in ImageJ, 
and for a line to be drawn in the same place across a ventricle on both images. The plugin 
‘Align Image by line ROI’ was then used to scale the brightfield image, so the lines drawn 
across the ventricles are the same size. In the new-scaled brightfield images, the ischaemic 











pathology in the striatum. These lesion regions of interest ‘ROI’ were then superimposed 
onto the fluorescent images of VGLUT1 and PSD95 detection for analysis within the area 
(Figure 5.1).  
The peri-lesion ROI’s were delineated as the region of 100μm wide around the outside of 
the lesion ROI within the striatum. These were constructed on ImageJ by using a 
Figure 5.1 Lesion and peri-lesion ROI’s delineated from cresyl violet 
stained sections. For each mouse, the lesion ROI was delineated from the 
ischaemic lesion from the image of cresyl violet stained section. The peri-
lesion was constructed as a region of 100μm wide, surrounding the lesion. 
ROI’s were superimposed onto the images to measure the %densities of 
VGLUT1, PSD95, Iba1 and GFAP for analysis. The images were flipped 
horizontally to measure the %densities of the markers on the contralateral 
hemisphere. 
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segmented line with the width set to 100μm, to draw around the lesion ROI. The ‘Line to 
Area’ function was then used to convert the line to an area with a width of 100μm to get 
the peri-lesion ROI (Figure 5.1). The lesion ROI and peri-lesion ROI for each mouse was 
superimposed onto the images with VGLUT1 staining and with PSD95:eGFP signal 
detection. The %density of VGLUT1 and PSD95 was measured with an autothreshold to 
cover the area of positive staining.  
The same approach was used to measure the %densities of Iba1 and GFAP within the 
lesion and peri-lesion, however, as these were imaged using the brightfield the ROI’s could 
be delineated from the images of creysl violet stained sections without scaling them first.  
5.2.10.2 Sham analysis 
The %densities of VGLUT1, PSD95, Iba1 and GFAP were also measured in the ipsilateral and 
contralateral striatum of the sham mice, and compared to the %densities in the 
contralateral striatum of the MCAO mice. This analysis was performed by measuring the 
%density of these markers within a square ROI of 19mm3, which is the average area of the 
ischaemic lesion ROI’s. The square ROI was consistently placed in the middle of the 
striatum on each hemisphere, to mirror the areas that are lesioned in the ipsilateral 
striatum of MCAO mice.  
5.2.11 Colocalisation of microglia and PSD95:eGFP terminals 
Sections from around – 0.10mm from bregma were taken from two WT and TgSwDI (x 
PSD95:eGFP), from the 3 month histology cohort. Microglia were detected with 
immunofluorescent detect of TMEM119, as described in Section 2.6.3.3. The tissue was 
imaged used confocal microscopy (Section 2.6.4.1), with 63x objective.  
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5.2.12 Western blot detection of VGLUT1, PSD95, Iba1 and GFAP 
Western blot analysis was used to measure the protein levels of VGLUT1, PSD95, Iba1 and 
GFAP in enriched striatal tissue, taken from the ipsilateral and contralateral hemispheres of 
WT and TgSwDI mice, 24 hours, 1 month and 3 months after MCAO surgery. See Section 
2.7.1.3 for method details. 
5.2.13 Statistical analysis 
Mann-Whitney test was used to statistically compare the normalised ipsilateral CBF 
between WT and TgSwDI mice, 24 hours and 4 weeks after MCAO surgery. Two-way 
ANOVA was used to statistical determine whether there was a surgery or genotype effect 
on limb placement %errors at 3 days, 6 weeks and 11 weeks after surgery. Bonferroni’s 
multiple comparison test was used for post-hoc analysis. Two-way ANOVAs were used to 
compare the area of ischaemic neuronal pathology and axonal pathology at the different 
brain levels between WT and TgSwDI mice, whilst a Mann Whitney test was used to 
compare the total volume of ischaemic neuronal pathology and axonal pathology between 
the genotypes.  
Two-way ANOVAs were used to compare between the %densities of VGLUT1, PSD95, Iba1 
and GFAP in the ipsilateral and contralateral striatum of WT and TgSwDI sham mice. Two-
way ANOVAs were also used for the comparison between the %densities of these markers 
in the contralateral striatum of WT and TgSwDI after either sham or MCAO surgery. Post-
hoc analysis was performed using Bonferroni’s multiple comparison test. 
The %densities of VGLUT1, PSD95, Iba1 and GFAP immunostaining in the lesion and peri-
lesion areas were statistically analysed with two-way ANOVA, to determine whether there 
were differences between the ipsilateral and contralateral hemispheres, and between WT 
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and TgSwDI mice. Plus, two-way ANOVAs were used to compare the %densities of these 
same markers from the contralateral striatum from WT and TgSwDI after sham and MCAO 
surgery. Post-hoc analysis was performed using Bonferroni’s multiple comparison test. 
Spearman’s rank correlation was used to establish whether %densities of VGLUT1 and 
PSD95 compared against %densities of Iba1 and GFAP.  
Two-way ANOVA’s were used to compare the protein levels between the hemispheres and 
genotypes, at 24 hours, 1 month and 3 months after MCAO, measured with western 
blotting. Bonferroni multiple comparisons was used as a post-hoc test. 
For all analysis, p<0.05 was considered to be statistically significant. 
5.3 Results 
5.3.1 There were no differences in ipsilateral cortical CBF reduction between 
WT and TgSwDI mice at 24 hours and 4 weeks after MCAO surgery. 
Cortical CBF was measured in the ipsilateral and contralateral cortex of WT and TgSwDI 
mice, 24 hours and 4 weeks after MCAO surgery, to determine whether there was a 
genotype effect on CBF reduction. Ipsilateral CBF, normalised to the contralateral 
hemisphere, was compared between WT and TgSwDI mice (Figure 5.2) Although at both 
time points CBF was reduced compared to the contralateral hemisphere (dotted line at 
100%), there was no significant differences between WT and TgSwDI at 24 hours after 
MCAO (p > 0.999) and at 4 weeks (p = 0.8541). The values measured at 24 hours and 4 
weeks were recorded from different cohorts of animals on different days, therefore, no 
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Figure 5.2 No difference in ipsilateral cortical blood flow between WT and TgSwDI mice at 
24 hours and 4 weeks after surgery. (A) Laser speckle imaging used to measure cortical 
cerebral blood flow, ipsilateral normalised to contralateral. There were no differences in 
cortical blood flow reductions between WT and TgSwDI mice at (B,C) 24 hours and (D,E) 4 
weeks after MCAO. Data presented as mean ± SD, n = 8-10 per group. Man-Whitney test. 
 
177 
statistical comparison was made between the two time points. However, the values from 
the two time-point do suggest that there may have been some restoration of blood flow 
between the acute and chronic time points post-MCAO. The result indicated that 
TgSwDIAPP expression does not worsen CBF reductions following MCAO surgery, and that 
any downstream effect of genotype on pathological changes is not a result of perfusion 
differences.  
5.3.2 MCAO resulted in an acute motor deficit with long-term recovery, with no 
difference between WT and TgSwDI mice. 
Movement problems in the contralesional limbs are common symptoms in patients with 
ischaemic damage/stroke in the middle cerebral artery territory, as injury to the striatum 
will cause motor impairment (Jorgensen et al. 1995; Cramer et al. 1997). A version of the 
ladder-rung test was used to determine whether 15 minutes of MCAO resulted in motor 
impairment, and whether there would be a worsened outcome in TgSwDI mice.  
The apparatus set up for the ladder-rung test is shown in Figure 5.3A. A clear plastic ladder 
with regular rungs was suspended in a horizontal orientation, between a neutral start cage 
and the mice’s home cage. These cages were stacked on top of empty upturned cages to 
raise them high enough for a camcorder to be placed underneath. The mice were given 
three trials of walking across the ladder and later their limb placements were analysed. For 
each mouse, the number of correct limb placements, partial limb placements and slips 
were recorded (Figure 5.3B) and the sum of partial placements and slips were divided by 
the total number of steps taken, to give a limb placement %error. This experiment was 
performed on groups of WT and TgSwDI mice 3 days, 6 weeks and 11 weeks after sham or 
MCAO surgery. 
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Figure 5.3 MCAO resulted in acute motor deficit. There were no deficits at later time-points. 
The ladder-rung test was used to probe for motor deficits. (A) Apparatus set up. (B) Type of limb 
placements. (C) At 3 days after surgery, there was a significant increase in limb placement % 
errors in MCAO mice compared to sham, in both WT and TgSwDI. At 6 weeks (D) and 11 weeks 
(E) there were no significant differences between the limb placement % errors in MCAO and 
sham mice, or with between WT and TgSwDI mice. Data presented as mean ± SD, n = 5-7 per 
group. Two-way ANOVA with Bonferroni’s multiple comparison test. */***p<0.05. 
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At 3 days post-MCAO, there was an increase in the limb placement %error for MCAO mice 
in comparison to the shams (F (1, 20) = 26.45, p < 0.0001) (Figure 5.3C) and post-hoc 
analysis revealed that this increase occurred in both WT and TgSwDI mice. There was, 
however, no effect of genotype (F (1, 20) = 0.0673, p = 0.798) and no interaction between 
these factors (F (1, 20) = 0.961, p = 0.339). At 6 weeks, there was an overall effect of 
surgery (F (1, 20) = 6.554, p = 0.0187) (Figure 5.3D), however, Bonferroni multiple 
comparisons test did not show a significant surgery difference in either WT or TgSwDI 
mice. There was also no affect of genotype (F (1, 20) = 0.485, p = 0.494) or an interaction (F 
(1, 20) = 0.0368, p = 0.850) at 6 weeks. Finally, at 11 weeks there was no effect of surgery 
(F (1, 20) = 1.379, p = 0.254), genotype (F (1, 20) = 0.0335, p = 0.857) or an interaction (F (1, 
20) = 1.633, p = 0.216) (Figure 5.3E).  
These results indicate that at the acute stage there is an initial motor deficit caused by 
MCAO surgery, and the lack of statistical significance at later time-points suggests a 
possible restoration of motor ability. It also showed that there is no genotype effect, 
therefore, TgSwDIAPP expression does not cause greater motor deficit in these mice. The 
changes within ischaemic lesions at acute stages have been well characterised in many 
studies, however, the chronic changes are less well understood. Although the motor 
deficits are restored by 3 months post-MCAO, it is important to understand what damage 
is present in the brain at this time-point, and whether it is that affected by TgSwDIAPP 
expression. To answer those questions, the mice were culled the week after they had 
finished their last ladder-rung test, and their brains were harvested for histological analysis 
to address these questions. 
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5.3.3 MCAO caused long-term ischaemic neuronal and axon pathology, with no 
differential effect between WT and TgSwDI. 
5.3.3.1 Ischaemic neuronal pathology 
The next aim of the study was to determine whether transient MCAO causes long-term 
neuronal damage and whether these changes were exacerbated in TgSwDI mice. Cresyl 
violet stains cells bodies, and was used to analyse the regions of ischaemic neuronal 
pathology (Figure 5.4A). Fifteen minutes of MCAO resulted in diffuse ischaemic damage 
predominantly in the striatum. Two animals were excluded from the study as they showed 
no sign of ischaemic damage; whilst another three animals were excluded as their 
pathology was too severe and quite different from the other animals, with large infarcts 
and pan necrosis in the striatum and cortex. 
Eight coronal sections were taken at specific levels throughout the brains and stained with 
cresyl violet. The images in Figure 5.4A are of cresyl violet stained sections at level  -
0.10mm from bregma, from WT and TgSwDI mice after either sham or MCAO surgery, 
imaged with 20x objective. The inserts show that in both hemispheres of the striatum in 
sham mice the neuron pathology looks normal in both genotypes, as many large neuronal 
cell bodies are present. The contralateral striatum of the MCAO mice for both genotypes 
appears to be indistinguishable from the shams, indicating that the surgery did not induce 
ischaemic neuron damage the contralateral hemisphere. In the ipsilateral hemispheres, 
however, there were diffuse regions with a clear absence of large neuron cell bodies. 
These regions of damage in the ipsilateral hemispheres were manually mapped out on line 
drawings of the coronal sections (Figure 5.4B), whilst observing the sections under the 
microscope. This is a standardised method for measuring tissue damage in stroke models 
(Osborne et al. 1987), to prevent under-estimation of the extent of tissue damage due to 
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Figure 5.4 MCAO caused long-term ischaemic neuronal pathology, with no difference 
between WT and TgSwDI. (A) Cresyl violet stain was used to analyse ischaemia 
neuronal pathology, which was manually mapped out (B). (C) Areas of ischaemic 
neuronal pathology throughout the brain and (D) volume of ischaemic neuronal 
pathology were indistinguishable between WT and TgwDI. Data presented as mean ± 
SD, n = 6,7 per group. Two-way ANOVA and Mann-Whitney test. Scale bar = 1mm, 
100μm insert. Grey boxes = inserts. 
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varying amounts of atrophy. The area of ischaemic neuron pathology and atrophy was 
measured from the line drawings, which were plotted against the distance from bregma. 
Statistical analysis showed that there was no significant difference in the area of ischaemic 
neuronal pathology between WT and TgSwDI mice at any of the coronal brain levels 
(F(1,88) = 1.727, p = 0.192) (Figure 5.4C). The volume of pathology for each brain was 
calculated as the area under the curve when pathology area is plotted against distance 
from bregma. There was no difference between the volume of ischaemic neuronal 
pathology between WT and TgSwDI mice (p = 0.713) (Figure 5.4D). These results showed 
that MCAO leads to long-term ischaemic neuronal pathology; however, TgSwDIAPP 
expression did not exacerbate the damage.  
5.3.3.2 Axonal pathology  
Axon damage has been shown to occur in regions of neurodegeneration in focal ischaemia 
models (Stephenson et al. 1992). To determine whether long-term axon pathology occurs 
following MCAO and whether there is a differential effect between WT and TgSwDI mice, 
axon bulbs were detected by immunohistochemistry for amyloid precursor protein (APP) 
(Figure 5.5A). APP is transported along axons under physiological conditions, however 
when axons become damaged, the protein accumulates into bulbs (Stephenson et al. 
1992). The same method for measuring the volume of neuron pathology was applied to 
the analysis of axon pathology; regions containing axon bulbs on the ipsilateral hemisphere 
were manually mapped on the same line drawings of coronal levels (Figure 5.5B). As 
before, the areas of axonal pathology were plotted against the distance from bregma and 
the volumes were calculated. There were no significant differences in the areas of axonal 
pathology at each coronal level compared between WT and TgSwDI mice (F(1,88) = 1.719, 
p = 0.193) (Figure 5.5C). Furthermore, the volumes of axon pathology were indistinct 
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Figure 5.5 MCAO caused long-term axonal pathology, with no difference between 
WT and TgSwDI. (A) APP immunostaining was used to analyse axonal bulb 
pathology, which was manually mapped out (B). (C) Areas of axonal pathology 
throughout the brain and (D) volume of axonal pathology were indistinguishable 
between WT and TgSwDI. Data presented as mean ± SD, n = 6,7 per group. Two-way 
ANOVA and Mann-Whitney test. Scale bar = 100μm. 
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between WT and TgSwDI, (p = 0.615) (Figure 5.5D). This demonstrated that focal ischaemia 
causes axonal pathology throughout the brain, but this is not exacerbated by TgSwDIAPP 
expression. 
5.3.4 MCAO lead to long-term loss of glutamatergic pre- and postsynaptic 
terminals within the lesion territory.  
The previous study reported in Chapter 3 showed that glutamatergic pre- and postsynaptic 
terminals were resilient to modest global hypoperfusion, even in the CA1 where there 
were small areas of focal ischaemic damage in a subset of animals. We questioned whether 
a model using a more severe focal reduction in blood flow would cause synaptic changes, 
and whether another disease comorbidity, TgSwDIAPP expression, would exaggerate these 
changes. The next stage of the current study, therefore, was to determine whether MCAO 
results in long-term loss of pre- and post- glutamatergic synaptic terminals within the 
ischaemic territory, and whether there is a difference between WT and TgSwDI mice. The 
synaptic densities were analysed within the ischaemic lesion and the peri-lesion to 
determine whether synaptic terminals were vulnerable in regions with ischaemic neuron 
damage, and in the surrounding tissue with normal neuropathology. 
5.3.4.1 Presynaptic terminal, VGLUT1 
The densities of VGLUT1+ terminals were analysed with immunohistochemistry and image 
analysis. Before analysing the VGLUT1 %density in the ischaemic lesion, it was important to 
check that the VGLUT1 %density in the contralateral hemispheres could be used as the 
control measurements by comparing them to the sham mice. Immunofluorescent 
detection of VGLUT1 (in tissue from -0.10 mm from bregma level) and slidescanner imaging 
was undertaken for all animals at the same time. In the images, %density was measured a 
185 
square region of interest in the striatum from both hemispheres of sham animals and from 
contralateral hemisphere of MCAO animals (Figure 5.6A). Measurements from both 
hemispheres of WT and TgSwDI sham mice were compared to determine whether there 
was a genotype effect, and whether the sham surgery caused any synapse loss. These 
measurements were analysed with a two-way ANOVA, which found no differences 
between the striatal hemispheres (F (1, 18) = 0.644, p = 0.433), or between the genotypes 
(F (1, 18) = 0.000596, p = 0.981), and no interactions (F (1, 18) = 0.410, p = 0.530), 
confirming that in the sham mice VGLUT1 %densities were stable between both 
hemispheres and indistinguishable between the two genotypes (Figure 5.6B). The 
measurements for the contralateral hemispheres from the sham and MCAO mice were 
then compared to determine whether MCAO surgery affects synapses in the contralateral 
hemisphere. Two-way ANOVA analysis revealed that there was an overall significant 
surgery effect (F (1, 20) = 4.600, p = 0.0444), however, Bonferroni’s multiple comparison 
test did not show a significant effect of surgery for either genotype. The data appears to 
show a slight increase in the VGLUT1 %density in the contralateral striatum of MCAO mice 
compared to the shams (Figure 5.6C). There was no genotype effect (F (1, 20) = 0.572, p = 
0.458) and no interaction (F (1, 20) = 0.000554, p = 0.982) in these measurements. This 
result may indicate that MCAO surgery stimulates a small increase in the density of 
glutamatergic presynaptic terminals in the contralateral striatum. As these changes are 
small, the contralateral hemispheres of MCAO mice were used as the controls for the 
analysis of VGLUT1 changes in the ischaemic lesion. 
Next, the VGLUT1 %density was measured from the lesion and peri-lesion in sections from 
MCAO mice. Specific regions of interest (ROI) for the lesion and peri-lesion were 
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Figure 5.6 MCAO lead to long-term loss of glutamatergic presynaptic terminals within 
the lesion, and in the peri-lesion of TgSwDI mice. (A, D) Immunostaining for VGLUT1 used 
to detect glutamatergic presynaptic terminals. (B) VGLUT1 %density in sham mice was 
stable between the contralateral and ipsilateral striatum, with no difference between the  
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constructed from the cresyl violet stained section from each individual mouse (described in 
Section 5.2.10.1, and see Figure 5.1). These sections were from -0.10 mm bregma level, as 
at this level the area of ischaemic neuron damage is at its largest. The lesion ROI’s were 
made by drawing around the area of ischaemic neuron pathology in the ipsilateral striatum 
with ImageJ, whilst the peri-lesion ROI was constructed by delineating an area of 100μm 
width around the lesion. To measure densities of markers on the contralateral 
hemispheres, the images were flipped horizontally.  
The %density of VGLUT1+ presynaptic terminals were measured within the lesion and peri-
lesion (Figure 5.6D), and compared between the hemispheres and genotypes to determine 
the long-term affect that MCAO and β-amyloid has on these structures. There was a 
significant surgery effect, reducing VGLUT1 %density in the striatal lesion in comparison to 
the contralateral hemisphere (F (1, 22) = 107.3, p < 0.0001), however, there was no 
difference between the genotypes (F (1, 22) = 0.565, p = 0.460) and no interaction (F (1, 22) 
= 0.646, p = 0.430) (Figure 5.6E). Post-hoc analysis revealed that the surgery effect was 
present in both WT and TgSwDI mice. There was a significant effect of surgery on the 
VGLUT1 %density in the peri-lesion (F (1, 22) = 9.296, p = 0.0059), although there was no 
effect of genotype (F (1, 22) = 0.0946, p = 0.761) and no interaction (F (1, 22) = 1.002, p = 
0.328) (Figure 5.6F). Bonferroni’s multiple comparison test showed that the surgery effect 
genotypes. (C) VGLUT1% comparison between the contralateral striatum of sham mice and 
MCAO mice of both genotypes showed an overall effect of surgery, but post-hoc analysis 
showed no significant differences between the groups, and no genotype effect. (E) VGLUT1 
%density was reduced in the lesion in both WT and TgSwDI mice, no genotype effect. (F) 
VGLUT1 %density was reduced in the peri-lesion of only TgSwDI mice, although there was no 
overall genotype effect. Data presented as mean ± SD, n = 6,7 per group. Two-way ANOVA 
with Bonferroni’s multiple comparison test. ***p<0.0001, *p<0.05. Scale bar = 1mm, 100μm 
insert. White boxes = inserts. 
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causing a reduction VGLUT1 %density in the peri-lesion only reached significance in the 
TgSwDI mice. This result indicated that while presynaptic glutamatergic terminals are 
reduced in the focal ischaemic lesion, they are more resilient in the peri-lesion particularly 
in WT mice. Although there was no overall genotype effect, the significant reduction of 
VGLUT1 %densities in only TgSwDI mice may indicate that concurrent TgSwDIAPP 
expression does result in exaggerated degeneration of glutamatergic presynaptic terminals 
in the peri-lesion.  
5.3.4.2 Postsynaptic terminals, PSD95 
The next step was to determine whether MCAO surgery and TgSwDIAPP expression have 
an effect on the density of postsynaptic glutamatergic terminals. The mice used in this 
study express PSD95:eGFP, therefore, the density of PSD95+ postsynaptic terminals could 
be readily analysed in the same sections used to detect VGLUT1. As before, the %density of 
PSD95 was measured in contralateral striatum of the MCAO mice and in both hemispheres 
of the sham mice, and analysed to determine whether the PSD95 %density in the 
contralateral striatum remained stable after MCAO surgery. There were no significant 
differences in the PSD95 %density between the contralateral and ipsilateral striatum in the 
sham mice (F(1,18) = 0.570, p = 0.460), nor was there a genotype effect (F(1,18) = 0.576, p 
= 0.458) or an interaction (F(1,18) = 0.891, p = 0.358) (Figure 5.7B). This shows that the 
sham surgery does not cause a loss of postsynaptic terminals and there is no baseline 
genotype effect. When the PSD95 %density for contralateral striatum for the sham and 
MCAO mice were compared, similarly to VGLUT1, there was a significant surgery effect 
(F(1,20) = 7.485, p = 0.0127), but no effect of genotype (F(1,20) = 0.554, p = 0.465) and no 
interaction (F(1,20) = 0.873, p = 0.361) (Figure 5.7C). Post-hoc analysis revealed that there 
was a significant increase in PSD95 %density in the contralateral striatum of WT MCAO 
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Figure 5.7 MCAO lead to long-term loss of glutamatergic postsynaptic terminals 
within the lesion and peri-lesion. (A, D) PSD95:eGFP to detect glutamatergic 
postsynaptic terminals. (B) PSD95 %density in sham mice was stable between the 
contralateral and ipsilateral striatum, with no difference between the genotypes.  
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mice compared to the shams, whereas there was no difference in TgSwDI mice. This 
analysis showed that there was a small increase of postsynaptic terminals in the 
contralateral striatum of WT animals following MCAO, however, as the difference was 
slight it was decided that the contralateral hemisphere would still be used as the control 
for analysing the effect of MCAO on postsynaptic terminals in the ipsilateral striatum. 
The %density of PSD95 was measured in the same sections from MCAO mice as VGLUT1, 
using the same regions of interest (Figure 5.7D). The PSD95 %densities were significantly 
reduced in the striatal lesion in comparison to the contralateral hemisphere (F (1,22) = 
148.3, p < 0.0001), although there was no effect of genotype (F (1,22) = 0.760, p = 0.393) 
and no interaction (F (1,22) = 0.469, p = 0.501) (Figure 5.7E). Post-hoc analysis showed that 
surgery effect on PSD95 %density occurred in the lesion of both WT and TgSwDI mice. 
PSD95 %densities were also significantly reduced in the ipsilateral peri-lesions compared to 
the contralateral hemispheres (F (1, 22) = 15.10, p = 0.0008), there was no effect of 
genotype (F (1,22) = 0.0255, p = 0.875) and no interaction (F (1,22) = 0.250, p = 0.622) 
(Figure 5.7F). Post-hoc analysis showed that surgery effect on PSD95 %density occurred in 
the peri-lesion of both WT and TgSwDI mice. These results showed that long-term loss of 
excitatory postsynaptic terminals occurs in the ischaemic lesion, as well as in the peri-
lesion where there is no ischaemic neuronal damage. There was no difference between WT 
(C) There was a small significant increase in PSD95 %density in the contralateral striatum of 
WT MCAO mice, compared to WT sham mice, with no differences in the TgSwDI mice. (E) 
PSD95 %density was reduced in the lesion of both WT and TgSwDI mice, compared to the 
contralateral hemisphere. (F) PSD95 %density was reduced in the peri-lesion of WT and 
TgSwDI, compared to the contralateral hemisphere. Data presented as mean ± SD, n = 6,7 per 
group. Two-way ANOVA with Bonferroni’s multiple comparison test. ***p<0.0001, *p<0.05. 
Scale bar = 1mm, 100μm insert. White boxes = inserts. 
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and TgSwDI, showing that concurrent TgSwDIAPP expression did not worsen post-synaptic 
loss within the lesion or peri-lesion.  
5.3.5 MCAO induced chronic glial responses within the lesion territory, with no 
differential effect between genotypes.  
Chronic glial responses have been shown to be a feature of focal ischaemic injury, and are 
sensitive to β-amyloid pathology. There is also evidence that glial cells may have roles in 
synaptic loss and neurodegeneration. The next stage of the investigation, therefore, was to 
determine whether concurrent focal ischaemia and TgSwDIAPP expression would 
exacerbate the levels of glial cells, microglia/macrophages and astrocytes, and whether 
these related to synaptic loss. The densities of microglia/macrophages and astrocytes were 
analysed within the ischaemic lesion and the peri-lesion to determine whether chronic glial 
responses occurred in regions with ischaemic neuronal damage, and in the surrounding 
tissue with normal neuropathology. 
5.3.5.1 Microglia/Macrophages, Iba1 
Microglia/macrophage cells were detected using Iba1 immunohistochemistry and 
measured by image analysis, with similar methods to the synaptic analysis. As before, the 
levels were measured in the sham mice and compared with the contralateral hemisphere 
of MCAO mice (Figure 5.8). There were no significant differences in the Iba1 %densities 
between the contralateral and ipsilateral striatum of sham mice (F (1,18) = 0.273, p = 
0.607), with no genotype effect (F (1,18) = 1.725, p = 0.206), and there was no interaction 
between these factors (F (1,18) = 5.216, p = 0.0347) (Figure 5.8B). This data showed that 
neither sham surgery or TgSwDIAPP expression lead to chronic elevation of 
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Figure 5.8 MCAO induced chronic microglia/macrophage elevation within the 
lesion. (A, D) Iba1 immunohistochemistry to detect microglia/macrophages. (B) 
Iba1 %density in sham mice was stable between the contralateral and ipsilateral 
striatum, with no difference between the genotypes. (C) Iba1 %density was 
unchanged between contralateral striatum of sham and MCAO mice, with no  
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microglia/macrophages in the striatum. Iba1 %density in the contralateral striatum of 
sham and MCAO mice, and found no effect of surgery (F (1,20) = 1.166, p = 0.293), no 
effect of genotype (F (1,20) = 0.101, p = 0.754), and no interaction (F (1,20) = 3.673, p = 
0.0697) (Figure 5.8C). This showed that the levels of microglia/macrophages were stable 
between the contralateral striatum of sham and MCAO mice, therefore, the contralateral 
hemisphere was used as the control for analysing the effect of MCAO on 
microglia/macrophages in the ipsilateral striatum. 
Iba1 %density was measured in the lesion and peri-lesion of each animal (Figure 5.8D), 
using the same ROIs as for the VGLUT1 and PSD95 measurements. There was a surgery 
effect increasing the Iba1 %density in the ipsilateral lesion (F(1,22) = 88.94, p < 0.0001), 
with no genotype effect (F (1,22) = 1.322, p = 0.263) and no interaction (F (1,22) = 
0.000137, p = 0.971) (Figure 5.8E). Post-hoc analysis showed that Iba1 levels increased in 
the lesion of both genotypes. In the lesion the Iba1+ cells appear to have an activated 
morphology, as they have larger cells bodies with shorter and thicker processes, whereas 
they are smaller with thinner and longer processes in the contralateral striatum, as can be 
seen in the inserts in Figure 5.8D. In the peri-lesion, however, the Iba1 %densities were not 
increased compared to the contralateral hemisphere (Figure 5.8F). These results 
demonstrate that a focal ischaemic lesion leads to a chronic elevation of 
microglia/macrophages contained within the lesion, and not in the surrounding peri-lesion. 
The changes were not exaggerated by concurrent TgSwDIAPP expression. 
effect of genotype. (E) Iba1 %density was elevated in the lesion, compared to the 
contralateral hemisphere, with no effect of genotype. (F) Iba1 %density was unchanged in the 
peri-lesion compared to the contralateral hemisphere, with no effect of genotype. Data 
presented as mean ± SD, n = 6,7 per group. Two-way ANOVA with Bonferroni’s multiple 
comparison test. ***p<0.0001. Scale bar = 1mm, 100μm insert. Grey boxes = inserts. 
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5.3.5.2 Astrocytes, GFAP 
Reactive astrogliosis is another key pathological feature found in chronic stroke tissue and 
Alzheimer’s disease tissue. The next aim of the study was to determine whether MCAO 
resulted in long-term elevation of reactive astrocyte within the striatal lesion. Reactive 
astrocytes were analysed by immunohistochemical detection of GFAP. As with Iba1, the 
%densities of GFAP were first measured in both hemispheres of the sham animals and 
contralateral hemispheres of the MCAO animals (Figure 5.9A). The levels of astrocytes 
were very low in the sham  animals and the contralateral striatum of MCAO animals. In 
sham mice, there were no significant differences in GFAP %densities between the striatal 
hemispheres (F(1,18) = 1.345, p = 0.261), plus no genotype effect (F(1,18) = 0.743, p = 
0.4002) and no interaction (F(1,18) = 0.163, p = 0.692) (Figure 5.9B). Furthermore, the 
GFAP %densities from the contralateral hemispheres from sham and MCAO mice were 
indistinct (F(1,20) = 0.118, p = 0.734), with no genotype effect (F(1,20) = 0.000766, p = 
0.978) and no interaction (F(1,18) = 0.209, p = 0.653) (Figure 5.9C), showing that there was 
no effect of surgery and genotype on these measures and that the MCAO contralateral 
hemispheres were suitable to use as controls measuring astrocytes in the ischaemic lesion. 
GFAP was detected in the next serial sections taken as used for VGLUT1/PSD95 and Iba1, 
and the same ROIs were used for the image analysis (Figure 5.9D). The GFAP %density was 
significantly elevated in the lesion compared to the contralateral hemisphere (F(1,22) = 
553.1, p < 0.0001), however, there was no genotype effect (F(1,22) = 0.927, p = 0.346) and 
no interaction (F(1,22) = 0.892, p = 0.355) (Figure 5.9E). Post-hoc analysis showed that the 
increase in reactive astrocytes was present in the lesion of both WT and TgSwDI mice. The 
astrocytes within the lesion and peri-lesion have an activated morphology, with 
overlapping processes so individual cells are difficult to distinguish, see inserts in 
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Figure 5.9 MCAO induced chronic astrocyte elevation within the lesion and peri-lesion. 
(A, D) GFAP immunohistochemistry used to detect reactive astrocytes. (B) GFAP %density 
in sham mice was stable between the contralateral and ipsilateral striatum, with no 
difference between the genotypes. (C) GFAP %density was unchanged between  
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Figure 5.9D. There was a surgery effect, increasing the GFAP %density in the peri-lesion in 
the ipsilateral hemisphere compared to the contralateral (F(1,22) = 125.5, p < 0.0001), 
however, there was no genotype effect (F(1,22) = 0.0880, p = 0.770) and no interaction 
(F(1,22) = 0.0949, p = 0.761) (Figure 5.9F). Post-hoc analysis showed that this occurred in 
both genotypes. This is an interesting finding, as it shows that within the striatum, the area 
of reactive astrogliosis extends beyond the borders of the ischaemic lesion and is more 
widespread than microgliosis.  
These results demonstrate that a focal diffuse ischaemic lesion leads to a chronic elevation 
of astrocytes within the lesion and the peri-lesion. Surprisingly, there was no differential 
effect between WT and TgSwDI mice, suggesting that concurrent TgSwDIAPP expression 
did not exacerbate the neuroinflammatory response within the lesion or peri-lesion. 
5.3.5.3 Microglia/macrophage density and not astrocyte density inversely related to 
PSD95 %density in the lesion. 
There is evidence that microglia/macrophages and astrocytes may have a role in synapse 
dysfunction and degeneration in disease. The %density of Iba1 in the lesion was plotted 
against the %density of VGLUT1 (Figure 5.10A) and PSD95 %density (Figure 5.10B). Iba1 
%density in the lesion did not significantly correlate with VGLUT1 %density (Spearman r = -
0.4011, p = 0.1759), however, it did significantly inversely relate to the PSD95 %density in 
the striatal lesion (Spearman r = -0.5714, p = 0.0449). This is an interesting result, as it 
contralateral striatum of sham and MCAO mice, with no effect of genotype. (E) GFAP 
%density was elevated in the lesion compared to the contralateral hemisphere, with no 
genotype effect. (F) GFAP %density was increased in the peri-lesion compared to the 
contralateral hemisphere, with no effect of genotype. Data presented as mean ± SD, n = 6,7 
per group. Two-way ANOVA with Bonferroni’s multiple comparison test. ***p<0.0001. 
Scale bar = 1mm, 100μm insert. Grey boxes = inserts. 
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shows that an increase in the density of microglia/macrophages directly relates to the loss 
of glutamatergic postsynaptic terminals within the ischaemic lesion. The %density of GFAP 
was then plotted against %densities of VGLUT1 (Figure 5.10C) and PSD95 (Figure 5.10D). 
GFAP %density did not significantly correlate with either VGLUT1 (Spearman r = -0.3462, p 
= 0.2471) or PSD95 %densities (Spearman r = -0.1703, p = 0.5786) in the lesion. The peri-
lesion %densities of VGLUT1 and PSD95 were plotted against Iba1 and GFAP, however, 
there was no evidence of correlation indicating that the levels of glutamatergic pre- and 
post-synaptic terminals do not relate to the levels of microglia/macrophages or astrocytes 
Figure 5.10 Microglia/macrophages density inversely related to the levels of 
glutamatergic postsynaptic terminals in the lesion. (A) Iba1 %density did not 
relate to the VGLUT1 %density in the lesion, however, (B) it did significantly 
inversely relate to the PSD95 %density in the lesion. (C) GFAP %density did not 




in the peri-lesion (data not shown). Recently there has been a growing body of literature 
proposing that microglia strip synaptic terminals during brain injuries and diseases. A 
preliminary study was undertaken to investigate whether synapses co-localised with 
microglia post-MCAO. Sections from WT and TgSwDI mice x PSD95:eGFP, 3 months after 
MCAO were immunostained for microglia-specific TMEM119 and imaged with high power 
confocal microscopy to assess the potential co-localisation of microglia with PSD95 
terminals. In support of this within the ischaemic lesion in the striatum, microglial cells 
appeared to co-localise with PSD95+ clusters in the ischaemic striatum, whilst there is 
minimal colocalisation in the contralateral striatum (Figure 5.11). 
Overall, these results demonstrated that 15 minutes of MCAO resulted in chronic elevation 
of microglia/macrophages and astrocytes within the lesion, as well as an increase of 
astrocytes in the peri-lesion. Surprisingly, there was no effect of genotype, indicating the 
concurrent TgSwDIAPP expression did not exaggerate the levels of microglia/macrophages 
and astrocytes in the ischaemic lesion or peri-leison. The study found evidence that in the 
ischaemic lesion the levels of microglia/macrophages inversely related to the density of 
PSD95+ synaptic terminals. Furthermore, a preliminary study with confocal microscopy 
appeared to show physical interaction between microglia and PSD95+ terminals in the 
lesion. 
5.3.6 Western blot analysis: temporal synaptic profile 
The results to date have shown that a diffuse ischemic lesion following transient MCAO 
leads to long-term loss of glutamatergic pre- and post- synaptic terminals and chronic 
neuroinflammation. This analysis, however, does not establish at what time-point post-
MCAO these changes occurred. The next stage of the investigation, therefore, was to 
determine the temporal profile of glutamatergic pre- and post-synaptic proteins levels and  
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Figure 5.11 Preliminary analysis in which TMEM119+ microglia appear to colocalise with 
PSD95+ clusters in the striatal ischaemic lesion, more than in the contralateral striatum. 
Scale bar = 15μm. 
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microglia/macrophages and astrocyte protein levels. Western blot analysis was used on 
additional cohort of WT and TgSwDI mice, at 24 hours, 1 month and 3 months post-MCAO. 
VGLUT1 protein levels were measured with western blotting and normalised to the levels 
of α-tubulin (Figure 5.12A). There were no significant differences in the VGLUT1 levels 
between the hemispheres and genotypes at any of the time-points (Figure 5.12B-C). The 
data was analysed with two-way ANOVAs and the results were: at 24 hours, surgery 
(F(1,30) = 0.597, p = 0.446), genotype (F(1,30) = 2.743, p = 0.108), and interaction (F(1,30) = 
0.320, p = 0.576); at 1 month, surgery (F(1,28) = 0.422, p = 0.521), genotype (F(1,28) = 
2.479, p = 0.127), and interaction (F(1,28) = 0.240, p = 0.628); and at 3 months, surgery 
(F(1,32) = 0.445, p = 0.510), genotype (F(1,32) = 0.817, p = 0.373), and interaction (F(1,32) = 
1.207, p = 0.280). PSD95 protein levels were measured using the same approach and 
normalised to α-tubulin levels (Figure 5.13A). The PSD95 protein levels, however, were 
significantly reduced with surgery at 24 hours post-MCAO (F(1,30) = 7.391, p = 0.0108), 
whilst there was no effect of genotype (F(1,30) = 0.119, p = 0.732) and no interaction 
(F(1,30) = 0.540, p = 0.468) (Figure 5.13B). Post-hoc analysis revealed that PSD95 protein 
levels were only significantly reduced in the ipsilateral striatum of TgSwDI mice at 24 hours 
post-MCAO. At 1 month and 3 months, however, there were no significant differences in 
PSD95 protein levels between the contralateral and ipsilateral striatum, and no difference 
between WT and TgSwDI mice (Figure 5.13C,D). The two-way ANOVA results at 1 month 
and 3 months after MCAO were: at 1 month, surgery (F(1,28) = 2.334, p = 0.138), genotype 
(F(1,28) = 0.0338, p = 0.855), and interaction (F(1,28) = 0.913, p = 0.348); and at 3 months, 
surgery (F(1,32) = 0.215, p = 0.646), genotype (F(1,32) = 1.128, p = 0.296), and interaction 
(F(1,32) = 0.0475, p = 0.829). Overall, this analysis found a significant reduction in PSD95 
protein levels in the ipsilateral striatum of TgSwDI mice at 24 hours after MCAO surgery,  
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Figure 5.12 Western blot analysis found no significant differences in VGLUT1 protein 
levels, compared between the ipsilateral and contralateral striatum, and between WT 
and TgSwDI mice, at 24 hours, 1 month and 3 months after MCAO. (A) VGLUT1 protein 
levels measured in the contralateral and ipsilateral striatum at the different time points 
after MCAO, normalised to α-tubulin. There were no significant differences in the striatal 
VGLUT1 protein levels between the contralateral and ipsilateral stratum, and between WT 
and TgSwDI mice, at (B) 24 hours, (C) 1 month and (D) 3 months after MCAO. Data 




Figure 5.13 Western blot analysis found a significant reduction in TgSwDI ipsilateral 
striatal PSD95 levels at 24 hours after MCAO, but not in the WT. (A) PSD95 protein levels 
measured in the contralateral and ipsilateral striatum at the different time points after 
MCAO, normalised to α-tubulin. (B) PSD95 levels were reduced in the ipsilateral striatum of 
TgSwDI mice at 24 hours, however, there was no significant surgery effect in WT mice, and 
no overall genotype effect. There were no significant differences in the striatal PSD95 
protein levels at (C) 1 month and (D) 3 months after MCAO, compared between the 
contralateral and ipsilateral striatum, and between WT and TgSwDI mice. Data presented 






but otherwise no other significant effects of surgery or genotype on VGLUT1 and PSD95 
protein levels. 
5.3.7 Western blot analysis: temporal glial profile 
The next stage of the investigation was to determine the temporal glial profile following 
MCAO. In the same tissue samples taken from WT and TgSwDI mice 24 hours, 1 month and 
3 months after MCAO, the protein levels of Iba1 (Figure 5.14A) were measured with 
western blotting and normalised to the levels of α-tubulin. At 24 hours, there were no 
significant differences in normalised Iba1 protein levels between the ipsilateral and 
contralateral striatum (F(1,30) = 1.824, p = 0.187), no genotype effect (F(1,28) = 0.304, p = 
0.586) and no interaction (F(1,28) = 0.500, p = 0.485) (Figure 5.14B). Statistical comparison 
of Iba1 measured at 1 after MCAO found that there was a significant surgery effect (F(1,28) 
= 18.73, p = 0.0002) and a significant genotype effect (F(1,28) = 4.504, p = 0.0428), with no 
interaction (F(1,28) = 3.154, p = 0.0866) (Figure 5.14C). Bonferroni’s multiple comparison 
test found a significant increase in Iba1 protein levels in ipsilateral striatum of WT mice 
compared to the contralateral striatum, however, there was not a significant effect in the 
TgSwDI mice. Furthermore, it revealed that the Iba1 protein levels were significantly higher 
in the ipsilateral striatum of the WT mice, compared to the ipsilateral striatum of TgSwDI 
mice. At 3 months, there was an overall significant effect of surgery on the Iba1 protein 
levels (F(1,32) = 7.825, p = 0.0087), although there was no genotype effect (F(1,32) = 1.297, 
p = 0.263) and no interaction (F(1,32) = 0.0110, p = 0.917) (Figure 5.14D). Bonferroni’s 
multiple comparisons test, however, did not find a significant difference between the Iba1 




Figure 5.14 Iba1 protein levels were increased in the WT ipsilateral striatum 1 month after 
MCAO, compared to the contralateral striatum and the TgSwDI striatum. There was a trend 
towards an Iba1 elevation in the ipsilateral striatum at 3 months. (A) Iba1 protein levels 
measured in the contralateral and ipsilateral striatum at the different time points after MCAO, 
normalised to α-tubulin. (B) There were no significant differences in the Iba1 protein levels at 
24 hours after MCAO, compared between the contralateral and ipsilateral striatum, in WT and 
TgSwDI mice. (C) Iba1 protein levels were increased in the ipsilateral striatum in WT at 1 month 
compared to the contralateral striatum, and significantly greater than TgSwDI ipsilateral Iba1 
levels. (D) At 3 months, there was an overall significant surgery effect on the Iba1 protein levels 
and a trend towards an increase in the ipsilateral striatum, although post-hoc analysis found no 
significant changes between the groups. Data presented as mean ± SD, n = 8-10 per group. Two-




Figure 5.15 GFAP protein levels were increased in the ipsilateral striatum 1 month after 
MCAO compared to the contralateral, of both WT and TgSwDI mice. And in the TgSwDI 
ipsilateral striatum at 3 months. (A) GFAP protein levels measured in the contralateral and 
ipsilateral striatum at the different time points after MCAO, normalised to α-tubulin. (B) 
There were no significant differences in the GFAP protein levels at 24 hours after MCAO. 
(C) GFAP protein levels were increased in the ipsilateral striatum compared to the 
contralateral, in WT and TgSwDI at 1 month. (D) Ipsilateral striatal GFAP protein levels were 
increased in ipsilateral striatum compared to the contralateral in TgSwDI mice, at 3 months 
after MCAO. Data presented as mean ± SD, n = 8-10 per group. Two-way ANOVA with 
Bonferroni’s multiple comparisons; ****/***p<0.0001. ***p = 0.0002. 
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indicating that there is a trend towards an increase in Iba1 in the lesioned striatum.  
The GFAP protein levels were also measured by western blotting in the same tissue and 
normalised to α-tubulin levels (Figure 5.15A). At 24 hours, there were no significant 
differences in the GFAP levels between the contralateral and ipsilateral striatum (F(1,30) = 
0.209, p = 0.651), no genotype effect (F(1,30) = 0.910, p = 0.348) and no interaction 
(F(1,30) = 0.0648, p = 0.801) (Figure 5.15B). By 1 month after MCAO, however, there was a 
significant increase in GFAP protein as a result of surgery (F(1,28) = 63.62, p < 0.0001), 
which post-hoc analysis showed to occur in both WT and TgSwDI mice, although there was 
no genotype effect (F(1,28) = 0.467, p = 0.500) or interaction (F(1,28) = 1.470, p = 0.236) 
(Figure 5.15C). Finally, in the 3 month groups, there was an effect of surgery (F(1,32) = 
17.01, p = 0.0002), but no effect of genotype (F(1,32) = 2.562, p = 0.119) or an interaction 
(F(1,32) = 2.090, p = 0.158) (Figure 5.15D). Post-hoc analysis revealed that MCAO surgery 
resulted in a significant increase in GFAP protein levels in the ipsilateral striatum of TgSwDI 
mice, whereas it did not reach significance in the WT mice.  
Taken together, the western blot analysis indicates that at 24 hours after MCAO the 
microglia/macrophage and astrocyte levels are unchanged, whereas at 1 month there is an 
elevation in the ipsilateral striatum compared to the contralateral hemisphere. At 3 
months, there was a trend towards an increase in neuroinflammation in the ipsilateral 
striatum, which appeared to be greater in TgSwDI mice.  
5.4 Discussion 
The current study demonstrated that glutamatergic pre- and post-synaptic loss is evident 
months after the initial focal ischaemic insult, which coincided with chronic increase in glial 
cell density. Contrary to the hypothesis, the study did not find an overt effect of 
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TgSWDIAPP expression on neuronal, synaptic or glial changes. There was, however, an 
indication that greater degeneration of glutamatergic presynaptic terminals occurred in 
the peri-lesion of TgSwDI mice compared to WT. Furthermore, there is a trend towards 
greater levels of microglia/macrophages and astrocytes in the lesioned striatum of TgSwDI 
mice at 3 months, as measured by western blotting.  
5.4.1 Focal ischaemia resulted in acute motor impairment and long-term 
ischaemic neuronal and axonal pathology, with no effect of genotype 
5.4.1.1 Behaviour impairment 
The striatum is a key brain region for motor function and damage to it in human stroke is 
associated with motor deficits (Corbetta et al. 2015). Impairment in motor function 
following stroke includes deficits in muscle control and limited mobility, usually in the 
contralateral upper limb and affects about 80% of patients (Cramer et al. 1997). These 
motor deficits are usually experienced transiently, as a degree of recovery can occur over 
time (Jorgensen et al. 1995; Cramer et al. 1997). In the present study, focal ischaemia 
induced acute motor impairment in the contralateral fore- and hindlimbs of mice 3 days 
post-MCAO, as measured by the ladder-rung test. At 6 weeks, however, there was no 
deficit in the MCAO animals, implying functional recovery by this time-point. Previous 
publications have demonstrated that focal ischaemia in rodent models leads to acute 
motor deficits with recovery over time. An example of this is the paper by Bouët et al., who 
found that 60 minutes of MCAO caused motor deficits on the accelerating rotarod at 3 
days post-surgery, which was alleviated by 6 weeks (Bouët et al. 2007).  
The version of the ladder-rung test used in the present study was adapted from (Farr et al. 
2006). The test is designed to give a score based on the locomotion, grip strength, and 
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balance of the mice, by calculating the percentage of limb placement errors (partial 
placements and slips) the mice make with their contralateral limbs, out of the total number 
of limb placements they make. Farr et al. did not count ‘partial placements’ as an error in 
their version of the test, however, the protocol was adapted for the present study to make 
the test sensitive enough to distinguish between the sham and MCAO mice, as very few of 
the lesioned mice slipped on the rungs. Moreover, the variation in the sham data was quite 
high, as many of these mice were also making a lot of ‘partial placements’. This may be 
because some were running across the ladder. Another reason could be that as the sham  
surgery involves permanent occlusion of the external carotid artery (ECA) (Section 2.2.2), 
therefore, it could cause some motor decline in these animals. This is a caveat for the 
study, and an improvement would be to include a trial of the ladder-rung test prior to 
surgery or to have additional naïve control groups that do not receive surgery. 
Furthermore, the test could be made more challenging, such as using an inclined ladder 
(Pin-Barre et al. 2014), which should improve the sensitivity of distinguishing between 
sham and MCAO mice, and reduce the variation. Another potential caveat of this test could 
be that the ladder was elevated to enable space for the camcorder to be placed 
underneath, however, this may have caused an anxiety response in the mice. Previous 
studies using the elevated plus maze have shown that MCAO causes greater anxiety in 
rodents (Winter et al. 2005; Zhang et al. 2017), therefore, this may have affected the 
performance of the test in the present study. 
There were no differences in the contralateral limb placement %errors between WT and 
TgSwDI mice after MCAO surgery. Alzheimer’s disease is not typically associated with 
motor impairment, although changes in posture and gait can be present (Pettersson et al. 
2002). Moreover, deficits in balance, motor coordination and locomotion have been found 
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in some mouse lines expressing human mutated APP as reviewed by (Lalonde et al. 2012). 
However, to date no motor impairment in TgSwDI mice has been reported. This study 
showed that TgSwDIAPP expression did not affect the motor abilities of mice after either 
sham or MCAO surgery. Previous publications have found a significant correlation between 
lesion volume and motor impairment after MCAO in rats (Rogers et al. 1997). As there was 
no difference in the size of the ischaemic lesion between WT and TgSwDI mice, therefore, 
it may be expected that there was also no difference in the motor deficit between the 
genotypes. 
An important consideration when interpreting behavioural data from mouse models of 
unilateral lesions is that the right and left brain hemispheres may play different roles in 
motor control, therefore, the results may change depending on which hemisphere the 
lesion is in. Research of stroke patients has revealed that contralesional arms perform 
different depending on which hemisphere is damaged (Mani et al. 2013). In the study 
investigating anxiety and hyperactivity in mice, they found that mice with MCAO in the 
right hemisphere had increased spontaneous locomotor activity, while mice with left 
MCAO had increased anxiety (Winter et al. 2005). In addition, right MCAO in rats has been 
shown to result in worsened neurological score, more limb faults on a balance beams, and 
longer latency in a Morris water maze (Zhai & Feng 2018; Gao & Zhang 2008). In the 
current study, MCAO was performed in the right hemisphere, therefore, we can predict 
that the motor deficits would have been even more modest if the vessel occlusion had 
been on the left. Another factor that is expected to influence the motor outcome after 
focal ischaemia is age. A recent paper showed that DH stroke mice of 3 months old 
recovered from motor impairment on the ladder rung test by week 4, whilst mice of 18 
months of mice were still impaired by the final measurement at 6 weeks (Nguyen et al. 
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2018). The mice used in the current study were 4-5 months old at the time of surgery, and 
if we had used older mice they would be expected to have delayed motor recovery. 
The present study confirmed the MCAO surgery induces acute motor impairment, 
however, it did not investigate whether cognition was affected. The development of 
cognitive decline and dementia occurs in around 30% of stroke patients (Bruno et al. 1996; 
Pohjasvaara et al. 1997; Pohjasvaara et al. 1998; Desmond et al. 2000). Deterioration of 
specific cognitive domains depend on the type of lesion, volume, numbers, location and 
severity (Kalaria et al. 2016). Functions relating to the frontal lobe are the most commonly 
affected in post-stroke dementia, such as working memory, processing speed and 
executive function (Chen et al. 2016). A number of studies have investigated whether focal 
ischaemia in rodents is sufficient to induce cognitive impairment, however, the results 
have been conflicting. Maze tests with visuospatial cues, such as the 8-arm radial arm maze 
(RAM) and Morris water maze (MWM), have been used to find working and spatial 
memory impairment, respectively, in rats after MCAO surgery (Okada et al. 1995; 
Yonemori et al. 1996; Markgraf et al. 1992). These mazes, however, require the rats to 
have good motor abilities to perform, which is confounding for this model. Bingham et al. 
used a modified protocol of the MWM to minimise the impact of sensory and motor 
impairments, and found only minimal deficits in spatial memory deficits after permanent 
MCAO in rats (Bingham et al. 2012). Alternative tests that have been used to probe for 
memory impairment are the passive avoidance test, and novel object recognition or 
relocation tests. Bouët et al. found that transient 60 minutes of MCAO in mice resulted 
contextual memory impairment, at 9 and 15 days post-surgery (Bouët et al. 2007). 
Contextual memory may be affected after MCAO surgery if the cingulate cortex is subject 
to remote changes (Popp et al. 2009), as the brain region has been shown to be involved in 
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contextual memory functions (Maren et al. 2013). Impairment in recognition memory has 
been found using the novel recognition test, 60 days after permanent MCAO in mice 
(Fréchou et al. 2019). Furthermore, Nguyen et al. demonstrated that young DH stroke mice 
experienced cognitive dysfunction in object relocation task by 7 weeks post-surgery, 
whereas older mice experienced impairment earlier at 4 weeks post-surgery (Nguyen et al. 
2018). Recognition memory involves the function of the perirhinal cortex (Barker & 
Warburton 2011), which is part of the ischaemic lesion in MCAO models with long or 
permanent occlusion (Bingham et al. 2012; Fréchou et al. 2019). A development of the 
present study could be to investigate long-term affect of MCAO on cognition with novel 
object recognition or relocation. Although 15 minutes of MCAO did not result in ischaemic 
lesions that included the perirhinal cortex, it may still induce activity changes in this region 
and result in recognition memory deficits.  
5.4.1.2 Ischaemic neuronal pathology 
The next aim of the study was to investigate the long-term impact of focal ischaemia and 
TgSwDIAPP expression on ischaemic neuron damage. The areas and the total volume of 
ischaemic neuron pathology were compared between WT and TgSwDI mice at 3 months 
post-MCAO, and found to be indistinct between the genotypes. This pathology was 
observed as diffuse selective neuron loss, predominantly in the striatum. The middle 
cerebral artery supplies blood to the striatum via the lenticulostriate arteries, which branch 
off from the MCA and penetrate the basal ganglia (see Figure 1.1). These vessels are ‘end 
arteries’ with poor collateral blood supply in this part of the brain, making this territory 
susceptible to ischaemic damage and a common location of strokes (Feekes et al. 2005; 
Feekes & Cassell 2006). 
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The model chosen for the current study was 15 minutes of intraluminal MCAO. We know 
that the extent of ischaemic damage depends on the occlusion time and type of MCAO 
surgery. Heiss and Rosner first demonstrated that neuronal death or recovery is dependent 
on the degree and duration of blood flow reduction, indicating that a 30% reduction of CBF 
for 45 minutes results in ischaemic damage to cortical neurons with unlikely chances of 
recovery (Heiss & Rosner 1983). Popp et al. quantitatively showed that longer MCAO (120 
minutes) in rats leads to larger and quicker forming ischaemic lesions, whereas 30 minutes 
of MCAO resulted in a smaller and delayed lesion development (Popp et al. 2009). Pedrono 
et al. used T2-weighted MRI to determine that 15 minutes of MCAO in mice was the 
shortest occlusion time needed to result in a striatal lesion 24 hours after surgery (Pedrono 
et al. 2010). The current investigation aimed to understand chronic changes following focal 
ischaemia; therefore, brief occlusion was needed to ensure the mice would survive for 3 
months after surgery. To this end, 15 minutes of MCAO was used for this study. 
In the present study, MCAO lead to long-term diffuse lesions of selective neuronal loss in 
the striatum. This type of neuropathology is also known as partial/incomplete infarction, 
which describes lesions in where the extracellular matrix and the tissue structure remains 
largely remains intact, yet there is death of single neurons within this area (Lassen 1982; 
Baron et al. 2014). The neuropathology was not confined to the striatum, however, as all 
mice had changes in the ipsilateral substantia nigra pars reticulata (SNR), as seen by a loss 
of large neurons and many smaller cell bodies, presumably neuroinflammatory cells. The 
substantia nigra is not a region that is directly fed by the MCA, however, it does connect to 
the striatum by a number of pathways which are crucial for motor function (Kravitz & 
Kreitzer 2012). Damage to brain regions that have neuronal connectivity with the site of 
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primary brain injury is known as secondary neurodegeneration, which is investigated 
further in Chapter 6 (Figure 1.7). 
Early neuronal damage after vessel occlusion occurs from the ischaemic cascade, as 
described in Section 1.4.1.1. In cases of short occlusion durations, the process of ischaemic 
neuronal damage may be delayed and more selective. This is supported by observations 
that after 15 minutes of MCAO in rats, neuron death is first detected at 7 days afterwards 
and the levels of surviving neurons in the striatum gradually decreased until the final 
measurement at 16 weeks (Fujioka et al. 2003). Another important theory is that in cases 
of transient occlusion models, reperfusion causes neuronal injury rather than or in addition 
to ischaemia (Baron et al. 2014). Reperfusion injury can occur due to an increase in 
reactive oxygen species when blood flow is restored, as anti-oxidants are depleted during 
ischaemia. Increased reactive oxygen species results in oxidative stress, cell damage and 
promoting further neuroinflammation (reviewed by Wu et al. 2018).  
The present study found no significant difference between the areas and volumes of 
ischaemic neuronal pathology between WT and TgSwDI mice. This was unexpected, as 
previous studies had found that the volume of ischaemic neuron pathology was increased 
in mouse models with β-amyloid. Mice expressing APP695SWE were shown to have larger 
infarcts than WT mice, 24 hours after permanent distal MCAO (Zhang et al. 1997). 
Furthermore, in young and old Tg2576 mice, 45 minutes of MCAO resulted in larger infarct 
volumes compared to their WT littermates, 3 days following surgery (Milner et al. 2014). 
The discrepancy between our data and the papers referenced here could be a result of 
using different TgAPP models. Milner et al. showed that β-amyloid deposits were present 
in penetrating arteries in the cortex in Tg2576 mice, therefore, they predict that vessel 
constriction from cerebral amyloid angiopathy (CAA) worsened the effect of MCAO (Milner 
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et al. 2014). TgSwDI mice do not get CAA in the cortex, although they do get some vascular 
β-amyloid deposition in the thalamus (Salvadores et al. 2017), which may not affect the 
vessels in the MCA territory. Moreover, laser speckle analysis in the present study 
determined that there was no difference in ipsilateral cortical CBF between WT and 
TgSwDI mice after MCAO surgery. 
As described in Section 5.2.5, the areas of ischaemic neuronal pathology were detected 
with cresyl violet stain and were manually mapped out from eight coronal sections 
throughout the brain. This method is widely used in the pre-clinical stroke field, developed 
by Osborne et al. (Osborne et al. 1987). The approach overcomes issues with atrophy, 
which is prominent in chronic stroke models due to the resolution of the injured area. The 
ischaemic lesions were quite challenging to map, however, as areas of damage were quite 
diffuse and cresyl violet is not a neuron-specific stain. An improved approach would be to 
use immunohistochemistry for NeuN to detect neuronal cell bodies and more sensitively 
show regions of neuronal loss. Another limitation of this approach could be that the tissue 
sections were thick at 30μm; although this was needed to ensure good tissue quality for 
slidescanner imaging, it may have masked smaller ischaemic lesions. Despite these 
limitations, there was no evidence of a genotype effect on ischaemic neuronal pathology 
after MCAO surgery. 
5.4.1.3 Axonal pathology 
Axons are vulnerable to degeneration with ischaemia. In ‘Time is Brain – Quantified’, the 
author states that for every minute an ischaemic stroke goes untreated, 7 miles of axons 
are lost (Saver 2006). Axonal pathology has been observed in patients with brain 
infarctions (Ohgami et al. 1992) and in rodent models of focal ischemia in regions of 
neuron damage and nearby white matter tracts (Yam et al. 1998; Stephenson et al 1992). 
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In the current study the areas of ipsilateral axon pathology were analysed at the different 
coronal levels and the volumes of pathology calculated. There was no significant difference 
in the areas or volumes of axon pathology between WT and TgSwDI, indicating that β-
amyloid in TgSwDI mice did not cause greater vulnerability to axon degeneration. The area 
of axon pathology was largest in the striatum at level -0.10mm from bregma, however, 
axonal bulbs were consistently present in the ipsilateral internal capsule and substantia 
nigra. Previous studies have shown that APP+ axon bulbs can occur in the lesioned striatum 
within 24 hours after occlusion in rodents (Yam 1998; Gresle et al. 2006). Furthermore, 
Zhang et al. showed that 30 minutes of MCAO in rats lead to the formation of axon bulbs 
by 6 hours afterwards in the striatum, cortex and hippocampus (Zhang et al. 2012). The 
present study demonstrated that axon pathology spreads to brain regions connected to 
the striatum, the ipsilateral internal capsule and SNR, by 3 months after MCAO. 
Axon damage may be an outcome of the degeneration of neuron cell bodies, however, 
there is also evidence that disconnected axons can survive for days to weeks after the 
neuronal cell body has apoptosed (Mack et al. 2001). This indicates that neuron death and 
axon degeneration could occur by distinct pathways. Axon degeneration may occur 
through pathways initiated by large calcium influx, as part of extracellular glutamate 
release and excitotoxicity. Under physiological conditions, oligodendrocytes in the myelin 
sheath provide metabolic support to axons by transporting lactate to them (Lee et al. 
2012). The release of glutamate into the peri-axonal space and activation of glutamate 
receptors on the myelin sheath stimulates glycolysis, which produces lactate to transport 
to axons (Saab et al. 2016). This fuel enables axonal mitochondria to synthesise ATP and 
maintain the ion balance within the axons with Na+/K+-ATPase. During ischaemia when the 
local glucose supplies become depleted, the production of lactate and ATP is reduced, 
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therefore, the ion balance in the axon cannot be maintained and the axons and synapses 
experience an overload in Ca2+ ions. This can lead to the activation of calcium-sensitive 
proteases, calpains, which cause the disassembly of the axonal cytoskeleton (Vargas & 
Barres 2007). In addition, there is evidence that activation of NMDA-receptors in the 
myelin sheath contribute to the propagation of axon degeneration. A recent study 
demonstrated that when isolated mouse optic nerves were subjected to oxygen-glucose 
deprivation, they had increased release of vesicular glutamate into the peri-axonal space 
under the myelin sheath, which coincided with more axon injury (Doyle et al. 2018). 
Furthermore, they found that the pre-treatment of mice with QNZ-46, which specifically 
blocks the activity of GluN2C/D subunits of extrasynaptic NMDA-receptors, lead to a 
smaller lesion volume and fewer signs of white matter pathology 24 hours after transient 
MCAO. Slow debris clearance has been proposed as another major contributor to axon 
degeneration. Microglia and macrophages mop up myelin debris, however, this function 
may become impaired in injury, if the phagocytic phenotypes of these cells are repressed 
(Lloyd et al. 2017). 
Amyloid precursor peptide (APP) is often used to detect the bulbs of degenerating axons. 
APP is normally transported along axons, however, it aggregates when axons are disrupted 
in injury such as stroke (Imai et al. 2002). Although this is a widely used method of 
analysing axon pathology, particularly in acute stroke, it is important to note that this 
approach shows the end-stage of the degeneration process. Using this method of 
detection, therefore, is likely to result in an underestimated view of the extent of axon 
degeneration particularly in chronic stroke, as in this study (Hinman 2014). Another 
method for analysing degenerating axons is to detect non-phosphorylated neurofilament 
epitopes with the SMI-32 antibody. Neurofilaments in axons are normally highly 
217 
phosphorylated and become dephosphorylated when damaged (Trapp et al. 1998; Leifer & 
Kowall 1993). SMI-32 is useful for studying axon injury within the core of a lesion and may 
have revealed a larger area of axonal pathology if it had been used in the current study. 
Antibodies for APP and SMI-32 were both used to investigate the axon pathology up to 72 
hours following distal ET-1 MCAO (Gresle et al. 2006). The results showed different 
immunostaining patterns, with SMI-32 predominantly in the cortical ischaemic core, 
whereas APP bulbs were present in remote areas of the striatum and corpus callosum on 
both the contralateral and ipsilateral hemisphere.  
As previously described, the areas of axonal pathology were manually mapped out and 
then measured. This approach was useful for quantifying the volume of pathology for each 
brain, however, it is limited in that the densities of axon bulbs would not be consistent 
throughout. The concentration of axon bulbs in a given brain region could be more 
sensitively analysed by counting, image analysis or using a grading system. Fluoro-Jade 
stains are commonly used to detect degenerating neurons (Schmued & Hopkins 2000; 
Schmued et al. 2005). They have been used in focal ischaemia models to detect 
degenerating neurons in the ipsilateral hemisphere (Liu et al. 2009). Although the exact 
mechanism by which it works is not understood, it seems to be a good method for 
identifying damaged neurons, axons and dendrites; as immunostaining for APP+ axon bulbs 
shows axons that have degenerated, whilst Fluoro-Jade may reveal axons and neurons that 
are in the process of degenerating.  
It was surprising not to find an exaggerated affect on axonal pathology in TgSwDI mice in 
this study, as there is evidence indicating that β-amyloid is neurotoxic (Walsh et al. 2002) 
and axon swellings have been shown to be an early feature of Alzheimer’s disease (Stokin 
et al. 2005). This might be because TgSwDI mice have quite diffuse β-amyloid deposits, 
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which may not be sufficient to damage axons. In a study of TgCRND8 mice expressing YFP-
H in cortical neurons, they found that many axons could transverse the amyloid plaques 
without swelling, or have small local swellings without disintegrating (Adalbert et al. 2009). 
This study highlighted how resilient axons can be to β-amyloid pathology.   
5.4.2 Focal ischaemia resulted in long-term synaptic degeneration in the 
striatum. 
Synapses have a large metabolic demand needed to support their function, with 
postsynaptic activity and propagation of action potentials being the most energetically 
expensive processes (Attwell & Laughlin 2001). With this, synaptic transmission is highly 
susceptible to glucose shortage during ischaemia. Electrophysiology studies have shown 
that synaptic silencing is an early effect of ischaemia or hypoxia (Bolay & Dalkara 1998; Sun 
2003; Mittmann et al. 1998), and more recently multiphoton imaging studies have 
revealed that dendritic spines, which postsynaptic densities project from, are rapidly lost in 
the ischaemic region, starting at 10 minutes after occlusion (Zhang et al. 2005; Zhang & 
Timothy H. Murphy 2007). These studies also demonstrated that if there is restoration of 
blood flow, dendrites and spines may be able to recover. This would suggest that synapses 
are the first neuronal structures to be damaged during ischaemia, which can be reversed 
with timely reperfusion (Zhu, Wang, Ju, Ran, et al. 2017). Less attention, however, has 
been given to the long-term impact of focal ischaemia on synapses.  
The results in the present study showed that brief focal ischaemia resulted in long-term 
reductions of glutamatergic pre- and postsynaptic terminals within the ischaemic lesion; 
whilst in the peri-lesion there was significant loss of glutamatergic postsynaptic terminals 
in both genotypes, there was only significant loss of presynaptic terminals in TgSwDI 
animals. As previously described in Section 1.4.1.1, vessel occlusion initiates the ischaemic 
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cascade which causes energy depletion, ion imbalance and depolarisation for a focal 
population of neurons, and initiating degenerative processes. Excessive glutamate release 
and activation of AMPA- and NMDA-receptors of neighbouring neurons causes this wave of 
depolarization to spread, in so-called spreading depolarisation (Hartings et al. 2003; Lai et 
al. 2014). In the present study, the loss of synaptic terminals was found to often cover 
most of the striatum at anatomical level -0.10mm from Bregma, which may result from 
spreading depolarisation throughout this brain region. This is consistent with a recent 
study that captured striatal spreading depolarisation occurring in a rat corticostriatal slice, 
using intrinsic optical signal imaging (de Lure et al. 2019). 
The current study demonstrated that glutamatergic pre- and postsynaptic terminals are 
vulnerable to ischaemic damage. There is evidence that presynaptic failure occurs through 
different mechanisms to postsynaptic failure. A study investigating the electrical activity of 
neurons in the peri-lesion, hours after transient MCAO (1 hour) in rats, found results which 
suggested that presynaptic mechanisms had become impaired whilst postsynaptic 
excitability was preserved (Bolay et al. 2002). Their results showed a decrease in 
phosphorylated synapsin-1, which they predict will cause a dysfunction in vesicle docking 
and transmitter release in the presynaptic terminal. A later study found that endocytosis 
and exocytosis were both impaired in hypoxic conditions in cortical neuron cultures 
(Fedorovich et al. 2017), which is consistent with the theory that presynaptic failure occurs 
through dysfunction of vesicle recycling. In the present study, VGLUT1 was used as a 
marker for glutamatergic presynaptic terminals, which has previously been shown to be 
reduced in the striatum and cortex at 7 days after 90 minutes MCAO in rats (Sánchez-
Mendoza et al. 2010). The function of this protein is to load glutamate into the presynaptic 
vesicles (Kaneko et al. 2002; Kaneko & Fujiyama 2002; Smith & Bolam 1990), therefore, its 
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loss may be part of the disruption in vesicle recycling. VGLUT1 interacts with endophilin in 
clathrin-dependent endocytosis for quick glutamate uptake, and when the stimulation is 
larger and prolonged the machinery does not interact with endophilin and VGLUT1 recycles 
glutamate more slowly (Voglmaier et al. 2006). This suggests that the reduction of 
VGLUT1+ terminals in the lesions may be a consequence of a decreased density of 
presynaptic terminals that recruit VGLUT1 to the endocytic vesicles for glutamate uptake, 
as the system has been slowed due to extracellular glutamate overload. Another 
mechanism by which the glutamatergic neurotransmission may be impaired is by VGLUT1 
nitrosylation by NO radicals. This process has been shown to occur in the frontal cortex and 
hippocampus in a mouse model with β-amyloid pathology, APP/PS1 mice (Wang et al. 
2017). The same authors had previously found that a nitric oxide donor was able to 
increase the level of nitrosylated VGLUT1 and reduce the uptake of glutamate (Wang et al. 
2015). Considering that the generation of reactive oxygen and nitrogen species is a 
downstream event of focal ischaemia, this mechanism could be involved in the reduction 
of glutamate endocytosis and synaptic vesicle recycling following focal ischaemia. 
Another mechanism that may be involved in ischaemia-induced synaptic degeneration is 
the activation of a family of proteases, known as calpains. These enzymes are calcium 
sensitive, therefore, they can become activated as a result of calcium influxes through 
stimulated NMDA- and AMPA-receptors during the ischaemic cascade. Calpain activation 
has been proposed to be a key player in both pre- and postsynaptic degeneration in 
ischaemia, as they can cleave important synaptic proteins (Curcio et al. 2016; Yamashima 
2016). SNAP-25 is an important presynaptic protein needed for vesicle fusion and 
exocytosis (Rizo & Xu 2015), and has been shown to be cleaved by calpains in cell culture 
(Ando et al. 2005). Furthermore, SNAP-25 protein levels were found to be reduced in post-
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mortem tissue from vascular dementia patients, indicating that this protein is vulnerable to 
ischemic damage (Sinclair et al. 2015). Calpains have been shown to work selectively on 
synaptic proteins, however, as calpain-I resulted in reduced protein levels of VGLUT2, 
whilst VGLUT1 and synaptophysin appeared to be unchanged (Lobo et al. 2011). These 
studies indicate that specific synaptic proteins can degenerate through different 
mechanisms, even though they are present in the same or similar types synaptic 
structures. Analysis of one synaptic protein, therefore, may be insufficient to fully 
determine the impact of ischaemia on whole synaptic structures.  
The results in the present study indicated that brief focal ischaemia also leads to long-term 
degeneration of excitatory postsynaptic terminals. Postsynaptic failure is likely to occur 
through pathways stimulated by over-activation of AMPA- and NMDA-receptors. There is a 
growing body of evidence that the PSD95-NMDAR-nNOS mechanism is a key process in 
synaptic failure during ischaemia, and that blocking this process may have therapeutic 
potential. GluN2B subunits of synaptic NMDA-receptors bind to PSD95, which in turn 
interacts with neuronal nitric oxide synthase (nNOS). Simultaneous binding of GluN2B and 
nNOS to PSD95 tethers them together and ensures the activation of nNOS during calcium 
influxes, thus generating reactive oxygen and nitrogen species which trigger mechanisms 
of neuronal injury (Lai et al. 2014). A recent study demonstrated that blocking the NMDAR 
GluN2B-PSD95 interaction actually protected against secondary injury in a model of 
haemorrhagic stroke; reducing the number apoptotic and necrotic cell death in the peri-
lesion cortex, and increased the association with Neuoligin-1 and Neurexin-1, which is 
predicted to be neuroprotective (Wang et al. 2018). Conversely, PSD95 may also have 
neuroprotective functions during ischaemia if it forms pro-survival interactions with other 
NMDA-receptor subunits. Recently it has been proposed that NMDAR GluN2A subunits 
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interact with PSD95 and promote neuronal and synaptic survival through γ-
enolase/PI3K/Akt signalling pathway, by blocking cleavage of synaptic proteins by calpains 
(Shah et al. 2019). They found that treating rats with the antioxidant melatonin enhanced 
this pathway after permanent MCAO and lead to increased synaptophsyin 
immunoreactivity in the cortex and striatum compared to vehicle treated rats, 24 hours 
after surgery. NMDA-receptors are not the only glutamate receptors that have been shown 
to be involved in ischaemic damage in focal ischaemia. A recent study demonstrated that 
an AMPA-receptor antagonist, perampanel, reduced the lesion volume, 
neuroinflammatory response and functional impaired 7 days after 90 minutes of MCAO in 
rats (Nakajima et al. 2018). Calcium-dependent calpains also degrade postsynaptic 
proteins, such as NMDA-receptor subunits (Curcio et al. 2016). Taken together, the 
literature indicates that focal ischaemia can initiate a number of downstream mechanisms 
leading to glutamatergic pre- and postsynaptic loss within the lesion. 
In the present study, there was a differential effect in the loss of VGLUT1+ and PSD95+ 
synaptic terminals in the peri-lesion. Whilst PSD95 %densities were significantly reduced in 
both WT and TgSwDI mice, there was only a significant reduction of VGLUT1 %density in 
TgSwDI mice. This result may indicate that in the WT animals, glutamatergic presynaptic 
terminals are more resilient to degeneration than postsynaptic terminals. Moreover, this 
could highlight a selective vulnerability of these specific proteins to calpain degradation, as 
VGLUT1 has been found to be resilient to this (Lobo et al. 2011), whereas PSD95 is not 
(Gascon et al. 2008). The finding also implies that glutamatergic presynaptic terminals in 
the peri-lesion are more vulnerable to degeneration in mice expressing TgSwDIAPP. This is 
consistent with evidence that VGLUT1 protein levels are reduced in the prefrontal cortex of 
Alzheimer’s disease brains (Kashani et al. 2008), and a progressive decrease of VGLUT1 
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immunoreactivity in the cortices of Tg2576 mice with age (Giuliani et al. 2019). 
Furthermore, in Alzheimer’s brains, punctate β-amyloid colocalises with VGLUT1 (Sokolow 
et al. 2012) and there is an inverse relationship between VGLUT1 and Aβ42 levels 
(Rodriguez-Perdigon et al. 2016). 
The present study did not find any evidence that TgSwDIAPP expression worsened 
degeneration of glutamatergic postsynaptic terminals. There is conflicting evidence as to 
whether or not PSD95 is vulnerable to β-amyloid, as investigations of its protein levels in 
human Alzheimer’s brain tissue have found increases (Gong et al. 2009) and decreases 
(Gylys et al. 2004). The inconsistencies in these studies, however, may result from the 
differences in the brain regions analysed and different stages of the disease (Savioz et al. 
2014). The evidence indicating that β-amyloid does contribute to PSD95 loss, and that the 
levels of PSD95 positively correlated with the levels of Aβ42 from fractions taken from 
sporadic and familial Alzheimer’s brains (Shinohara et al. 2014). Moreover, in a mouse 
models of β-amyloid pathology, Koffie et al. demonstrated that the density of PSD95 
terminals progressively decrease around the core of amyloid plaques (Koffie et al. 2009). 
Conversely, research conducted during my MSc project found is no difference in the 
density of PSD95+ terminals in cortex and thalamus of heterozygous TgSwDIxPSD95:eGFP 
mice. This is supported by the findings in the sham mice in the current study, as there was 
no difference in PSD95 %densities between the genotypes. The β-amyloid deposition in 
TgSwDI mice is diffuse, which can be seen with 6E10 immunostaining in Figure 6.8. Masliah 
et al. reported that diffuse amyloid plaques in Alzheimer’s brain do not cause synaptic loss 
(Masliah et al. 1990). Instead, soluble oligomeric β-amyloid has been shown to be the 
species which causes inhibition of long-term potentiation (Walsh et al. 2002). TgSwDI mice 
do not produce much soluble β-amyloid (Xu et al. 2007), which may underpin the lack of 
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genotype effect on synapses in this study. A future development of this study, therefore, 
could be to investigate the effect of concurrent focal ischaemia and β-amyloid on synapses 
with a different TgAPP line, such as APP E693Δ, which produces β-amyloid oligomers 
without plaques, and causes synaptic loss (Tomiyama et al. 2010). In addition, the study 
could be expanded to investigate whether other glutamatergic postsynaptic proteins are 
affected, as PSD95 may be selectively resilient. There is evidence that the function of 
NMDAR-GluN2B subunits are vulnerable to β-amyloid leading to inhibition of long-term 
potentiation and calpain activation (Hu et al. 2009; Ferreira 2012). GluN2B, therefore, may 
be a more sensitive target for detecting β-amyloid – induced synapotoxicity. 
The peri-lesion may also be a site of synaptic recovery, as ischaemic injury can promote 
synaptogenesis, axonal sprouting, activation and migration of neural progenitor cells, 
which tend to occur from days to weeks/months after the initial injury (Sandvig, Augestad, 
et al. 2018). By 3 months after MCAO there may have been some synaptic recovery, 
especially as there was no overall significant motor deficits in the animals at 6 and 11 
weeks post-surgery. Previous studies have found that synaptic recovery occurs in the peri-
lesion region; such as an observation of progressive reconstruction in YFP+ dendritic spines 
in the cortical peri-lesion in mice after distal MCAO with in vivo two-photon microscopy 
(Mostany et al 2010). Their results showed rapid spine density reductions after surgery, but 
the spines started to gradually increase again between 16 and 90 days afterwards. Another 
study demonstrated that spine loss in the peri-lesion of a photothrombotic occlusion lesion 
was restored by 6 weeks after surgery (Brown et al. 2007). In the present study, therefore, 
there may have been a degree of synaptic recovery overtime. This possibility is further 
supported by a recent study which demonstrated that the number of VGLUT1+ terminals 
was increased in the cortical peri-lesion compared to the density of the contralateral 
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hemisphere, at 21 days after cortical photothrombosis (Stokowska et al. 2017). Their 
results also showed an increase in GAP43 in the same region, which is a marker for axonal 
sprouting and rewiring. The studies described here found evidence of synaptogenesis in 
the cortex, which is known to be a more neural plastic brain region. There are a limited 
number publications that have investigated synaptogenesis in peri-lesion striatum after 
focal ischaemia, however, there is evidence that new neurons can form in the striatum in 
adult rodents, either through migration of neural progenitor cells from the subventricular 
zone or by a distinct mechanism (Dayer et al. 2005; Luzzati et al. 2006). An ischaemic lesion 
in the striatum could initiate neural progenitor migration and synaptic/neuronal recovery 
in the peri-lesion. A development of the current study could be to investigate neuronal 
recovery in the striatum 3 months after MCAO, by probing for synaptogenesis and 
neurogenesis could be probed for with immunohistochemistry detection of GAP43, and 
doublecortin (DCX) with BrdU treatment (Rao & Shetty 2004). This data would 
demonstrate whether 15 minutes of MCAO initiates long-term synaptic recovery in the 
peri-lesion, and whether this is affected by concurrent β-amyloid.  
There was an indication from the present study that synaptic plasticity occurs in the 
contralateral striatum after MCAO, as there was a small increase in the PSD95 %density in 
the WT animals and a trend towards an increase in VGLUT1 %density as well, in 
comparison to the sham levels. Focal ischaemia may stimulate contralateral synaptic 
plasticity to compensate for ipsilateral injury and help functional recovery. Takatsuru et al. 
found evidence of contralateral synaptic plasticity in the somatosensory cortex, as the 
%gain of dendritic spines in this region had increased between 3 days and 1 week after 
photothrombotic thrombosis (Takatsuru et al. 2009). This process may have occurred in 
the contralateral striatum in the present study. As previously stated, GAP43 could be used 
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as a marker to detect regions of synaptic plasticity within the current study, to determine 
whether there is any evidence of these restoration mechanisms after brief MCAO. This 
analysis showed that the synaptic density was not totally stable in the contralateral 
striatum after MCAO surgery, which is a caveat for using the contralateral striatum as the 
control for the ipsilateral synapse measurements. The contralateral striatum was kept as 
the control, however, as the difference between the shams was small; there was no 
genotype effect between the contralateral synapse densities; and this enabled the 
approach of using the specific, delineated lesion and peri-lesion regions of interest for each 
mouse.  
Western blotting was used to access the temporal profile of VGLUT1 and PSD95 protein 
levels, to determine at what time-point after MCAO the synapse degeneration occurs. As 
previously described, a number of studies have demonstrated that longer or permanent 
focal ischaemia leads to rapid dendritic blebbing and loss of synaptic structures (Zhang & 
Murphy 2007; Enright et al. 2007; Zhang et al. 2005), however, it is unclear whether brief 
focal ischaemia causes rapid synaptic loss or progressive synaptic degeneration over time. 
The western blot results from the present study showed no significant differences in the 
VGLUT1 protein levels in the ipsilateral striatum compared to the contralateral in WT and 
TgSwDI, at 24 hours, 1 month or 3 months after 15 minutes of MCAO. This is a perplexing 
result, as the histological analysis at 3 months showed that VGLUT1 %density was reduced 
in the lesion, and peri-lesion of TgSwDI mice. Similarly, there were no significant 
differences in PSD95 protein levels apart from a decrease in the ipsilateral striatum of 
TgSwDI mice at 24 hours post MCAO. This result was consistent with previous reports that 
postsynaptic proteins are vulnerable at acute stages after MCAO (Murotomi et al. 2012). 
227 
Although there were no significant differences in the VGLUT1 protein levels between the 
hemispheres, there may be a slight trend towards an increase in protein levels in the 
ipsilateral striatum of the TgSwDI mice at 24 hours after MCAO, which would be consistent 
with the results by Sánchez-Mendoza et al. (Sánchez-Mendoza et al. 2010). The data was 
highly variable and difficult to interpret, which may result from issues with sampling. As 
described in Section 2.5.2, the striatum was dissected from the thawed brain slices just 
before homogenisation. Although great care was taken to remove just the striatum from 
these sections, tissue from other brain regions may have contaminated the samples and 
introduced variation in the synaptic protein levels. Another issue could be that synaptic 
proteins were too dilute in the sample and required further enrichment to increase 
sensitivity. Enriching for synaptoneurosomes in the striatal homoegenates could be an 
approach for improving the sensitivity of synaptic protein detection (Bai & Witzmann 
2007). 
Another concern could be that the western blots lack specificity for VGLUT1. There are 
three isoforms of VGLUT(1-3), therefore, antibodies raised against one isoform could 
potentially interact with the others. The VGLUT1 antibody used for the present study, 
however, was chosen based on the high quality of staining and colocalisation with other 
presynaptic markers (Micheva et al. 2015; Melone et al. 2005). Another concern was that 
VGLUT proteins could be expressed in astrocytes, as well as by glutamatergic presynaptic 
terminals, although there is no strong evidence to support this. Sánchez-Mendoza et al. 
published confocal microscopy images from their MCAO study which show overlapping 
signals for VGLUT2 and VGLUT3, but not VGLUT1, with GFAP within the ipsilateral corpus 
callosum (Sánchez-Mendoza et al. 2010). This paper, however, lacks sufficient quantitative 
analysis for this data. In another study, observations were made of VGLUT1+ terminals 
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being closely associated with astrocyte processes in the frontal cortex, striatum and 
hippocampus, using immunofluorescent microscopy and immunogold electron microscopy 
(Ormel et al. 2012). Yet, the images taken using both methods appear to show VGLUT1 
clusters around astrocyte processes rather than within them, which supports the concept 
of the tripartite synapse and astrocytic processes being entwined with synapses (Araque et 
al. 1999). Finally, Li et al. investigated the expression VGLUT isoforms in cultured mouse 
astrocytes and found no evidence to support it (Li et al. 2013). Taken together, these 
studies indicate that VGLUT1 is not expressed by astrocytes and that the antibody used for 
VGLUT1 detection is specific, although we did not check the specificity ourselves. The 
specificity of the PSD95 antibody was checked during protocol optimisation, by comparing 
the PSD95 immunostaining on a western blot with samples from PSD95KO and WT mice, 
and seeing no staining for the KO samples.  
Another caveat of the study was that, due to the availability of mice, the 1 month cohort 
were from the xPSD95:eGFP line, whilst the 24 hour and 3 month cohorts were not. This 
can be observed in the PSD95 western blots, as the 1 month groups have two bands for 
PSD95 and PSD95:eGFP. Statistical analysis, therefore, was performed with a two-way 
ANOVA at each time-point, rather than comparing between time-points, as the 1 month 
group is a different line compared to the others.  
Overall, the present study demonstrated that brief focal ischaemia leads to long-term 
degeneration of glutamatergic pre- and postsynaptic terminals in the lesion, with greater 
vulnerability to postsynaptic terminals in the peri-lesion. There was also indication of 
TgSwDIAPP expression causing greater degeneration of presynaptic terminals in the peri-
lesion.  
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5.4.3 Focal ischaemia results in chronic glial responses within the lesion. 
Chronic post-ischaemic neuroinflammation is known to be a contributor or consequence of 
delayed neuronal damage after ischaemia. There is a large body of literature focused on 
the acute inflammatory response to focal ischaemia, whilst less is known about the chronic 
effect. The present study focused on quantifying the density of glial cells, Iba1+ 
microglia/macrophages and GFAP+ astrocytes, which are known to be sensitive to 
environmental changes. Although these cells are involved in neuroinflammatory responses 
(Section 1.4.4), the breath of the analysis performed in these studies was insufficient to 
determine whether these cells are in an activated, neuroinflammatory state. This would 
require an investigation into the expression of specific inflammatory markers, to indicate 
whether these cells are in an activated pro-inflammatory or anti-inflammatory state (see 
Chapter 7). 
In the present study, elevated levels of microglia/macrophages and astrocytes were 
present within the ischaemic lesion, 3 months after surgery. This is consistent with 
histological analysis of post-mortem stroke tissue has revealed that chronic elevation of 
glial and immune cells is still present in weeks to months after the initial injury (Mena et al. 
2004). Furthermore, Kristian Doyle and colleagues, who showed that markers for 
microglia/macrophages, phagocytes, antigen presentation, B cells and T cells were present 
in ischaemic lesions, 7 weeks after distal MCAO with hypoxia surgery in mice (Doyle et al. 
2015). In the present study, western blot analysis indicated that at 24 hours after MCAO 
there was only a trend towards increased microglia/macrophage and astrocytes levels in 
the leisoned striatum, whereas this was largely increased by 1 month, and the had reduced 
somewhat by 3 months. Although there was no overt genotype effects, there was 
indication that the levels of glial cells are slightly exaggerated in TgSwDI mice. 
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5.4.3.1 Microglia/macrophages  
Activated microglia/macrophages within ischemic lesions and the surrounding tissue are 
expected to play key roles in the pathophysiology (Mabuchi et al. 2000). In injured tissue 
these cells take on an ‘amoeboid’ morphology with larger cell bodies and thicker 
processes, which is associated with their activation state (Schilling et al. 2003). This type of 
morphology was observed in Iba1+ cells in the ischaemic lesions in the current study. Iba1 
is expressed by both microglia and macrophages, which is involved in phagocytosis 
(Ohsawa et al. 2000). Recent publications, however, have presented data indicating that 
microglia and macrophages have distinct roles in the ischaemic brain. By analysing other 
cell-specific markers, progress is being made in understanding the relative contribution of 
microglia and macrophages following focal ischaemia, especially at acute time-points. A 
previous study using flow cytometry to investigate neuroinflammation in rats after 
thromboembolic MCAO, differentiated between microglia and macrophages by their 
expression of CD11bmedium/CD45low and CD11bmedium/CD45high, respectively (Lehmann et al. 
2014). They found that at 24 hours post-surgery, there was an increase of infiltrated 
macrophages into the lesioned hemisphere, however, there was no difference in the 
number of microglia compared to the contralateral hemisphere. Microglial increase in the 
ipsilateral hemisphere may be delayed compared to the increase in macrophages. Rajan et 
al. found an increase in ipsilateral microglial numbers between 1 and 3 days, with an even 
greater elevation at 7 days post-MCAO in the ipsilateral hemisphere (Rajan et al. 2018). 
Additional studies agree that there is a large increase in microglial numbers in the 
ischaemic hemisphere between 3 and 7 days post-MCAO; whilst infiltrated macrophage 
numbers increase but the levels are still much lower than microglia (Wattananit et al. 
2016; Zarruk et al. 2017; Yoon et al. 2018). The present study did not find a significant 
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difference in Iba1 protein levels between the ipsilateral and contralateral striatum, 
however, there does appear to be a slight increase in the group average for the lesioned 
hemispsheres. This could indicate that a small increase in the microglia/macrophage levels 
has occurred in the lesioned striatum at 24 hours, and may have been further elevated 
over the following week, which would be consistent with the studies described (Rajan et al. 
2018; Yoon et al. 2018; Zarruk et al. 2017; Wattananit et al. 2016). 
There is a growing body of research indicating that microglia and macrophages have 
complex, injury-specific activation states, rather than expressing either M1 or M2 
activation states. A study using single-cell RNA sequencing analysis found at least nine 
transcriptionally distinct microglial states (Hammond et al. 2019). Moreover, these states 
can express pro-inflammatory and anti-inflammatory proteins, and change with injury 
progression. Zarruk and colleagues showed that mRNA levels for the pro-inflammatory 
cytokine TNF-α was highly expressed in ipsilateral microglia at 3 and 7 days after 
permanent MCAO, whereas its expression in macrophages was very low by comparison 
(Zarruk et al. 2017). A number of studies propose that whilst microglia have a pro-
inflammatory phenotype following focal ischaemia, infiltrating macrophages are expressing 
anti-inflammatory and wound-healing properties (Rajan et al. 2018; Benakis et al. 2015). 
This theory is supported by observations that at 3 days post-MCAO, ipsilateral 
macrophages expressed significantly higher levels of Arg-1 and YkI40 genes, which code for 
Arginase-1 and Chitinase-3-like protein 1 (CHI3L1), compared to microglia (Rajan et al. 
2018). Arginiase-1 is an enzyme needed in the process of catalysing L-arginine into 
polyamines and L-proline, which are needed for cell growth, especially smooth muscle 
cells, and for collagen synthesis (Durante et al. 2007). CHI3L1 is thought to have anti-
inflammatory effects, as when its knocked-out the mice had greater levels of microgliosis 
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and astrogliosis in a traumatic brain injury model (Wiley et al. 2015). In another study, 
however, analysis of the total RNA extracted from FACs- sorted cells taken 7 days after 
MCAO (30 minutes) in mice, showed that the distinction between pro-inflammatory and 
anti-inflammation function of microglia and macrophages was not clear-cut (Kronenberg et 
al. 2018). Although there was a trend towards microglia expressing genes with a pro-
inflammatory phenotype, and anti-inflammatory phenotype for macrophages, it did not 
show a dichotomous pattern and both cell types expressed genes involved in similar 
functions. Similarly, Rajan and colleagues found that infiltrated macrophages expressed 
higher levels of Nos2 gene than in microglia, indicating that they too can have some pro-
inflammatory function (Rajan et al. 2018).  
In the present study, Iba1 protein levels were significantly increased in the ipsilateral 
striatum at 1 month after MCAO in WT mice. Other studies that have found long-term 
elevation of microglia/macrophages after focal ischaemia, in the peri-lesional cortex at 14 
days (Kluge et al. 2017) and at 28 days (Jones et al. 2015), following photothrombotic 
occlusion. Whereas in another study, they showed an initial increase in macrophage 
numbers, which had decreased again by day 14 after MCAO (Wattananit et al. 2016). Taken 
together, these results may indicate that the levels of different glial and inflammatory cells 
peak at different times after ischaemia. Furthermore, variations in the surgical procedure 
used to induce ischaemia will impact the glial and inflammatory response; as shown by 
Zhou et al., who found higher levels of Iba1+ cells in permanent MCAO, compared to 30 
and 90 minutes of MCAO in mice (Zhou et al. 2013). Kluge et al. demonstrated that at 14 
days after photothrombotic occlusion, microglia-expressing Cx3R1-GFP in the peri-lesion 
were responsive to laser stimulation and colocalised with CD68 immunofluorescence, 
indicating that the cells were functional and were phagocytic (Kluge et al. 2017). CD68 was 
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also elevated at 1 month after photothrombotic occlusion in the peri-lesion cortices in 
another study (Jones et al. 2015). These studies indicate that microglia are phagocytic at 
sub-acute or chronic stage within the lesioned hemisphere. The evidence that microglia are 
involved in the removal of neural tissue and synapses through phagocytosis is discussed 
later on in this section. The current study used Iba1 as a marker of microglia and 
macrophages. Immunostaining with TMEM119, which is exclusively expressed by microglia, 
could be used to make the distinction between these cells types (Bennett et al. 2016; Satoh 
et al. 2016). Furthermore, in the present study the Iba1+ cells in lesion and peri-lesion the 
phenotypic state of the Iba1+ cells in the lesion and peri-lesion could be further 
characterised, to determine if they are phagocytic cells and have roles in clearing cellular 
debris (Kluge et al. 2017). Future developments of this work could be to use single-cell RNA 
sequencing to determine the activation state of Iba1+ cells in the lesion at acute, sub-acute 
and chronic time-points after focal ischaemia, and whether their phenotypes indicate 
detrimental or protective roles. 
The data from the current study showed a significant inverse correlation between PSD95 
%density and Iba1 %density in the lesion, indicating that a loss of excitatory postsynaptic 
terminals relates to an increase in microglia/macrophages. This result may demonstrate 
that the microglia/macrophage are a contributor to synaptic loss in the ischaemic lesion. 
Recently, there has been a recent growing body of literature focused on the interface 
between neuroinflammation and synapse function in heath and disease, and from this the 
term ‘synaptoimmunology’ has been coined (Nisticò et al. 2017). For example, pro-
inflammatory cytokines released during CNS injury have been shown to have an effect on 
synaptic function. TNFα was found to reduce synaptic excitability in rat hippocampal slices 
(Tancredi et al. 1992) and promote a decrease in surface AMPA-receptor units in the 
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striatum (Lewitus et al. 2014). Release of pro-inflammatory cytokines after ischaemic injury 
may contribute to further synapse silencing in nearby brain regions.  
Another theory that has been gaining more attention is that activated 
microglia/macrophages engulf synaptic terminals in disease conditions, known as ‘synaptic 
pruning or stripping’. Work by Beth Stevens and colleagues have indicated that this 
happens during development to refine neural networks (Stevens et al. 2007; Schafer et al. 
2012). More recently other groups have investigated synapse stripping in disease models. 
Hong et al. published a study showing high-resolution confocal imaging data showing 
Homer+ postsynaptic terminals colocalising with Iba1, in a way which it appears to be 
within the cell body, after intravenous injections of β-amyloid (Soyon Hong et al. 2016). 
Furthermore, this group and others have proposed that complement components are the 
inflammatory markers that mediate synaptic pruning by microglia. This is supported by 
observations by Hong et al. that complement component 1q (C1q) colocalised with PSD95+ 
terminals in mice with Aβ pathology (Hong et al. 2016). Deficits in complement component 
3 (C3) and C1q lead to less synapse loss after nerve injuries and faster recovery (Berg et al. 
2012; Norris et al. 2018). Furthermore, blocking C3 pathways in models of focal ischaemia 
and traumatic brain injury lead to a decrease of microgliosis and astrogliosis and an 
increase in neuronal/synaptic structures (Alawieh et al. 2015; Alawieh et al. 2018). 
Preliminary data from the present study indicated that PSD95:eGFP+ terminals were co-
localised with TMEM119+ microglia within the ischaemia lesion, which would support the 
theory of synaptic stripping in disease (Rajendran & Paolicelli 2018) Colocalisation of 
microglia and synaptic terminals may also represent engulfment of debris rather then 
stripping active synaptic terminals. A recent study demonstrated that high-resolution 
microscopy was needed to sensitively show if pruning occurs. The authors proposed that 
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microglia do not engulf postsynaptic terminals, but rather ‘nibble’ them (Weinhard et al. 
2018). To further investigate whether synaptic pruning occurs in an ischaemic lesion, high-
resolution microscopy techniques are needed to determine whether the synaptic terminals 
are within the microglial cells. 
The present study did not find a significant effect of TgSwDIAPP expression on the densities 
of Iba1+ cells in the lesion or peri-lesion, nor was there significant differences in the Iba1 
protein levels. This was an unexpected finding, as previous research has shown an 
exaggerated immune response in the primary lesion of animals with both focal ischaemia 
and β-amyloid pathology compared to ischaemia alone (Amtul et al. 2015). We predicted 
that TgSwDIAPP expression would prime the microglia/macrophages, and so caused an 
exaggerated glial response after MCAO surgery, as described in Section 6.4.2. However, the 
analysis of Iba1 %density in the sham animals showed that there was no difference in the 
levels of microglia/macrophages WT and TgSwDI mice without MCAO surgery. This 
indicated that heterozygous TgSwDIAPP expression does not stimulate increased 
microglia/macrophage density in the striatum, in 9-month-old animals. It is known that β-
amyloid stimulates activation of glial and immune cells (Section 1.4.4), however, previous 
analysis by Xu et al. showed that the striatum of both heterozygous and homozygous 
TgSwDI mice is largely spared of β-amyloid deposition (Xu et al. 2007). Therefore, 
TgSwDIAPP expression may not impact the density of Iba1+ cells in either sham or MCAO 
mice, as β-amyloid deposition in the striatum in limited. 
5.4.3.2 Astrocytes 
Astrocytes are also known to respond quickly to ischaemia and hypoxia (Angelova et al. 
2015). During normal physiological conditions, they have small cell bodies with many fine 
processes and occupy their own distinct space within the tissue. On activation, however, 
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their morphology becomes hypertrophic, with thickened processes and increased 
expression of intermediate filament proteins, such GFAP and Vimentin. The degree of 
astrocyte activation is dependent on the severity of the stimulus, therefore, large injuries 
will result in glial scar formed from overlapping astrocytes with microglia and pericytes 
(Sofroniew 2009; Pekny et al. 2018). The GFAP+ astrocytes in the lesions and peri-lesions 
had a morphology that may indicate an activated state, compared to the cells in the 
contralateral striatum with faint processes. 
The current study found no significant differences in GFAP proteins levels between 
ipsilateral and contralateral striatum at 24 hours after MCAO. This result is consistent with 
a recent publication showing no activated astrocytes in the striatum at 24 hours after 
MCAO (30 minutes), whilst there clear clustering of GFAP+ cells at 48 hours (Buscemi et al. 
2019). In the present study, the protein levels of GFAP were greatly increased in the 
ipsilateral striatum at 1 month after MCAO. Similar results were published by Yoon et al., 
who found a large elevation of astrocytes in the lesioned hemisphere at 1 month after 
MCAO (2 hours) in rats; whilst the astrocytic levels were low at the other time point 
measured, between 0 hours and 7 days after surgery (Yoon et al. 2018). At 3 months after 
MCAO, the GFAP protein levels had appeared to decrease again, and there was only a 
significant increase in the ipsilateral striatum of TgSwDI mice, although there was also a 
trend towards an increase in WT mice as well. The histological analysis also shows that an 
astrocytic response remains prominent in the ipsilateral striatum at 3 months after 
surgery. This result indicates that whilst the reactive astrocyte levels in the ipsilateral 
striatum have decreased between 1 and 3 months, there is still a long-lasting response in 
the lesion and peri-lesion. 
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An interesting finding in our histological cohort was that whilst Iba1+ cells were only 
elevated within the lesion, GFAP+ cells were increased in the lesion and peri-lesion. 
Previously, research has indicated that reactive astrocytes are more prominent in the peri-
lesion than microglia/macrophages. A histological study investigating spatio-temporal glial 
responses following 30 minutes MCAO in mice, found that by 1 week GFAP+ cells clustered 
in the peri-lesion, but were largely absent from the lesion, whereas the Iba1+ cells were 
elevated throughout the lesion (Buscemi et al. 2019). Another study, by Yoon et al. showed 
a delayed increase in astrocytes in the border of an infarct, 1 month after 2 hours MCAO 
(Yoon et al. 2018). In the current study, the astrocytes were overlapping throughout the 
lesion rather than clustering around the edge. These discrepancies may be explained by 
the fact that the lesions in the present study were not infarcts, but were lesions of diffuse 
and selective neuronal loss. The heighted levels of astrocytes in the present study may act 
like a glial scar to protect the surrounding healthy tissue (Sofroniew 2015). 
There is evidence that astrocytes play different roles at the different stages after focal 
ischaemia. As previously mentioned, upregulation of intermediate filament proteins, GFAP 
and Vimentin, is a hallmark of reactive astrocytes. In a model of neurotrauma, knock out 
mice GFAP-/-Vim-/- had significantly less synaptic complexes after injury compared to WT 
mice at 4 days after injury, whereas at 14 days they had more synapse complexes 
(Wilhelmsson 2004). In that model, astrogliosis had neuroprotective effects at the acute 
stages after injury, whilst being detrimental later on. GFAP-/-Vim-/- mice were more recently 
used in a study of focal ischaemia with cortical photothrombosis (Liu et al. 2014), which 
showed an impairment in motor function 3-28 days after surgery, and shorter corticospinal 
tract axons in the spinal cord, compared to WT mice. In this study, therefore, astrogliosis 
appeared to protect neuronal recovery throughout the disease process. The authors 
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proposed that GFAP-/-Vim-/- mice had attenuated glial scar formation, preventing 
containment of neurotoxic compounds from diffusing into healthy tissue. 
Reactive astrocytes may have other neuroprotective activities following focal ischaemia. 
Lin et al. propose that astrocytes mediate long-term post-ischaemic neuronal survival and 
repair (Lin et al. 2016). This study demonstrated that blocking the action of IL-17A, either 
with a knock out mouse or a specific antibody, lead to a reduction in new neuronal cells 
and in levels for presynaptic proteins, SNAP25 and synaptophysin, in the ischaemic 
striatum, 35 days after 60 minutes MCAO. They also showed that mRNA and protein levels 
of IL-17A have two peaks after ischaemia, one at 3 days and another smaller one at 28 
days. When using an antibody to neutralise IL-17A activity, they treated the mice with it 
from 14 days after MCAO in order to inhibit the second peak. This demonstrated that 
delayed IL-17A increase had neuroprotective function, which they suggest occurs though 
promoting the migration and survival of neural progenitor cells (Lin et al. 2016). They 
found that astrocytes cultured from the damaged brains colocalise with IL-17A 
immunoreactivity on activation, although other inflammatory cells in the brain may release 
IL-17A. γδ-T cells have been shown to contribute to acute tissue damage by IL-17A release 
after ischaemia, likely by promoting the recruitment of neutrophils (Gelderblom et al. 
2012).  
Another method by which astrocytes may promote neuronal recovery after ischaemia is 
through the secretion of thrombospondins. Knock out mice of thrombospondin 1 and 2 
have been found to have reduced synaptophsyin and PSD95 levels, and reduced axon 
sprouting, in the peri-lesion at 28 days after focal ischaemia (Liauw et al. 2008). These 
results support that hypothesis that thrombospondins facilitate axon sprouting and 
synaptogenesis by interactions with the extracellular matrix (Christopherson et al. 2005). 
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Furthermore, peri-synaptic astrocyte processes have been found to physically contact 
synaptic terminals, where they may promote stability of synapses (Bernardinelli et al. 
2014; Carmona et al. 2009). In the present study, the large increase in GFAP protein levels 
in the ipsilateral striatum could be involved in promoting neuronal recovery at this time-
point, although it did not coincide with an increase in VGLUT1 and PSD95 protein levels. 
The current study could be developed to investigate whether astrocytes are participate in 
synaptogenesis in the peri-lesion, 3 months after MCAO, with detected 
immunohistochemistry markers for axonal plasticity GAP43, astrocytes GFAP, and 
endogenous PSD95:eGFP. Additional exploration could be conducted into whether 
thrombospondins or epthrin signalling is involved, as previously suggested (Carmona et al. 
2009; Overman et al. 2012; Liauw et al. 2008).  
Recently there was been advancements in understanding the complexities of reactive 
astrocyte transcriptome in different injuries, similarly to microglia (Liddelow & Barres 
2017). Rakers et al. used RiboTag to isolate and sequence astrocyte-specific mRNAs at 72 
hours post-tMCAO, and found that the astrocytes were expressing genes associated with 
neuroprotection and neurotoxicity (Rakers et al. 2019). Among the genes upregulation was 
Stat3 (Signal transducer and actor of transcription 3), which is involved in IL-6/JAK/STAT3 
pathway leading to cytokine production. The researchers made an astrocyte-specific 
conditional Stat3 knockout mouse, and found that this had smaller ischaemic lesions than 
WT mice following tMCAO (Rakers et al. 2019). Moreover, there is evidence that activated 
microglia may induce a neurotoxic phenotype in astrocytes (Liddelow et al. 2017), 
therefore, astrocytic transcriptome may be influenced by the chronic neuroinflammation 
following ischaemia. Future development of the present study would be to use techniques 
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to elucidate the astrocyte transcriptome at acute, sub-acute and chronic following MCAO, 
and to determine whether they have more neurotoxic or neuroprotective functions. 
In the present study, there was an implication that the GFAP protein levels were increased 
in the ipsilateral striatum of TgSwDI mice, and not WT mice, although there was no overt 
genotype effect. As previously discussed, the expectation was that TgSwDIAPP expression 
would prime the glial cells, and MCAO surgery would lead to an exaggerated response of 
microglia/macrophages and astrocytes in these animals (discussed in Section 6.4.3). The 
evidence indicates that TgSwDIAPP expression did cause a small increase in astrocyte 
levels, therefore, a future development of this study could be to determine if there is a 
genotype-effect on the astrocytic transcriptomes. TgSwDIAPP expression may stimulate 
different post-ischemic phenotypes in astrocytes compared to in WT mice, which may 
affect their functions. 
5.4.4 Conclusions 
This study demonstrated that brief focal ischaemia lead to long-term neuronal and axonal 
pathology, degeneration of glutamatergic pre- and postsynaptic terminals, and chronic glial 
responses within the lesion territory. Moreover, the levels of microglia/macrophages were 
inversely related to postsynaptic loss, implying that these cells may have roles in synaptic 
degeneration post-ischaemia. Although there were no overt genotype effects, there was 
an indication the TgSwDIAPP expression caused greater presynaptic degeneration in the 
peri-lesion and higher astrocyte levels in the lesioned striatum. The implication of this 
study is that focal ischaemia causes more pathological changes than human mutated APP 
expression.  
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Chapter 6:  The long-term impact of focal ischaemia 
and concurrent TgSwDIAPP expression on 
glutamatergic synapses and glial responses in 
connected brain regions 
6.1 Introduction 
The results in the previous chapter demonstrated that focal ischaemia leads to long-term 
degeneration of neurons, axons and glutamatergic synaptic terminals within the lesion 
territory, which coincided with elevated levels of microglia/macrophages and astrocytes. 
Contrary to the initial hypothesis, these changes were mostly unaffected by the expression 
of TgSwDIAPP, although there was indication of greater astrocyte elevation in TgSwDI 
mice. There is a growing appreciation for the impact of secondary neurodegenerative 
changes following a focal ischaemic injury. Evidence in humans and rodent models have 
revealed that neurodegeneration can occur spreading from the primary injury site to 
remote brain regions it connects with, known as diachisis (J. Zhang et al. 2012; Abe et al. 
2003; Nakane et al. 1992; Winter et al. 2015). Neuroimaging of patients with lesions in the 
striatum have also shown development of neuropathology in the substantia nigra and 
thalamus at later stages (Nakane et al. 1992). Both of these brain regions are in circuits 
with the striatum, as part of the motor network. The schematic diagram in Figure 1.7 
shows this network in a mouse brain: inhibitory neurons project from the striatum to the 
substantia nigra pars reticulata (SNR) in the direct pathway, whilst inhibitory and excitatory 
projections connect the striatum, globus pallidus (GPe) and subthalamic nucleus (STN) and 
SNR, which projects back to the thalamus (Benarroch 2016). These projections run through 
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the internal capsule white matter tract (Reinius et al. 2015). In the present study, 
secondary neurodegeneration and glial responses were investigated in the internal 
capsule, SNR and thalamus. 
There is a gap in the literature as to whether concurrent β-amyloid pathology worsens 
secondary neurodegeneration and glial responses after focal ischaemia. Nguyen et al. 
found that distal MCAO in WT mice lead to neuropathology in remote brain regions of just 
the ipsilateral hemisphere, whilst pathology changes were found in both hemispheres in a 
TgAβPP mouse (Nguyen et al. 2018). The present study sought to determine whether focal 
ischaemia resulted in neurodegeneration and glial responses in remote regions through 
diachisis, and whether these changes were exaggerated in TgSwDI mice.  
6.1.1 Hypothesis 
Focal ischaemia leads to long-term degeneration of glutamatergic synaptic terminals and 
axons in remote brain regions by diachisis, coinciding with chronic glial responses, 
culminating in progressive functional decline. In cases with concurrent β-amyloid, 
secondary neurodegeneration and glial responses is exacerbated, causing worsened 
functional decline. 
6.1.2 Aims 
The aim of this study was to determine whether transient MCAO causes long-term 
degeneration of axons and glutamatergic synaptic terminals in remote brain regions that 
connect with the striatum, and whether this is related to the extent of cellular 
inflammation. Further, we aimed to elucidate whether these changes are exaggerated in 
TgSwDI mice.  
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6.2 Materials and Methods 
6.2.1 Animals, surgery and tissue collection 
The tissue used in the present study was from the same mice used in Chapter 5. The 
animals, surgery and tissue collection procedures were all according to Sections 5.2.1, 5.2.2 
and 5.2.4.  
6.2.2 Detection of axonal pathology 
Axonal bulbs were detected in the internal capsule and SNR, in tissue sections from -
2.06mm and -.2.92mm from bregma. Immunohistochemistry for APP was performed on 
this tissue as previously described Section 5.2.6. 
6.2.2.1 Analysis in the internal capsule 
The APP+ axon bulbs were counted in the ipsilateral and contralateral internal capsule and 
normalised to the area of this structure, using the cell counter plugin on ImageJ. The 
density of APP+ axon bulbs was compared between the hemispheres and genotypes using 
two-way ANOVA.  
6.2.2.2 Analysis in the SNR 
The APP+ axon bulb density was very high in the SNR, therefore, it was not possible to 
count the individual bulbs. Instead the %density of bulbs was measured using a threshold 
to cover the positive staining. The ipsilateral SNR was delineated from the cresyl violet 
imaged and superimposed on to the images of APP immunostained sections. As the SNR 
constantly appeared to be smaller on the ipsilateral side, likely due to atrophy, the 
ipsilateral ROI was used to measure the density on the contralateral side as well. The 
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%density of APP+ axon bulbs was compared between the hemispheres and genotypes 
using two-way ANOVA.  
6.2.3 Detection of glutamatergic synaptic terminals in the SNR and thalamus. 
6.2.3.1 Analysis in the SNR 
Postsynaptic terminals were visualised by PSD95:eGFP signal in the SNR using slide scanner 
microscopy, see Section 5.2.7. The %density was measured as previously described in 
Section 5.2.9.1, within a ROI delineated from the ipsilateral SNR, as used in 6.2.2.2. The 
same ROI’s were used to measure the signal on the ipsilateral and contralateral 
hemispheres.  
6.2.3.2 Analysis in the thalamus 
Glutamatergic pre- and postsynaptic terminals were detected in the thalamus using 
immunohistochemistry of VGLUT1 and slide scanner microscopy, see Section 5.2.7. As 
before, the %density of this signal was measured in ImageJ with a threshold. The regions of 
interest were the VPM and VPL thalamic nuclei, which had been delineated from images of 
the cresyl violet sections, similar to in Section 5.2.9.1. The %density of PSD95 and VGLUT1 
was compared between the hemispheres and genotypes using two-way ANOVA.  
6.2.4 Detection of microglia/macrophages and astrocytes 
In additional sections taken from 2.06mm and -.2.92mm from bregma, 
immunohistochemistry was used to detect Iba1+ and GFAP+ cells, as in Section 5.2.8. The 
%density of these signals were analysed using the same method as in 5.2.9.1., within the 
ROIs: internal capsule, SNR, VPM and VPL, which were delineated from slide scanner 
images of cresyl violet stained sections. The ROI’s for the SNR were taken from the 
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ipsilateral hemisphere and flipped for analysis on the contralateral hemisphere. For the 
other regions, the areas were delineated from both hemispheres in the cresyl violet 
images. The %densities of Iba1 and GFAP were compared between the hemispheres and 
genotypes using two-way ANOVA. 
6.2.5 Detection of β-amyloid deposits 
Sections from -2.06mm from bregma were taken from TgSwDI mice, 3 months after either 
MCAO or sham surgery. Detection of β-amyloid was undertaken with 
immunohistochemistry of 6E10, according to Section 2.6.3.1. As before, the %density of 
the stain was measured with a threshold, in the ROIs delineated from the contralateral and 
ipsilateral VPM and VPL from the cresyl violet sections of each mouse.  
6.2.6 Statistical analysis 
The density for each marker, in each brain, was compared between with two-way ANOVA, 
with surgery and genotype as factors. Post-hoc analysis was performed with Bonferroni’s 
multiple comparison test. Spearman’s rank correlation was used to determine relationships 
between the densities of the markers. For all analysis, p < 0.05 was considered to be 
statistically significant. 
6.3 Results 
The previous chapter had demonstrated that MCAO surgery induces long-term 
glutamatergic synaptic loss and chronic glial responses in the striatum. In this chapter 
sought to determine whether MCAO surgery results in secondary axon and glutamatergic 
synaptic loss, plus chronic glial responses, in these connected brain regions by diaschisis, 
and this is exacerbated by TgSwDIAPP expression. Therefore, pathological changes were 
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investigated in the regions that connect with the striatum: internal capsule, SNR and 
thalamus.  
6.3.1 MCAO lead to long-term secondary neurodegeneration in the internal 
capsule and substantia nigra, but not the thalamus, and with no genotype 
effect. 
6.3.1.1 Internal capsule 
The first aim of the study was to investigate the pathological changes in the internal 
capsule, the white matter tract which connects the striatum and substantia nigra. As 
before, APP immunohistochemistry was used to analyse the levels of axon degeneration in 
this region. The results in the previous chapter had shown that there is axon pathology in 
the internal capsule, however, this was done by measuring the volume of tissue containing 
axon bulbs. Here, the number of axon bulbs was counted and normalised to the area of the 
internal capsule, for a more sensitive measurement of axon pathology (Figure 6.1A). 
Statistical analysis with two-way ANOVA demonstrated that there was a significant surgery 
effect (F(1,20) = 24.47, p < 0.0001), with no genotype effect (F(1,20) = 0.382, p = 0.544) and 
no interaction (F(1,20) = 0.0985, p = 0.757) (Figure 6.1B). Post-hoc analysis revealed that 
there was an increase in the density of axonal bulbs in the ipsilateral internal capsule of 
both WT and TgSwDI mice. This finding indicated that a focal ischaemic lesion in the 
striatum caused secondary neurodegeneration leading to axon degeneration in the internal 
capsule, which was not exacerbated in TgSwDI mice.  
6.3.1.2 Substantia nigra 
The striatum projects to the substantia nigra through direct and indirect pathways (Figure 
1.7). The axon bulb densities were measured in the ipsilateral and contralateral SNR of WT 
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Figure 6.1 MCAO leads to long-term axonal degeneration in the ipsilateral internal capsule. 
(A) APP immunohistochemistry used to detect axonal bulbs in the internal capsule. (B) There 
was significantly higher density of axonal bulbs in the ipsilateral internal capsule compared to 
the contralateral, in both WT and TgSwDI mice. Data presented as mean ± SD, n = 5,7 per 
group. Two-way ANOVA with Bonferroni’s multiple comparison test. **/ *p<0.05. Scale bar = 
50μm.  
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and TgSwDI mice, 3 months after MCAO. There were many more axon bulbs in the 
ipsilateral SNR compared to the internal capsule, and the bulbs often clustered together, 
making it difficult to count them individually. The %density of APP+ bulbs, therefore, was 
used to measure the level of axon degeneration in the SNR. The region of the ipsilateral SNR 
was delineated from the cresyl violet stained sections. As the ipsilateral SNR consistently 
looked smaller than the contralateral SNR, the region of interest for the ipsilateral side was 
also used for the contralateral side when the image was flipped horizontally. This method 
of analysis was also used for measuring the %density of PSD95, Iba1 and GFAP. There was a 
significant surgery effect on APP+ axon bulbs %density in the ipsilateral SNR (F (1,20) = 
23.44, p < 0.0001), but there was no genotype effect (F (1,20) = 0.0059, p = 0.940) and no 
interaction (F (1,20) = 0.556, p = 0.465) (Figure 6.2B). Post-hoc analysis showed that 
increase in axon bulb density was increased in both the WT and TgSwDI ipsilateral SNR. 
Next, the density of postsynaptic terminals in the SNR was analysed to determine whether 
there was an impact of MCAO surgery and TgAPP expression (Figure 6.3A). There was a 
significant surgery effect, reducing PSD95 %density in the ipsilateral SNR (F (1, 20) = 24.12, 
p < 0.0001), with no genotype effect (F (1, 20) = 1.346, p = 0.260) and no interaction (F (1, 
20) = 0.0761, p = 0.786) (Figure 6.3B). Bonferroni’s multiple analysis showed that the 
significant reduction of PSD95 %density in the ipsilateral SNR of WT and TgSwDI mice. 
Taken together, MCAO resulted in long-term axon and glutamateric postsynaptic terminals 
in the ipsilateral SNR, however, there was no exaggeration in TgSwDI mice.  
6.3.1.3 Thalamus 
In the striatonigral pathway, glutamatergic transmission projects from the SNR to the 
thalamus (Figure 1.7). Thalamic nuclei, the ventral posteromedial (VPM) nucleus and the 
ventral posterolateral (VPL) nucleus, have been shown to be vulnerable to secondary  
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Figure 6.2 MCAO lead to long-term axonal degeneration in the ipsilateral SNR. (A) APP 
immunohistochemistry used to detect axonal bulbs in the SNR. (B) There was significantly 
higher density of axonal bulbs in the ipsilateral SNR compared to the contralateral, in both 
WT and TgSwDI mice. Data presented as mean ± SD, n = 5,7 per group. Two-way ANOVA 
with Bonferroni’s multiple comparison test. **/ *p<0.05. Scale bar = 50μm.  
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neurodegeneration following permanent MCAO (Abe et al. 2003). The thalamus is also a 
prominent region for β-amyloid pathology in TgSwDI mice (Davis et al. 2004). Thus, the 
impact of focal ischaemia and TgSwDIAPP expression on pre- and postsynaptic terminals in 
the thalamus was investigated. As before, the cresyl violet stained sections were used to 
delineate the regions of the VPM and VPL on the ipsilateral and contralateral hemispheres, 
and the regions were superimposed onto the sections stained for VGLUT1 and PSD95 
(Figure 6.4A). 
VGLUT1 %density in the VPM was not affected by surgery (F (1, 22) = 1.900, p = 0.182) or 
genotype (F (1, 22) = 0.944, p = 0.342), and no there was no interaction between them (F 
(1, 22) = 0.592, p = 0.450) (Figure 6.4B). Similarly, there was no effect of surgery (F (1, 22) = 
1.747, p = 0.200) or genotype (F (1, 22) = 0.394, p = 0.537) of VGLUT1 %density in VPL, and 
no interaction (F (1, 22) = 0.295, p = 0.592) (Figure 6.4C).  
The %density of PSD95 was measured using the same method as for VGLUT1. This analysis 
revealed that there was a significant increase in PSD95 %density in the VPM with surgery (F 
(1, 22) = 24.11, p < 0.0001), however, there was no genotype effect (F (1, 22) = 0.329, p = 
0.572) and no interaction (F (1, 22) = 0.329, p = 0.572) (Figure 6.4D). Post-hoc analysis 
showed that PSD95 %density was increased in the ipsilateral VPM of both WT and TgSwDI 
mice. In the VPL, the two-way ANOVA revealed that there was an overall surgery effect on 
the PSD95% density in the ipsilateral hemisphere (F(1, 22) = 5.46, p = 0.0289), but no 
genotype effect (F(1, 22) = 0.543, p = 0.469) and no interaction (F(1, 22) = 0.215, p = 0.647) 
(Figure 6.4E). Although there was an overall surgery effect, Bonferroni’s multiple 
comparison test did not find a significant difference between the hemispheres of either WT 
or TgSwDI mice. Overall, there was no difference in the density of glutamatergic 
presynaptic terminals in either thalamic nuclei, however, there was evidence that focal  
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ischaemia stimulated an increase in postsynaptic terminals in the ipsilateral VPM thalamus, 
with no genotype effect. 
6.3.2 MCAO leads to long-term glial responses in remote brain regions, with an 
exaggerated effect in the internal capsule and thalamus of TgSwDI mice 
6.3.2.1 Internal capsule 
Chronic glial responses have been linked with white matter disruption, as previously found 
in models of hypoperfusion from our lab (Kitamura et al. 2017; Coltman et al. 2011). The 
next question to address in this study, therefore, was whether chronic glial responses 
occurred in the internal capsule after focal ischaemia in the striatum, and whether there is 
a differential effect between WT and TgSwDI mice. The density of microglia/macrophages 
was detected with immunohistochemistry analysis for Iba1 (Figure 6.5A). The regions of 
the internal capsule were delineated from the cresyl violet stained sections and the Iba1 
%density was measured in these regions. There was a significant surgery effect (F(1, 22) = 
119.8, p < 0.0001) and genotype effect (F(1, 22) = 10.42, p = 0.0039) increasing Iba1 
%density in the ipsilateral internal capsule, although there was no interaction (F(1, 22) = 
0.842, p = 0.369) (Figure 6.5B). Bonferroni’s multiple comparisons test showed that there 
was a significant Iba1% density increase in the ipsilateral internal capsule compared to the 
contralateral hemisphere; and a greater increase in the TgSwDI ipsilateral internal capsule 
compared to the WT.  
The density of astrocytes was also analysed with GFAP immunohistochemistry in 
neighbouring coronal sections from the same mice (Figure 6.5C). There was a surgery 




GFAP %density (Figure 6.5D), with an interaction between the factors (F(1, 22) = 0.0766, p 
= 0.785). Bonferroni’s multiple comparison test revealed that GFAP %density is increased in 
the ipsilateral internal capsule in both WT and TgSwDI mice, plus there was a greater 
increase in both hemispheres of TgSwDI mice compared to the WT. Taken together, these 
results indicate that focal ischaemic injury in the striatum leads to long-term chronic 
elevation of microglia/macrophages and astrocytes in the internal capsule, and concurrent 
TgSwDIAPP expression causes a greater increase in neuroinflammation as compared to 
WT.  
To determine whether there is a relationship between the density of degenerated axons 
and microglia/macrophages and astrocytes in the ipsilateral internal capsule, the densities 
of axon bulbs were plotted against Iba1 and GFAP %densities and analysed with Spearman 
rank. There was no correlation between axon bulb density with the densities of Iba1 (r = 
0.2098, p = 0.5137) (Figure 6.5E), or GFAP (r = 0.03497, p = 0.921) (Figure 6.5F). The levels 
of microglia/macrophages and astrocytes do not directly relate to the density of 
degenerating axons in the internal capsule. 
Figure 6.5 MCAO lead to chronic increases in microglia/macrophage and astrocyte levels 
in the ipsilateral internal capsule, which were exaggerated in TgSwDI mice. (A) Iba1 
immunohistochemistry used to detect microglia/macrophages in the internal capsule. (B) 
There was an increase in Iba1 %density in the ipsilateral internal capsule compared to the 
contralateral, with an even greater increase in the TgSwDI mice. (C) GFAP 
immunohistochemistry used to detect astrocytes in the internal capsule. (D) There was an 
increase in GFAP %density in the ipsilateral internal capsule, with exaggerated GFAP 
%densities in both hemispheres of TgSwDI mice, compared to WT. (E) There was no 
relationship between the densities of axon bulbs and microglia/macrophages in the 
ipsilateral internal capsule. (F) Similarly, there was no relationship with the densities of 
axon bulbs and astrocytes in the ipsilateral internal capsule. Data presented as mean ± SD, 
n = 6,7 per group. Two-way ANOVA with Bonferroni’s multiple comparison 
test.****p<0.0001. **/*p = 0.05. Scale bar = 200μm.  
256 
6.3.2.2 Substantia nigra 
The next stage of this study was to determine whether chronic glial responses occurred 
within the SNR following MCAO and whether it is exacerbated in TgSwDI mice. As before, 
microglia/macrophage were detected with Iba1 immunohistochemistry (Figure 6.6A). 
Iba1% density was significantly increased with surgery (F(1,22) = 17.29, p = 0.0004), 
although there was no genotype effect (F(1,22) = 0.421, p = 0.523) and no interaction 
(F(1,22) = 2.122, P = 0.159) (Figure 6.6B). Bonferroni’s multiple comparisons test showed 
that there was an increase in Iba1% density in the ipsilateral SNR in WT mice only. Next, the 
astrocyte levels were analysed in the SNR (Figure 6.6C). There was an effect of surgery on 
the GFAP %densities in the SNR (F(1, 22) = 155.5, p < 0.0001), but there was no effect of 
(F(1, 22) = 1.055, p = 0.315) and no interaction (F(1, 22) = 0.113, p = 0.740) (Figure 6.6D). 
There was a significant increase in the astrocyte levels in the ipsilateral SNR in both WT and 
TgSwDI mice. Taken together, these results demonstrate that focal ischaemic injury in the 
striatum results in chronic neuroinflammation in the SNR and concurrent TgSwDI 
expression does not cause an exaggerated response.  
The density of axon bulbs was plotted against the densities of microglia/macrophage and 
astrocytes, to determine whether there is a relationship between axon degeneration and 
glial cells in the ipsilateral SNR. APP+ axon bulb %density did not correlate with Iba1 
%density (r = 0.1189, P = 0.716) or GFAP %density (r = 0.5245, P = 0.0839) (Figure 6.6E,F). 
This indicates that in the ipsilateral SNR long-term axon degeneration is either a cause or 







Next, the chronic glial responses were investigated in the VPM and VPL thalamic nuclei 
(Figure 6.7). There was a significant effect of genotype in the VPM Iba1 %density (F(1, 22) = 
10.51, p = 0.0037), whilst there was a trend towards a surgery effect, although it did not 
reach significance (F(1, 22) = 3.975, p = 0.0593) and no interaction (F(1, 22) = 0.166, p = 
0.688) (Figure 6.7B). Bonferroni’s multiple comparison test showed that there was an 
increase in Iba1 %density in the ipsilateral VPM in TgSwDI mice, compared to the ipsilateral 
VPM of WT mice. In the VPL, there was a genotype effect on the Iba1 %densities (F(1, 22) = 
8.881, p = 0.0068), whereas there was no effect of surgery (F(1, 22) = 2.959, p = 0.0037) 
and no interaction (F(1, 22) = 0.853, p = 0.338) (Figure 6.7C). Post-hoc analysis showed that 
there was an increase in Iba1 %density in the ipsilateral VPL of TgSwDI, compared to the 
ipsilateral VPL of WT mice. Taken together, this analysis revealed that there was a trend 
towards an increase in the microglia/macrophage levels in the thalamus of the lesioned 
hemisphere, however, there was an exaggerated increase in the TgSwDI mice.   
 
Figure 6.6 MCAO lead to chronic microglia/macrophage and astrocyte levels in the 
ipsilateral SNR. (A) Iba1 immunohistochemistry used to detect microglia/macrophages. (B) 
Iba1 %density was significantly increased in the ipsilateral SNR, compared to contralateral, 
in WT mice only. (C) GFAP immunohistochemistry to detect astrocytes. (D) GFAP %density 
was elevated in the ipsilateral SNR, compared to contralateral, in both genotypes. (E) Iba1 
%density did not correlate with the APPs+ axon bulbs %density in the ipsilateral SNR. (F) 
Similarly, there was no relationship with the densities of axon bulbs and astrocytes in the 
ipsilateral SNR. Data presented as mean ± SD, n = 6,7 per group. Two-way ANOVA with 





Next, the levels of astrocytes were measured in the same thalamic regions and compared 
between the ipsilateral and contralateral hemispheres, and between the genotypes. In the 
VPM, there was a significant effect of genotype (F (1, 22) = 9.128, p = 0.0063) and almost a 
significant effect of surgery (F (1, 22) = 4.177, p = 0.0531), with no interaction (F (1, 22) = 
3.718, p = 0.0668) (Figure 5.7D). Bonferroni’s multiple comparison test showed that there 
was a greater GFAP %density in the ipsilateral VPM of TgSwDI mice, compared to the 
ipsilateral VPM of WT mice. Although it did not quite reach significance, there appears to 
be a trend towards an increase in GFAP %density in the ipsilateral VPM compared to the 
contralateral in TgSwDI. The GFAP %densities were also measured in the VPL. There was a 
significant genotype effect (F (1, 22) = 8.852, p = 0.007) and significant surgery effect (F (1, 
22) = 6.415, p = 0.0.019), although there was no significant interaction (F (1, 22) = 8.852, p 
= 0.007) (Figure 5.7E). Bonferroni’s multiple comparisons test found that there was a 
significant increase in the GFAP %densities between the ipsilateral VPL of TgSwDI mice and 
the WT; plus there was a significant increase between the ipsilateral and contralateral VPL 
of TgSwDI mice. Overall, this analysis showed that focal ischaemia leads to a trend of 
increased reactive astrocyte levels in the ipsilateral thalamus, which is exaggerated in 
TgSwDI mice.  
Figure 6.7 Microglia/macrophage and astrocytes densities increased in the TgSwDI VPM and 
VPL, compared to WT mice. (A) Iba1 and GFAP immunohistochemistry. Iba1 %density 
increased in the TgSwDI ipsilateral (B) VPM and (C) VPL, compared to the ipsilateral VPM and 
VPL in WT mice, with no significant surgery effect. GFAP %density increased in the TgSwDI 
ipsilateral (D) VPM and (E) VPL, with greater GFAP %density in TgSwDI ipsilateral VPL 
compared to contralateral VPL. Data presented as mean ± SD, n = 6,7 per group. Scale bar = 
1mm, insert 200μm. Two-way ANOVA with Bonferroni’s multiple comparison test. **p<0.05. 
Scale bar = 1mm, insert 200μm.  
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Taken together, these results demonstrate that TgSwDI mice have chronic elevated levels 
glial cells in the ipsilateral thalamus, 3 months after MCAO surgery. Plus, there was a trend 
towards an increase in microglia/macrophages and astrocytes in the ipsilateral 
hemispheres compared to the contralateral, however, the changes were mostly too small 
to reach statistical significance. The densities of Iba1 or GFAP did not correlate with the 
densities of VGLUT1 or PSD95 (data not shown), indicating that the levels of these 
neuroinflammatory cells were not related to the small increases observed in the synaptic 
terminals levels.  
6.3.3 β-amyloid levels in TgSwDI mice were unchanged with MCAO surgery  
As there was a genotype effect on chronic neuroinflammation in the ipsilateral thalamus of 
TgSwDI, the next stage in the investigation was to determine whether there was a surgery 
effect on β-amyloid levels in TgSwDI mice after sham or MCAO surgery. β-amyloid burden 
was detected with 6E10 immunohistochemistry, which could be observed as small, diffuse 
deposits mainly in the thalamus (Figure 5.8A). The %density of the β-amyloid deposits was 
measured in the VPM and VPL of TgSwDI mice 3 months after either sham or MCAO 
surgery. The results showed that there were no significant differences between the VPM 
hemispheres (F (1, 22) = 2.221, p = 0.154); no significant differences between sham and 
MCAO mice (F (1, 22) = 1.491, p = 0.238); and no interaction (F (1, 22) = 0.113, p = 0.741) 
(Figure 5.8B,C). The results showed that the β-amyloid deposits in these animals was small 
and highly varied; plus MCAO did not cause an increase β-amyloid deposition in either the 
ipsilateral or contralateral hemispheres. β-amyloid %density did not correlate with the 
%density of Iba1 or GFAP (data not shown), indicating that the increase of 
microglia/macrophages and astrocytes in TgSwDI mice is not directly related to the burden 
of β-amyloid deposits.  
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Figure 6.8 β-amyloid burden was unchanged in the VPM and VPL of TgSwDI mice 
after MCAO or sham surgery. (A) 6E10 immunohistochemistry detection of β-
amyloid. No differences in β-amyloid burden in the (B) VPM or (C) VPL of either 
hemispheres after sham or MCAO surgery. Data presented as mean ± SD, n = 5,6 
per group. Scale bar = 1mm, insert 200μm. Two-way ANOVA. 
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6.4 Discussion  
Overall, this study demonstrated that focal ischaemia lead to secondary 
neurodegeneration and chronic glial responses in remote brain regions connected to the 
primary lesion site. There was evidence of increased axon degeneration in the ipsilateral 
internal capsule, plus axon and glutamatergic postsynaptic terminals in the ipsilateral SNR. 
Plus, there was an increased density of PSD95+ postsynaptic terminals in the ipsilateral 
thalamus. These brain regions also had elevated levels of microglia/macrophages and 
reactive astrocytes. An important finding was that in TgSwDI mice there were higher levels 
of glial cell levels in the ipsilateral internal capsule and thalamus, compared to WT mice. 
Understanding secondary neurodegenerative changes following focal ischaemia is 
important, as it has been proposed that worsening of functional outcome after stroke is a 
consequence of delayed damage in these remote brain regions (Zhang et al. 2012). These 
brain regions are connected in the nigrostriatal pathway, which is part of the motor, limbic 
and cognitive systems (Groenewegen 2003), therefore, degeneration in this pathway 
would be expected to cause disruption of a number of brain functions. 
6.4.1 Focal ischaemia resulted in long-term secondary neurodegeneration  
The present study found a significant increase in axon bulbs in the ipsilateral internal 
capsule, which is the white matter tract that connects the striatum and the SNR. White 
matter damage is a common pathological feature of stroke injury. On average, 95% of 
ischaemic stroke patients have white matter injury, and around 50% of the ischaemia 
processes involve the white matter (Ho et al. 2005). The present study focused on whether 
there was a greater density of axon bulbs in the ipsilateral internal capsule compared to 
the contralateral. There may, however, be other changes in the white matter, such as 
demyelination, loss of axon-glia integrity and reduced conductance of the tract, which will 
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affect the function of the nigrostriatal pathway. An interesting study by Weishaupt et al. 
showed that secondary neurodegeneration after prefrontal ischaemia resulted in 
Fluorojade-B+ axon degeneration and elevated numbers of Iba1+ cells in the internal 
capsule, however, there were no differences in the levels of myelin basic protein (MBP) in 
this region (Weishaupt et al. 2016). This study may indicate that secondary 
neurodegeneration occurs through the axons and demyelination is not a contributor to this 
process. A development of the current study could be to investigate whether there is a 
reduction in the myelin sheath in the ipsilateral internal capsule sheath, and whether this is 
exaggerated in TgSwDI mice; by immunohistochemistry detection of MBP, or myelin 
associated glycoprotein (MAG) which is normally expressed in the peri-axonal regions of 
oligodendrocytes and will only be expressed with white matter disruption, as previously 
shown by our group (Coltman et al. 2011). In the present study, there was no genotype 
effect on the density of axon bulbs in the internal capsule, which is surprising as evidence 
that β-amyloid can be damaging to axons (Lambert et al. 1998), and is toxic to 
oligodendrocytes (Xu et al. 2001). Plus, diffusion tensor imaging has shown disruption of 
white matter tracts in mice with injected β-amyloid (Sun et al. 2014). In the present study, 
there was a clear exaggeration of neuroinflammatory cells in the TgSwDI mice. It may be 
that whilst the density of axon bulbs is indistinguishable between WT and TgSwDI mice, the 
exacerbated neuroinflammatory response in TgSwDI mice may cause degeneration of 
oligodendrocytes, demyelination and worsened white matter conductance, as discussed 
later.  
The present study showed neurodegenerative changes in the SNR, as there was a 
significant increase in the density of axon bulbs and a significant loss in the density of 
glutamatergic postsynaptic terminals. Previous publications have found that secondary 
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changes occur in the SNR after MCAO surgery in rodents. Permanent MCAO in rats resulted 
in neurodegeneration and gliosis in the ipsilateral SNR at 14 days after surgery (Nakanishi et 
al. 1997; Tamura et al. 1990). Furthermore, significant losses of neurons have been found 
in the ipsilateral SNR of mice starting at 7 days after 30 minutes of MCAO, whereas there 
was no significant loss of nigral neurons at 4 days post-surgery (Prinz et al. 2015). In the 
current study, neuronal and synaptic degeneration in the ipsilateral substantia nigra was 
observed after 3 months following 15 minutes of MCAO and although it is unclear when 
these changes occurred, results from other studies would suggest that nigral degeneration 
occurred at a time earlier than the three months endpoint.  
The mechanism by which secondary neurodegeneration of the nigrostriatal pathway 
occurs remains unclear. A theory is that secondary neurodegeneration occurs via trans-
synaptic retrograde degeneration, as neuronal damage occurs through neuronal networks, 
rather than spreading to adjacent brain regions. A recent in vitro study investigated how 
neurodegeneration can spread trans-synaptically between cortical and striatal neurons in a 
microfluidic chamber (Deleglise et al. 2018). They found that when the cortical neurons 
were damaged with either axotomy or chemical hypoxia, this resulted in blebbing of axons 
and dendrites. Furthermore, they demonstrated that blocking NMDA-receptor activity 
alleviated the damage (Deleglise et al. 2018). Evidence presented in previous studies has 
also shown that blocking NMDA-receptor activity can reduce the effects of secondary 
neurodegeneration (Prinz et al. 2015). The activity of NMDA-receptors appears to have a 
key role in secondary neurodegeneration of the substantia nigra after MCAO. At the site of 
the primary ischaemic injury, energy depletion leading to ion imbalance causes the 
neurons to become excitotoxic and to release excessive amounts of glutamate into the 
synaptic cleft. Glutamate then binds and over-activates the NMDA-receptors to the next 
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neuron in the circuit, causing the large influxes of calcium ions and stimulating degradative 
processes (Lai et al. 2014). Over time, this process may continue to progress from the 
primary ischaemic core, along the nigrostriatal pathway, resulting in axon degeneration in 
the internal capsule and SNR. A number of studies have found that blocking NMDA-
receptor activity alleviates secondary degeneration in rodent models. Prinz et al. 
demonstrated that treating mice with MK801 after MCAO alleviated long-term neuronal 
loss in the ipsilateral substantia nigra (Prinz et al. 2015).  
The current study focused on investigating the loss of excitatory postsynaptic terminals 
and axon pathology in the substantia nigra. VGLUT1, which was used as a marker to detect 
glutamatergic presynaptic terminals in the striatum and thalamus, is not expressed in the 
substantia nigra, however, its isoform VGLUT2 is and could be used to further study the 
impact of focal ischaemia on presynaptic terminals in this region (Fremeau et al. 2001). 
As discussed in the previous chapter, focal ischaemic injury can stimulate some neuronal 
recovery. There is evidence that recovery and rewiring can occur between brain regions 
that were previously disconnected. A study using confocal microscopy showed cells in the 
ipsilateral striatum that had colocalising signals for NeuN-immunoreactivity, BrdU for DNA 
synthesis and fluorogold which had been injected into the substantia nigra, 12 weeks after 
MCAO in rats (Sun et al. 2012). The authors suggest that this shows that at 12 weeks post-
surgery, new striatal cells have formed in the ischaemic hemisphere, which have grown 
new projections with the cells in the substantia nigra. The paper shows images with these 
markers at 2 and 9 weeks post-MCAO, when these markers do not all colocalise (Sun et al. 
2012). Although this study lacks numerical quantification of these changes, it does appear 
to show some neural rewiring between the striatum and substantia nigra after MCAO 
surgery. A development of the present study could be to determine the extent of neural 
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rewiring in the substantia nigra and striatum 3 months following MCAO in mice, and 
determine whether there is a differential effect between WT and TgSwDI mice. As 
previously discussed, GAP34 is a marker of axonal sprouting and is commonly used to 
determine regions of synaptic plasticity and rewiring following ischaemia (Frey et al. 2000). 
Conducting this analysis at multiple time-points would enable us to gain insight into the 
temporal progression of secondary neurodegeneration and recovery in this model. 
The current study did not show a differential effect in synaptic degeneration in the 
substantia nigra between WT and TgSwDI mice. As previously discussed, there is a body of 
evidence indicating that β-amyloid is synaptotoxic (Section 1.7.2). The literature indicates 
that soluble oligomeric β-amyloid is the main toxic form, and the levels of soluble β-
amyloid are very low in TgSwDI (Xu et al. 2007). The use of a mouse model with high levels 
of soluble oligomeric β-amyloid, such as APP E693Δ (Tomiyama et al. 2010), may have 
induced exaggerated synaptic loss following focal ischaemia. 
The thalamus received GABAergic afferents from the SNR and sends glutamatergic 
efferents to the striatum (Figure 1.7), therefore, it is another brain region that may 
undergo secondary changes following focal ischaemia in the striatum. The densities of 
glutamatergic VGLUT1+ pre- and PSD95+ postsynaptic terminals were analysed in the 
ventral posteromedial (VPM) and ventral posterolateral (VPL) thalamic nuclei, as these 
regions are important for sending motor and sensory function (Yamawaki & Shepherd 
2015). Moreover, these are the regions where β-amyloid deposition occurs most 
prominently in TgSwDI mice (Xu et al. 2007). Despite this, there was no genotype effect on 
the %densities of VGLUT1 or PSD95 in the VPM or VPL, which further indicates that 
glutamatergic synaptic terminals are resilient to the expression of TgSwDIAPP. An 
interesting finding, however, was the increase of PSD95 %density in the ipsilateral VPM 
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compared to the contralateral for both genotypes. There also appeared to be a trend 
towards an increase in the PSD95 %density in the ipsilateral VPL, although these did not 
reach statistical significance. The thalamus has previously been shown to have the 
potential for synaptogenesis following focal ischaemia, as treadmill training after transient 
MCAO in rats resulted in increased synaptophysin protein levels in the ipsilateral thalamus, 
compared to the contralateral thalamus and the no exercise groups (Seo et al. 2010). As 
previously discussed, the present study could be developed to determine the extent of 
neural rewiring in brain regions connected to the striatum and to determine whether there 
is a differential effect between WT and TgSwDI mice, by investigating changes in GAP43 
immunostaining, or the colocalisation of NeuN-immunoreactivity and BrdU signal.   
Overall, this study showed that brief focal ischaemia leads to long-term secondary 
neurodegeneration, as there was significant axon degeneration in the ipsilateral internal 
capsule, plus axon degeneration and glutamatergic postsynaptic loss in the ipsilateral SNR. 
In addition, there was evidence of synaptogenesis, with an increase in PSD95+ postsynaptic 
terminals in the ipsilateral thalamus. TgSwDIAPP expression did not exacerbate the 
changes caused by focal ischaemia, indicating that they are resilient to β-amyloid 
pathology associated with this transgenic model.  
6.4.2 Focal ischaemia lead to chronic glial responses in remote brain regions, 
with exaggerated levels in the ipsilateral internal capsule and thalamus. 
The present study showed that focal ischaemia induces a long-term elevation of 
microglia/macrophage and reactive astrocyte levels in the ipsilateral internal capsule, 
which was exaggerated in TgSwDI mice. This is consistent with previous findings that focal 
ischaemia can induce an increase in Iba1+ cells in the ipsilateral internal capsule 
(Weishaupt et al. 2016). Chronic glial and inflammatory responses are associated with 
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white matter injury in many CNS diseases. Previous work conducted by our group has 
demonstrated that the density of Iba1+ cells in the corpus callosum correlated with the 
extent of functional impairment of this white matter tract in a model of chronic cerebral 
hypoperfusion (Kitamura et al. 2017). Furthermore, treatment with anti-inflammatory 
drug, minocycline, reduced the functional impairment and microgliosis in the same model 
(Manso et al. 2018), and reduced white matter damage after transient MCAO in rats 
(Faheem et al. 2019). As previously discussed, microglia have roles in ‘mopping-up’ myelin 
debris, however, repressing the phagocytic activation state may lead to impairment in this 
function and promote further toxicity (Lloyd et al. 2017). 
A particularly interesting result in this study was that the chronic neuroinflammatory was 
exaggerated in TgSwDI mice after focal ischaemia. Previous studies have found an 
association between Alzheimer’s pathology and white matter neuroinflammation. Positron 
emission tomography (PET) neuroimaging has been used to show that the levels of 
activated microglia in the internal capsule is increased in Alzheimer’s patients compared to 
control subjects (Suridjan et al. 2015). Moreover, there was indication that the levels of 
activated microglia inversely related to visuospatial function, which implies that glial 
activation in the white matter has a role in functional decline. This exaggerated immune 
response in the TgSwDI mice may be a result of ‘primed’ or ‘sensitised’ glia. Based on 
evidence described below, it has been proposed that chronic or repeated activation of 
microglia and astrocytes sensitises them and leads to an exaggerated immune response on 
subsequent stimulation. Research conducted by Cunningham and colleagues demonstrated 
that microglia and astrocytes are primed in the ME7 neurodegenerative prion disease 
model, and lead to exacerbated inflammation when subsequently challenged with LPS-
induced systemic inflammation (Cunningham et al. 2005), or cytokine administration into 
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the brain (Hennessy et al. 2015). Furthermore, Krstic et al. demonstrated that when WT 
mice are subjected to a prenatal systemic immune challenge and an additional one during 
adulthood, it results in microglial and astrocytic activation with β-amyloid and tau 
pathology; which was comparable to the pathology in a TgAPP model (Krstic et al. 2012). 
There is also evidence that an exaggerated glial responses occurs in the brains of Tg2576 
mice after LPS-induced systemic inflammation (Sly et al. 2001). In the present study, 
therefore, expression of TgSwDIAPP the resulting β-amyloid production may sensitise the 
microglia and astrocytes in the internal capsule, leading to an exaggerated 
neuroinflammatory response on focal ischaemia induction.   
The present study found no relationship between the densities of glial cells and axon bulbs 
in the ipsilateral internal capsule. Furthermore, whilst there was increased 
neuroinflammation in the internal capsule of TgSwDI mice, there was no genotype effect 
on the density of axon bulbs in this region. Together, this indicates that glial responses in 
the internal capsule are not directly related to the axon degeneration in this region. Glial 
responses may contribute to white matter injury by different mechanisms, such as 
disruption of the axon-glia interface and loss of white matter integrity. Previous work 
conducted by our group found that global chronic hypoperfusion leads to disruption of 
axon-glia interface in the corpus callosum, which appears to coincide with an increase in 
Iba1+ cells (Manso et al. 2018). This axon-glia interface is the organisation of myelin fibres 
into separate domains (node of Ranvier, paranode and juxtaparanode), which are required 
for efficient action potentiation propagation (Babbs & Shi 2013). Loss of axon-glia integrity, 
therefore, may contribute to the propagation of secondary neuronal dysfunction and 
degeneration through the internal capsule after focal ischaemia. Manos et al. also showed 
that there was a complete overlap between Iba1+ cells and microglia-specific marker 
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TMEM119 in the hypoperfused corpus callosum (Manso et al. 2018), therefore, we can 
speculate that Iba1+ cells in the ipsilateral internal capsule are also microglia. The white 
matter microglia may be causing disruption of the axon-glial interface by adopting a pro-
inflammatory activation state. Another group found that in a hypoperfusion model that the 
phagocyte marker, CD68, and other pro-inflammatory markers, were elevated in the white 
matter (Qin et al. 2017). Furthermore, CD68 expression was shown to be higher in white 
matter than grey matter of human stroke tissue (Zrzavy et al. 2017). The increased 
expression of CD68 may represent an activation of microglia to phagocytosis myelin debris. 
Reactive astrocytes may also partake in disruption of white matter integrity, through 
activation of the pro-inflammatory NF-κB pathway (Saggu et al. 2016a). As discussed in the 
previous chapter, the use of single-cell RNS sequencing has enabled huge advancements to 
be made in understanding the complex activation states of microglia/macrophages and 
astrocytes in injury. Future developments of the present study could be to use these 
techniques to elucidate the transcriptomes of these cells in the white matter, to determine 
whether they express neuroprotective or neurotoxic signals, and whether there is a 
phenotypic difference between those from WT and TgSwDI mice.  
The present study showed that focal ischaemia induced chronic glial responses in the 
ipsilateral SNR. Although the increase in Iba1 %density in the ipsilateral SNR only reached 
significance in the WT mice, there was a trend towards a significant increase in the 
ipsilateral SNR of TgSwDI mice. A recent neuroimaging study in humans used MRI to analyse 
the iron concentration (R* signal), which is rich in microglia and macrophages, and 
released from dying neurons. They found that the found higher R* signals in the ipsilateral 
substantia nigra at one year after the baseline recording, implying that chronic glial 
responses and dying neurons were present in this brain region long after the initial lesion 
272 
(Linck et al. 2019). Another study investigated the neuroinflammatory response in the SNR 
following 45 minutes of MCAO in mice, and found that at 24 hours after reperfusion there 
was already significant increases in immunostaining for GFAP, CD45, ICAM1 and Iba1 in the 
ipsilateral striatum (Rodriguez-Grande et al. 2013). Importantly, there were no significant 
losses of neurons in the ipsilateral SNR at this time-point, therefore, this study showed that 
elevated neuroinflammation had preceded neurodegeneration.   
Other publications have found evidence of chronic glial responses in regions of diachisis, 
such as in the ipsilateral thalamus following photothrombosis in the cortex. In a study using 
the photothrombotic occlusion model, 28 days after surgery there were elevated levels of 
Iba1+ cells in the ipsilateral thalamus (Jones et al. 2015). More recently, the same group 
reported that microglia/macrophages in the ipsilateral thalamus have an activated 
morphology (Kluge et al. 2017). They went further to investigate the functionality of these 
cells, by characterising their motility and protein expression. Whilst 
microglia/macrophages in the peri-lesional cortex were motile and responded to laser 
stimulation from 3-56 days post-stroke, they were non-responsive in the thalamus, starting 
at day 7 (Kluge et al. 2018). Long-term increase in MHC-II and CD68, which are needed for 
antigen presentation and debris clearance, in the ipsilateral thalamus (Kluge et al. 2018), 
whilst they consistently found a chronic decrease of P2Y12 compared to the contralateral 
thalamus (Kluge et al. 2017; 2018; 2018). Microglial P2Y12 has been implicated to be 
involved in cell motility and synaptic plasticity (Sipe et al. 2016), therefore, its reduction 
here may be representative of a shift to debris clearance functions. They also found that 
protein levels of activated astrocytic GFAP and S100B are increased in the ipsilateral 
thalamus (Kluge et al. 2018). An interesting finding in this paper was that they compared 
the protein levels measured in the thalamus of young and old mice 28 days after 
273 
photothrombosis, and found that whilst glial and inflammatory protein changes occurred 
in young and old mice, the loss of synaptic proteins only occurred in old animals. These 
findings may indicate that the microglia/macrophages and astrocytes in the ipsilateral SNR 
have a pro-inflammatory phenotype, and a development of the present study could be to 
characterise the functional state of these cells.  
In the present study there was a trend towards a positive correlation between with the 
density of APP+ bulbs and GFAP immunostaining in the ipsilateral SNR, although this did not 
reach statistical significance. This may suggest a relationship between the levels of 
astrocytes and the extent of axon degeneration in this region. Previous reports have found 
that elevated of GFAP+ astrocytes occurs in the ipsilateral SNR, which gradually increased 
from 1 to 4 weeks after surgery, whilst the density of intact neurons gradually decreased 
over the same time period after dMCAO (Wang et al. 2012). This paper also shows that 
axon sprouting marker GAP-43 and dendritic MAP2 are decreased in the ipsilateral SNR. 
Interestingly, they found oligodendrocytic Nogo-A is associated with secondary 
neurodegeneration, as blocking it promoted neural recovery and reduced astrogliosis 
(Wang et al. 2012). This is supported by observations that blocking Nogo receptor 1 in a 
model of white matter stroke leads to improved oligodendrogenesis and white matter 
repair (Sozmen et al. 2016). Another proposed mechanism for secondary 
neurodegeneration after focal ischaemia is the disruption of neuronal lysosomes and 
release of proteases. A recent study found that CathB, which is released from perforated 
lysosomes, was increased in the ipsilateral SNR as early at 1 week after distal MCAO (Zuo et 
al. 2018). They also show that blocking CathB reduces substantia nigral neurodegeneration 
and astrogliosis. Collectively, these studies may imply that reducing microgliosis and 
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astrocytosis in the substantia nigra may prevent secondary neurodegeneration in this 
region, and promote neural repair. 
The present study showed that TgSwDIAPP expression exaggerated the glial responses in 
the internal capsule, whilst having no significant effect on glial responses in the SNR. This 
may result from glial cells being more sensitive in the white matter than grey matter 
regions, based on evidence that there were more microglia and macrophages in the white 
matter than the grey matter in human stroke tissue (Zrzavy et al. 2017). Furthermore, 
white matter astrocytes have been shown to be more sensitive than their grey matter 
counterparts to oxygen-glucose deprivation, although this study was conducted in 
neonatal tissue and the relative sensitivity of these cells could be different in adulthood 
(Shannon et al. 2007). Taken together, the results imply microglia/macrophages and 
astrocytes in the internal capsule are particularly vulnerable to ischaemia and TgSwDIAPP 
expression.  
The levels of glial cells were analysed in the thalamus to determine the impact of focal 
ischaemia and TgSwDIAPP expression in this region. There was a trend towards a surgery 
effect increasing the density of microglia/macrophages and reactive astrocytes in the VPM 
and VPL thalamic nuclei, which did reach a significant increase in reactive astrocyte levels 
in the ipsilateral VPL of TgSwDI mice compared to their contralateral hemispheres. 
Moreover, there was evidence for exaggerated levels of microglia/macrophages and 
reactive astrocytes in the ipsilateral thalamus of TgSwDI compared to that of the WT mice. 
This result may indicate that TgSwDIAPP expression caused glial priming, which is 
exacerbated in the ipsilateral thalamus following focal ischaemia, as discussed above.  
Previous publications have shown that the thalamus is the main site of β-amyloid 
deposition in the TgSwDI line (Xu et al. 2007). Glial cells cluster around β-amyloid deposits, 
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in order to phagocytose them (Serrano-Pozo et al. 2011). The next stage of the study, 
therefore, was to investigate whether the elevated levels of glial cells in the ipsilateral 
thalamus of TgSwDI mice was the result of increase β-amyloid deposition after MCAO 
surgery. 
6.4.3 Focal ischaemia did not result in increased thalamic β-amyloid burden in 
TgSwDI mice. 
Contrary to previous publications, which have reported that focal ischaemia induces an 
increase in β-amyloid deposition (Groen et al. 2005; Mäkinen et al. 2008; Zhang et al. 2011; 
Garcia-Alloza et al. 2011; Nguyen et al. 2018; Kluge et al. 2018), no alterations in β-amyloid 
were found in the current study between TgSwDI mice after sham or MCAO surgery. These 
publications cited here may have found increased β-amyloid deposition with focal 
ischaemia as a result of severer surgical models or higher baseline β-amyloid production. 
Greon et al. found an increase in APP and β-amyloid immunoreactivity in the thalamus of 
Wistar rats 9 months after 2 hours of MCAO (Groen et al. 2005), whilst Zhang et al. showed 
that permanent distal MCAO lead to β-amyloid deposition in the ipsilateral thalamus of 
stroke-prone hypertensive rats (Zhang et al. 2011). These studies indicate that severe focal 
ischaemia in rats can induce production of β-amyloid, despite a lack of human mutated 
APP transgene expression. Moreover, Kluge et al. demonstrated that cortical 
photothrombosis resulted in elevated protein levels of β-amyloid oligomers in the 
thalamus of aged C57BL/6J mice, compared to sham control and young mice (Kluge et al. 
2018), which indicates that age increases their vulnerability to β-amyloid production. 
APPSwe:PS1dE9 transgenic mouse model was used by Garcia-Alloza et al., who found an 
increase in the burden of dense-core amyloid plaques in the ipsilateral hemisphere 7 days 
after 1 hour of distal MCAO (Garcia-Alloza et al. 2011). Nguyen et al. demonstrated that 
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permanent distal MCAO plus hypoxia (DH stroke model), induced greater deposition of 
Aβ42 and dense-core plaques in aged Thy1-hAPPLond/Swe mice (Nguyen et al. 2018). Both of 
these transgenic mouse lines have more aggressive β-amyloid pathology than TgSwDI, as 
they produce amyloid dense core plaques (Rockenstein et al. 2001; Minkeviciene et al. 
2008). Moreover, the focal ischaemia models used are more severe than in the present 
study as the duration of occlusion is longer. Taken together, the reason for a lack of 
surgery effect on the β-amyloid deposition is likely a result of brief occlusion time and 
relatively modest baseline β-amyloid production. 
Another explanation could be that the method used for detecting β-amyloid changes lacks 
sensitivity. 6E10 immunostaining detects all types of insoluble β-amyloid and APP deposits 
(Portelius et al. 2009), however, there may have been changes in the soluble pools of β-
amyloid. An improved method would be to use an ELISA to quantify the total levels of Aβ40 
and Aβ42 in soluble and insoluble fractions in the ipsilateral thalamus of TgSwDI mice after 
either sham or MCAO surgery. This approach was previously used by our group to 
determine the effect of cerebral hypoperfusion on specific β-amyloid pools (Salvadores et 
al. 2017). Collectively, the results demonstrated that β-amyloid burden was low and 
unaffected by MCAO surgery, indicating that TgSwDIAPP expression and focal ischaemia 
resulted in exaggerated glial responses even in the absence of wide-spread plaque 
deposition. 
6.4.4 Conclusions 
The present study demonstrated that focal ischaemia lead to long-term neurodegeneration 
and glial responses in brain regions that are connected with the primary lesion site. 
Concurrent expression of TgSwDIAPP lead to exaggerated glial responses in the internal 
capsule and thalamus. The implications of this study are the focal ischaemia leads to long-
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term global glial responses, which can be exacerbated by additional disease comorbidities. 
Future developments should focus on further characterising the chronic glial responses in 






Chapter 7:  Discussion and Conclusions 
7.1 Summary 
The studies presented in this thesis demonstrate that whilst modest chronic cerebral blood 
flow does not induce degeneration of glutamatergic synaptic terminals, brief focal 
ischaemia causes long-term glutamatergic synaptic loss in the primary lesion site and in 
distal, connected brain regions. These changes were found to coincide with chronic 
elevated levels of microglia/macrophages and astrocytes. These findings further confirm 
that focal brain lesions result in global pathological changes. Contrary to our predictions, 
the expression of TgSwDIAPP transgene did not result in overt worsening of synapse 
degeneration following focal ischaemia. It did, however, induce higher levels of 
microglia/macrophages and astrocytes in distal brain regions, which supports the 
prediction that multiple disease comorbidities can lead to exaggerated global glial 
responses. 
7.2 Implications and future directions 
Evidence presented in this thesis, and the publications discussed, demonstrate that focal 
ischaemic lesions can cause downstream secondary pathology in connected brain regions. 
Moreover, studies of patients with transient ischaemic attack and stroke have indicated 
that delayed atrophy in brain regions distal to the lesion sites are associated with cognitive 
deficits (Bivard et al. 2018; Diao et al. 2017). The implications of these studies are that 
secondary neurodegeneration following a focal ischaemic lesion are related to delayed 
cognitive decline, and preventing secondary neurodegeneration would be beneficial for 
alleviating cognitive impairment. Moreover, the data from this thesis and other rodent 
studies, showed that there are chronic glial responses in regions of secondary 
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neurodegeneration. Rodriguez-Grande et al. found that MCAO caused an increase in 
neuroinflammatory markers in the ipsilateral substantia nigra before neuronal loss 
occurred in this region (Rodriguez-Grande et al. 2013). Additionally, patient studies have 
revealed that elevated levels of several plasma inflammatory markers, such as IL-6, IL-12 
and C-reactive protein, are associated with risk of post-stroke dementia (Rothenburg et al. 
2010; Narasimhalu et al. 2015). Furthermore, a recent phase 2 trial investigated the 
therapeutic potential of a monoclonal antibody, called natalizumab, which binds to α-
integrin and inhibits leukocyte transmigration into the brain (Elkins et al. 2017). 
Natalizumab was administered 9 hours after ischaemic stroke onset, resulting in improved 
cognition and other functions by 3 months, compared to the placebo group, although 
infarct size was unchanged. Taken together, these studies imply that therapeutic 
intervention targeted to prevent post-stroke global neuroinflammation will reduce 
secondary neurodegeneration and cognitive decline. 
An important finding in the present studies was that expression of TgSwDIAPP exaggerated 
post-ischaemic glial cell levels in some brain regions. This supports the hypothesis that 
multiple disease comorbidities lead to worsened pathological changes. As discussed, the 
present studies focused on quantifying the density of glial cells, Iba+ 
microglia/macrophages and GFAP+ astrocytes. Future studies should elucidate the 
transcriptome of these cells to determine whether they are expressing pro-inflammatory 
or anti-inflammatory markers, and how additional comorbidities affect the post-ischaemic 
response. It may be that multiple comorbidities induce more neurotoxic phenotypes than 
ischaemia alone. The present study focused on the effect of concurrent TgSwDIAPP 
expression, however, there are many disease comorbidities associated with CVD and VCI. 
Old-age is associated with greater incidence of CVD and is the strongest risk factor for the 
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development of dementia. Moreover, rodent studies have revealed that focal ischaemia in 
aged animals results in exacerbated secondary synaptic and neurodegeneration (Kluge et 
al. 2018; Nguyen et al. 2018), and inflammatory signalling (Thammisetty et al. 2018). 
Future research should focus on interrogating the effect of different disease comorbidities 
with reduced CBF, to determine their effect on synaptic and neuronal degeneration, 
neuroinflammation and function outcome. 
Collectively, the data presented in this thesis and the literature discussed confirms the 
damaging effects reduced CBF has on the brain, and supports the importance of 
cerebrovascular health. Moreover, it emphasises the need for understanding glial 
activation and chronic neuroinflammation in conditions of reduced CBF, and how it may 
contribute to synaptic degeneration and cognitive decline. Finally, this thesis shows the 
importance of further gaining insight into how activated microglia and astrocytes can 
support recovery processes after brain injuries, and whether therapeutic intervention 
targeted at reducing glial responses and neuroinflammation, and promoting synaptic and 
neuronal restoration can be achieved.  
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Chapter 8:  Appendix 
8.1 Presentations 
 3 Minute Thesis presentation, ARUK Scotland PhD student meeting, Oct 2015 
 Presentation for CCACE PhD Student meeting, Edinburgh, Nov 2016 
 Poster Presentation at ARUK conference, Aberdeen, March 2017 
 3 Minute Thesis presentation, ARUK Scotland network retreat, Sept 2017 
 Poster Presentation at DRI launch event, Edinburgh, April 2018 
 
8.2 Public engagement workshops 
 ‘Drawing the Mind’ workshop on neuroanatomy for the ASCUS Lab, EISF, April 2017 
 Featured scientist at ASCUS Lab Open Session, July 2017 
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